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ABSTRACT 
The potential value of biocatalysts across a range of fields is substantial but not fully realised. 
This is due to shortcomings in both the inherent properties of enzymes, and in our 
understanding of how to engineer and design improved versions of the molecules we find in 
nature. The work presented in this thesis aims to address these shortcomings via two distinct 
approaches:  
First, I aim to do this by studying the molecular evolution of enzyme function, particularly in 
relation to protein dynamics and mutational epistasis. The intersection of these concepts is 
poorly understood and could be particularly relevant to the design and construction of novel 
biocatalysts. To investigate the role of dynamics and epistasis in the process of molecular 
evolution, three laboratory directed evolution experiments were investigated; the evolution of 
bacterial phosphotriesterase (PTE) towards the hydrolysis of a promiscuous arylester substrate 
2-naphthylhexanoate (2NH), (R0 to R22); the ‘reverse’ evolution of this final variant towards
phosphotriesterase activity (R22/Rev0 to NeoPTE/Rev12); and a constrained evolution, 
incorporating a non-ideal initial substitution into PTE and evolving for enhanced hydrolysis 
with 2NH, (S1 to S8). X-ray crystal structures of a number of these evolutionary intermediates, 
endpoints, and rationally designed variants together comprise a substantial dataset that can 
reveal structural and dynamic changes that underpin the functional changes observed 
throughout the various evolutions. In the initial R0 to R22 trajectory, it was determined that 
unproductive conformational sub-states were ‘frozen out’ throughout the experiment; motions 
valuable in the catalysis of the native phosphotriester substrate were eliminated through 
intramolecular hydrogen bonding and electrostatic networks. In the reverse trajectory (Rev0 to 
NeoPTE), the effects of an ‘epistatic ratchet’ were observed; the reacquisition of native activity 
occurred via a distinct genetic pathway, although reached a similar phenotype. This implies 
inherent epistatic restrictions in the reversal of an evolutionary trajectory. In the third trajectory, 
S1 to S8, the incorporation of an initial non-ideal substitution resulted in the evolutionary 
pathway reaching a distinct fitness peak, both genotypically and phenotypically. The 
constraints placed on the evolutionary trajectory through the initial substitution were 
substantial. The changes in dynamics throughout this trajectory were significantly different 
from those observed in the original R0 to R22 experiment, indicating evolution’s capacity to 
find multiple solutions to the same problem. These observations could prove valuable in future 
engineering efforts; tuning of protein conformational sampling to optimize a particular function 
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appears to be possible, and these observations could aid in the continued application of this 
method of engineering.  
The second methodology investigated in this thesis is that of enzyme immobilization and the 
engineering of functional materials. The application of enzymes in chemical synthesis, 
environmental bioremediation and medicine is limited by their longevity and stability towards 
organic solvents. In order to address these natural shortcomings of biocatalysts, proteins can 
be immobilized. Numerous immobilization techniques exist, and each has its own advantages 
and deficits. For example, immobilization through covalent attachment is robust, but may 
require the use of harsh conditions for immobilization, and often the solid supports cannot be 
recycled. Ionic immobilization is a gentler alternative, but can result in undesirable ‘leaching’ 
of protein from the solid support. Incorporation into gel matrices can have similar 
shortcomings. To circumvent these deficits in immobilization techniques, it is possible to 
engineer enzymes to better suit the medium onto which they are to be immobilized. 
Additionally, the combination of ionic immobilization and gel entrapment though the use of a 
charged hydrogel as the chosen support can address the failings of each technique in isolation. 
Work in this thesis details the engineering of a ‘supercharged’ enzyme and its immobilization 
in anionic hydrogels. The enzyme:hydrogel complexes showed no loss of catalytic activity 
after 100 days of use and were resilient to methanol and ethylacetate. They were also 
successfully employed in the kinetic resolution of a racemic mixture of a phosphoester 
substrate in continuous flow. The use of enzyme:hydrogel complexes is likely to be of value in 
a diverse range of applications such as enantioselective continuous-flow chemistry, 
detoxification of poisons, and the formation of functionalized biomaterials. 
Through the combination of these two distinct strategies – fundamental research of evolution 
of novel function, and application-driven production of biomaterials – our understanding of 
biocatalysts and their applications is expanded. Developing engineering strategies that mimic 
nature’s precise adjustment of protein dynamics, and combining the powerful catalysts that 
result with novel materials, will open avenues of catalysis that can be readily applied to 
medicine, environmentally-friendly syntheses, and large scale industrial processes. Our 
reliance on harsh chemical techniques is unsustainable, and biocatalysis represents an 
environmentally responsible future.  
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CHAPTER 1:  
EVOLUTION AND ENGINEERING - BROADENING THE APPLICATION 
AND UNDERSTANDING OF BIOCATALYSIS 
1
PART 1 
1.1 Directed Evolution 
The evolution of organisms is caused by evolution at a molecular level. Cumulative changes in 
genotype are selected for by the fitness of the corresponding phenotype in response to a survival 
pressure. By this mechanism, populations are enriched with phenotypes better adapted to their 
environments, propagating the valuable genotype. The results of this are biocatalysts that are, 
in some cases, so finely tuned to their roles that they are limited only by the rate of diffusion 
of substrates into and out of their active sites. To exploit the power of these catalysts in industry, 
synthesis, and medicine by modifying or engineering improved traits, the mechanisms of 
molecular evolution must be deeply understood. 
Directed evolution is a technique pioneered by Frances Arnold and Willem Stemmer. The 
technique aims to mimic natural evolutionary processes by introducing sequence diversity into 
a gene of interest, and selecting mutants that show an increase in ‘fitness’, or enhancement of 
a desired trait (Figure 1.1). In the early 1990s, Chen et al. utilised random mutagenesis and 
screening to develop a variant of subtilisin E that was 256 times more efficient in 60% DMF 
than the wildtype1,2. The random mutagenesis in this instance was achieved through error-prone 
PCR. In 1994, Stemmer demonstrated the application of in vitro homologous recombination 
(shuffling) in the evolution of cefotaxamine resistance of a p-lactamase system3. A pool of 
DNA fragments was obtained through the DNase I digestion of a gene of interest, and these 
fragments were allowed to recombine by primerless PCR4. The error rate of the DNA 
polymerase used ensured the incorporation of random mutations. The application of this 
technique saw a 32,000-fold increase in antibiotic resistance in the model system; this 
significant improvement relative to error-prone PCR (16-fold increase in resistance) was 
attributed to homologous recombination’s enhanced capacity to search sequence space. These 
pioneering studies paved the way for widespread application of directed evolution as a 
technique for protein engineering and investigation of natural evolutionary processes. 
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Figure 1.1 | A general workflow of laboratory directed evolution. a) A gene of interest is selected for evolution. 
b) A library of mutants is created through error-prone PCR, gene shuffling, staggered extension PCR, etc. c)
Resulting variants are screened for the desired phenotype. d) A selected variant is isolated and used for the next
round of directed evolution, or several variants are recombined to serve as a new parent gene. Stages a) to d) are
repeated as required. e) The product of the directed evolution experiment, a gene encoding the enhanced
phenotype, is isolated.
Methods for directed evolution have, themselves, evolved since the early 90s. The generation 
of mutant libraries is typically achieved through the use of error-prone PCR (random 
mutagenesis), site saturation mutagenesis, (focused mutagenesis) or homologous 
recombination (gene shuffling). In vitro error-prone PCR exploits the low fidelity of DNA 
polymerases in the presence of non-natural levels of manganese or magnesium5,6. When a gene 
is amplified by PCR under these conditions, mutation rates can be increased to 10-4 – 10-3 per 
base. This represents a controlled method of introducing sequence diversity, as the number of 
PCR cycles correlates with the number of mutations acquired. Error-prone PCR can also be 
achieved through the use of nucleoside analogues; PCR carried out in the presence of synthetic 
derivatives of dNTPs results in the incorporation of transition and transversion mutations, once 
again, at rates controlled by the number of PCR cycles7. If previous structural/functional 
knowledge of the system to be evolved is available, site saturation mutagenesis can be the more 
efficient technique. In this focused approach, individual codons can be targeted through the 
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application of cassette mutagenesis, generating libraries consisting of mutants varying at 
defined sites8. This technique can be used to generate combinatorial libraries, where numerous 
positions are scanned, revealing sites amenable to mutation and identifying regions that do not 
tolerate variation9. Homologous recombination, as discussed above, allows for mutations from 
different lineages to be combined, resulting in chimeric genes4. Alternatively, the staggered 
extension process (StEP) can be used to exploit partially-elongated PCR products, allowing 
those products to recombine through annealing10. 
After the generation of a library, the properties of mutant genes must be screened in order to 
identify beneficial mutations. Numerous methods for screening of libraries of mutants exist, 
and the efficiency of their application is dependent on the size of the library to be screened. 
Screening methods must incorporate a mechanism by which genotype and phenotype can be 
linked; once desirable phenotypes have been identified, there must be a method for retrieving 
the corresponding genetic information. Low-throughput screens like those employed by Chen 
et al. in the early advent of directed evolution can depend on the manual inspection of colonies 
on agar plates, and genetic information can be obtained by sequencing the colonies of interest2. 
Proteins with fluorescent or colorimetric properties can be similarly screened. Libraries in the 
order of 102 – 104 variants can be assessed this way11. To screen larger libraries, higher 
throughput methods are required. Cell surface display and phage display allow screening of 
candidates based on their binding to an immobilised target, and genetic information can be 
retrieved from the cell or bacteriophage. These methods can see libraries of 108 (cell surface 
display) to 1010 (phage display) screened. The use of water-oil emulsions to mimic the 
compartmentalisation of a cell membrane has resulted in the development of several high-
throughput screening methods. In vitro compartmentalisation (IVC) utilising fluorescence 
activated cell sorting (FACS) can be used to identify fluorescent proteins or fluorescent 
products of enzymatic reactions, and can be applied to libraries of 1010. Compartmentalisation 
in water-oil emulsions can also allow for screening of nucleases, DNA ligases, polymerases, 
and tRNA synthetases, with similar library sizes. The development of phage-assisted 
continuous evolution (PACE) has allowed for rapid screening of libraries consisting of up to 
1012 mutants. By co-opting the infection cycles of bacteriophages, the expression of a desired 
trait can be linked to the bacteriophages’ capacity to infect and hence replicate. Esvelt et al. 
demonstrated the application of PACE through the evolution of T7 RNA polymerase to 
recognise novel promoters, subjecting their system to 200 rounds of evolution in 8 days12. 
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The generation and screening of libraries has allowed the close study of evolution on the single-
molecule scale. While higher throughput techniques allow wider sequences spaces to be 
searched for adaptation, these methods typically neglect several aspects of natural evolution; 
genetic context and gene regulation13,14, population competition and coorperativity15, and the 
requirement of an organism to adapt in response to numerous selection pressures16. In nature, 
the evolution a protein does not take place in a vacuum, and adaptation on a cellular or organism 
level introduces new complexities. Its limitations in the broader context of evolutionary biology 
should be acknowledged, but directed evolution remains a powerful tool for investigating 
adaptation on a mechanistic level.  
One appeal of directed evolution is the accessibility of intermediates along the evolutionary 
pathway. While the phylogeny of existing proteins can be established using methods like 
Maximum Likelihood reconstruction of ancestral sequences17, directed evolution experiments 
provide insights that are otherwise inaccessible; having access to the entire trajectory of 
evolution that has occurred to reach a given end point allows for stepwise analysis of variants 
along a pathway, providing insights into the structural underpinnings of a functional change. 
Further, directed evolution does not necessarily rely on prior knowledge of the system of 
interest, allowing its application to proteins with unknown structures. Information gleaned 
from ‘irrational’ directed evolution experiments can inform future rational design experiments, 
as demonstrated by Paritala et al. in work that utilised directed evolution to identify previously 
unknown functional sites in the sulfur metabolism enzyme PAPR18. 
De novo design of proteins can benefit from the process of directed evolution. The 
computationally designed Kemp eliminase enzymes presented in work by Röthlisberger et al. 
initially demonstrated kcat/KM values in the range of 6 to 160 M-1 s-1 19.  After the application 
of directed evolution, consisting of seven rounds of library generation and selection, 
Röthlisberger and co-workers obtained a variant with a 200-fold increase in catalytic 
efficiency. Subsequent analysis of the variants obtained along this trajectory afforded insights 
into the structural basis of the changes20. Directed evolution has been utilised to improve the 
efficiency of a number of de novo proteins, including retro-aldol enzymes21 and Diels-
Alderases22, and has also found application in the design of protein-protein complexes23. 
Directed evolution experiments reveal fundamental aspects of the natural evolution process. 
Tokuriki et al. exploited the promiscuous activity of a bacterial phosphotriesterase (PTE) for 
arylester hydrolysis, and developed an 18 round experiment illustrating the trade-off between 
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the two activities, as well as the diminishing returns of later round mutations24. The trade-off 
between activities was asymmetrical, with specificity for the arylester substrate developing late 
in the trajectory (round 14); at the midpoint of the trajectory both activities were catalysed with 
high efficiency (kcat/KM ~ 105 for phosphotriester and arylester substrates) (Figure 1.2). The 
functional promiscuity of many enzymes, thought to be a result of divergent evolution, is well-
established25, and this asymmetrical trade-off provides insights into the mechanisms of 
specialisation of biocatalysts; the absence of a selection pressure for phosphotriesterase activity 
mirrors the release from selection pressure that accompanies gene duplication events26, 
allowing for promiscuous activities to be optimised.  
The diminishing returns of the trajectory were attributed to the ‘radiation’ of mutations from 
the active site; later round mutations were generally distant from the active site, and only 4 of 
the 18 mutations accumulated were found in the first shell of the active site. The early increases 
in arylesterase activity were a result of mutations in or near the active site, while later round 
mutations stabilised earlier ones, built networks of redundancy, and compensated for the 
destabilising effects of the initial function-altering mutations. (Figure 1.2)  
Figure 1.2 | The asymmetrical trade-off of phosphotriesterase and arylesterase activities (left), and the positions 
of mutations accumulated throughout the trajectory (right). While early round mutations are proximal to the active 
site, later round mutations radiate outwards. The active site is illustrated by bound transition state analogue HLN 
(teal sticks) and Zn2+ (white spheres). Figures adapted from Tokuriki et al.24 
The diminishing returns of functional optimisation are well-documented, both in evolutionary 
biology27–29 and in numerous other disciplines30, and can, in some cases, be attributed to 
epistasis.  
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1.2 Epistasis 
Epistatic effects are those in which the fixation of a mutation can have varying effects based 
on the genetic context into which it is introduced. In work by Chou et al., diminishing returns 
in the directed evolution of engineered bacteria Methylobacterium extorquens AM1 for growth 
on methanol were attributed to epistatic effects31. The rational combination of beneficial 
adaptations in three separate alleles demonstrated ‘magnitude epistasis’ (Figure 1.3); the 
higher the fitness of the genetic background, the lesser the effect of the beneficial adaptions. 
‘Sign epistasis’ is a more extreme example of the importance of genetic contexts in the 
accumulation of mutations: a mutation that is advantageous in one genetic context can be 
deleterious in another32 (Figure 1.3). The result of this is that the order of accumulation of 
mutations can be as vital to evolution as the identities of those mutations. Where sequence 
space can be visualised as an evolutionary landscape, epistatic effects can be equated to the 
limitations that constrain the pathways that lead uphill to fitness peaks.  
In work by Kvitek and Sherlock, two individually adaptive mutations (in different loci) in the 
directed evolution of S. cerevisae were determined to be deleterious when expressed in the 
same mutant33. This represents a ‘reciprocal sign’ epistatic effect (Figure 1.3); one in which a 
deleterious ‘valley’ exists between two local fitness peaks, preventing the progression of one 
lineage towards higher fitness.  
 
Figure 1.3 | Visual representations of a simple evolutionary trajectory from ab to AB. Blue edges represent 
‘allowed’ pathways, along which fitness is enhanced. Red edges represent ‘disallowed’ pathways, or deleterious 
mutations. No epistasis: each mutation is equally beneficial, regardless of genetic context. Magnitude epistasis: 
the second mutation acquired has a greater beneficial effect in the genetic context. Sign epistasis: the acquisition 
of mutation A is deleterious on background ab, but beneficial against aB. Reciprocal sign epistasis: the highest 
fitness peak, AB, is inaccessible from ab as both pathways require acquisition of deleterious mutations. Figure 
adapted from Poelwijk et al.34 
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Epistatic effects can exist on genomic scales, as described above, but also in individual 
proteins. Work by Ortlund et al. reports the crystal structure of a resurrected ancestor of a 
vertebrate glucocorticoid receptor (GR)35. Ortlund et al. showed that evolution of the GR saw 
its preference for its ligand alter from aldosterone to cortisol, and that the main cause for this 
change in preference was an epistatic pair of mutations, Ser106Pro and Leu111Gln. One 
mutation introduced a potential receptor-ligand contact, while the second altered the 
conformation of an α-helix, positioning the first mutation such that the new receptor-ligand 
contact could be made. Without the conformational change caused by Ser106Pro, Gln111 
would not be correctly oriented to contact cortisol. Bridgham et al. subsequently introduced 
the concept of an ‘epistatic ratchet’ in which key mutations in the evolution of modern GR to 
become specific for cortisol were shown to be irreversible; the receptor could not be mutated 
in the reverse order to re-acquire aldosterone specificity36. The basis for this was the epistatic 
relationship between the mutations. While the reversion of either Ser106Pro or Leu111Gln 
abolished cortisol binding, neither back-mutation alone provided any increase in aldosterone 
binding, meaning they could not be ‘selected for’. Through the analysis of these mutations, 
Bridgham et al. determined that any reversion to the receptor’s ancestral ligand would have to 
occur via an alternate pathway, as these ‘ratchet’ mutations form an evolutionary barrier that 
cannot be overcome by traditional selection and screening.  
The constraints placed on evolutionary processes by epistatic effects are numerous but difficult 
to identify as extant proteins have already overcome epistatic barriers (or accumulated 
beneficial or permissive epistatic mutations) in order to exist. However, techniques for the 
investigation of epistasis in a broader, evolutionary context have been developed, making use 
of ancestral sequence reconstruction37 (as above) and/or directed evolution38.  
In instances of directed evolution, the generation of mutant libraries plays a role in the visibility 
of epistatic effects. There is a relationship between the rate of mutation used to generate 
libraries, and the effects likely to be observed. In experiments with low rates of mutation – one 
mutation per mutant – single beneficial mutations will accumulate in a stepwise fashion. As 
they often require the concurrent acquisition of at least two mutations, rare sign epistasis events 
are more likely to be observed in experiments where the rate of mutation is high38. There are, 
however, instances of epistatic effects being indirectly introduced during an evolutionary 
trajectory; in work by Yang et al., a native active site residue (Phe68) was repositioned through 
the introduction of two mutations (Val69Gly and Phe64Cys) during the directed evolution of 
bacterial lactonase (AiiA) for enhanced phosphotriesterase activity39. While the identity of 
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residue 68 did not change during the trajectory, its catalytic role did. Epistatic constraints on 
the trajectory were identified through alanine scanning mutagenesis; Phe68Ala was beneficial 
on the WT background, but deleterious against either Val69Gly or Phe64Cys, meaning that 
early mutation at position 68 may have trapped the system at a local maximum and prevented 
the accumulation of beneficial mutations at positions 64 and 69. This serves to demonstrate the 
high degree of complexity in an evolving system, and the challenge of mimicking nature’s 
biocatalyst optimisation in the laboratory.  
The degree to which evolution is limited within sequence space has been demonstrated 
elegantly by several works, including that of Weinreich et al., in which they constructed and 
analysed the 32 possible combinations of five mutations previously identified to increase 
bacterial resistance to antibiotic cefotaxime40. The identification and mapping of neutral, 
beneficial and deleterious mutational effects in each combination resulted in the elimination of 
102 of the possible 120 pathways that could lead to the resistant gene. This illustrates the degree 
to which mutational trajectories are constrained by the ‘optimisation algorithm’ of evolution; 
escaping a local maximum would require the selection of ‘less fit’ phenotypes, which cannot 
happen under typical directed evolution conditions. Nature has methods to subvert this, 
however: gene duplication and neutral drift. When a gene is duplicated, one copy will no longer 
be under strict selective pressures; organismal fitness is ensured through the maintenance of 
one copy, allowing the second to explore sequence spaces that may not have been possible 
under a selection pressure41. 
1.3 Conformational Dynamics and Evolution 
The conformational dynamism of proteins is well established. Proteins undergo conformational 
change at a variety of time scales. On the shortest of these timescales (fs-ps), bonds vibrate and 
side chains rotate. On longer time scales (ns-ms), macroscale motions can take place; loops 
‘open’ and ‘close’, and domains can twist relative to each other or move on hinge-like regions 
(Figure 1.4). These larger motions are an area of continuing debate; while a large, flexible 
system like a protein is expected to possess conformational dynamism, how do these 
conformations affect the catalytic function of the enzyme? Works seek to establish the role of 
conformational dynamics in the catalytic step42, and others indicate that experimental models 
have not yet conclusively demonstrated this link43. While the link, or lack thereof, between 
conformational dynamics and the catalytic step remains a topic of controversy, the role of 
protein dynamism in substrate binding is well studied44–47, and cascades of conformational 
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change underpin numerous biological functions48. A further area of investigation is that of 
molecular evolution, and the degree to which conformational dynamics affects the evolution 
of protein function.  
 
Figure 1.4 | Protein motions, the timescales on which they occur, and the tools used to quantify them. Figure from 
Henzler-Wildman et al.49. 
Both natural and directed evolutions point to a number of factors that affect the propensity for 
proteins to evolve, or their ‘evolvability’, and conformational dynamism plays a substantial 
role.  
The interplay between the thermodynamic stability of a protein and its tolerance to substitutions 
is well documented, and a trade-off between enhanced activity upon incorporation of mutations 
and the stability of the protein has been consistently demonstrated50–52. Individual mutations 
are generally neutral or, on average, deleterious. A computational survey of 21 globular 
proteins found that mutation of surface residues was, on average, mildly destabilising (ΔΔG ~ 
0.6 kcal/mol), while mutation of core residues was more destabilising (ΔΔG ~ 1.4 kcal/mol)53. 
The trade-off between enhanced catalytic activity and thermodynamic stability has been 
demonstrated in the study of mutant TEM-1 β-lactamases. Mutants with increased activity 
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against cephalosporin antibiotics showed decreased thermodynamic stability, and lower 
activity with their original penicillin substrates54. Conversely, substitution of catalytic residues 
has been demonstrated by Beadle and Shoichet to be thermodynamically stabilising, albeit 
detrimental to catalytic function50,55. This has been attributed to the nature of enzyme active 
sites, which must inhabit a higher energy state that is preorganised to accept a substrate and 
facilitate catalysis56.  
Further studies by Bloom et al. relate the structural stability of a protein to the number of 
mutations accumulated, and predict an exponential decline in the likelihood of structure being 
retained with increasing numbers of substitutions57. Hence, proteins that possess greater 
thermodynamic stability are more amenable to the accumulation of substitutions58. The margin 
of permitted destabilisation was quantified in a model system, TEM-1 β-lactamase, by 
Bershtein et al.59. The notion of ‘threshold robustness’ was introduced; under low selection 
pressure, the majority of mutations were tolerated, but significant magnitude epistasis was 
observed after a stability ‘threshold’ was crossed, and deleterious effects of multiple 
substitutions compounded. The maintenance of structural stability in the face of mutation 
would suggest that highly stable, rigid proteins would be the best candidates for evolution; their 
structural stability could mitigate the destabilising effects of function-altering mutations. This 
is, however, not strictly the case; robustness alone cannot explain the capacities of some 
enzymes to evolve more than others.  
It is well-established that many, if not most, enzymes possess some degree of promiscuity; the 
capacity to turn over multiple substrates, or to catalyse multiple chemical reactions60. Of the 
several factors that underpin enzyme promiscuity, conformational flexibility is particularly 
fascinating; the capacity of a protein to interact with numerous ligands subverts both induced-
fit61 and lock-and-key62 models of substrate recognition and binding. A newer model proposes 
conformational diversity as the cause of functional promiscuity; a pre-existing equilibrium of 
different protein sub-states, each state differently capable of interacting with a number of 
ligands63. A number of examples of different functions being linked to distinct conformations 
of the same protein exist. The capacity of cytochrome P450 3A4 to bind two structurally 
distinct drugs has been attributed to substantial conformational changes of the active site64. A 
bifunctional variant of (βα)8 barrel HisA was observed to adopt two distinct loop 
conformations, with one conformation productive for each activity65. Studies of IgE antibody 
(SPE7) revealed that promiscuous interactions occurred via specific means; each of the four 
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ligands crystallised in complex with SPE7 showed distinct binding modes, with subtle 
conformational variations accompanying each66. 
Linking this model of functional promiscuity to molecular evolution provides a new framework 
in which to look at the evolution of new function; flexible, dynamic proteins are more likely to 
possess promiscuous activities, which can be selected for and enriched through evolution 
(Figure 1.5). The functional divergence of duplicated intrinsically disordered proteins supports 
this notion; the numerous metastable conformations accessible to intrinsically disordered 
proteins allow for interaction with an array of binding partners67. This framework, however, 
has limitations. New enzymatic function can evolve de novo; the ancestors of modern proteins 
do not always possess the modern activity, highlighted in particular by the evolution of 
enzymatic function from non-catalytic ancestors68–70. Additionally, high conformational 
freedom is associated with low structural stability, a factor already identified as being valuable 
in evolution. In fact, work by Dellus-Gur et al. highlights that while conformational flexibility 
can be important in the evolution of new function, the introduction of too much dynamism or 
disorder can impede evolution through negative epistasis71. It is important to note, also, that 
high conformational freedom is not a necessity for efficient catalysis; the ancestral 
reconstruction of ancient adenylate kinases by Nguyen et al. resulted in the identification of a 
highly thermostable, rigid ancestor that demonstrated high catalytic efficiency at low 
temperatures72. In fact, it is suggested that evolution minimises unnecessary motions, and 
enriches populations of conformations required for a given function73,74.  
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 Figure 1.5 | An ensemble of conformations results in catalytic promiscuity. Selection for one of these activities 
results in the enrichment of the relevant conformation, and the ‘freezing out’ of non-productive motions. Figure 
adapted from Campbell et al.75 
Combining and balancing robustness and innovability has resulted in a more nuanced 
hypothesis; evolvability requires structural ‘polarity’; a stable, often rigid scaffold, and a higher 
energy, conformationally dynamic active site76,77. This view can incorporate observations from 
Tokuriki’s analysis of core and surface mutations, (that they are, on average, detrimental to 
stability, although surface mutations less so53), and Shoichet’s study of catalytic residues (that 
their substitution is stabilising, reflecting the necessity of a high energy, preorganised active 
site for catalysis50,56). Taken together, a pattern emerges; surface regions and loops, often 
involved in substrate diffusion and catalysis, are conformationally and mutationally dynamic78; 
the hydrophobic core is rigid and confers thermodynamic stability, thus is less amenable to 
nonconservative substitution79–81; and catalytic residues, which are highly conserved for a 
particular function, are energetically dynamic and therefore readily substituted in the 
acquisition of new chemistry82.  
The greater the ‘disconnect’ between the scaffold, loops, and active site, the more likely the 
development of novel conformational sub-states and hence functions. The scaffold mitigates 
destabilising substitutions, and can itself take on stabilising mutations without directly 
affecting the functional sites of the protein, and the functional sites and flexible loops can 
undergo mutagenesis to obtain new function without pushing the protein past its 
thermostability threshold.  
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To better understand these synergistic roles, multiple conformations of proteins must be 
visualised and characterised. Methods for the qualification and quantification of sub-states are 
varied. Solution NMR allows monitoring of motions from the ps to s range83, and 
computational modelling of proteins can provide information about the energy minima that 
represent different sub-states, and the ways in which proteins can transition from one minimum 
to another84. 
X-ray crystallography, perhaps counterintuitively, can also provide detailed information about 
the conformational dynamism of proteins, and was utilised to great effect in the work by Dellus-
Gur et al. discussed previously71. While traditionally viewed as a ‘static’ method of 
observation, X-ray crystallography can be readily applied to the study of ensembles of 
conformations85. At the most basic level is the capacity of X-ray crystallography to reveal 
multiple conformations of a single sidechain; two conformations of a flexible residue can be 
distinguished by the observation of electron density representing both conformations. In the 
directed evolution experiment carried out Tokuriki et al., two distinct conformations of 
Arg254, the first mutation fixed, could be visualised in the X-ray crystal structure of the first 
round variant24. Each conformation was productive for one of the activities; Arg254 acted as 
an activity ‘switch’, an observation made possible through the modelling of conformational 
heterogeneity present in the X-ray data.  
Manual inspection of electron density typically underestimates the degree of heterogeneity 
present86; a problem exacerbated by traditional refinement techniques87. Modelling can be 
improved through the use of algorithms like qFit, which can identify and occupy instances of 
multiple side-chain conformations, and, more recently, multiple conformations of short 
glycine-rich regions and peptide flips88,89. The program Ringer has been demonstrated to 
identify alternative conformations at weak electron density levels (< 1 σ), allowing access to 
conformational data that may otherwise be interpreted as noise by manual modellers90. 
Generation and refinement of an ensemble of conformations can provide information about 
both the experimental error of the data and the conformational dynamism91. Ensemble 
refinement utilises molecular dynamics (MD) simulations to generate a collection of physically 
accessible conformations, which are then used to calculate structure factors92. This method can 
be used to identify dynamic regions and improve Rfree values93.  
While simpler than ensemble refinement, B-factors (or temperature factors) can be used as a 
proxy for flexibility and hence conformational variability in crystal structures (Equation 1.1). 
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These values indicate the degree to which electron density is spread or diffused as a result of 
thermal motions. 
𝐵𝐵 = 8𝜋𝜋2〈𝑢𝑢2〉 
Equation 1.1 | Definition of B-factor in the context of protein structures, where 〈u2〉 indicates mean square 
displacement. 
In highly flexible regions of a protein, high B-factors correspond to the disorder of electron 
density resulting from the capture of an ensemble of conformation94. Where resolution of 
multiple conformations is not initially possible, B-factor analysis can at least indicate the lack 
of a well-defined conformation and guide further investigation.  
Figure 1.6 | The monomer of PTE variant R0 (4PCP)74, represented in PyMol’s ‘sausage’ representation and 
coloured according to B-factor. Highly flexible loop 7 is highlighted in red. Pale orange spheres represent Zn2+. 
A criticism of X-ray crystallography is that it is typically carried out at cryogenic temperatures, 
with streams of nitrogen at 100 K used to reduce the damaging effects of X-ray radiation on 
crystallised samples. These temperatures result in the capture of a structure in an energy 
minima that may not be representative of the structure at physiological temperatures or in 
solution. The practice of snap freezing crystals in streams of nitrogen gas, or indeed by 
immersing the crystals directly into liquid nitrogen, goes some way to mitigating these effects; 
a study comparing cryogenic and higher temperature structures found minimal structural 
differences95. The presence of conformational heterogeneity in X-ray data, however, is highly 
dependent on the temperature of collection96. In work by Fraser et al., catalytically relevant 
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conformations of sidechains in cyclophilin A (CYPA) were deconvoluted through the 
combined application of Ringer and ambient-temperature crystallography90,97. Notably, the 
data collected at ambient temperatures agreed with sub-states identified through previous NMR 
analyses98. Further, identification of a minor rotamer through ambient-temperature 
crystallography allowed for the rational selection of a substitution to enrich this conformation, 
demonstrating the value of this sort of analysis in the biocatalyst engineering. More recently, 
room temperature X-ray crystallography has been applied to the investigation of redesigned 
ubiquitin variants73. A ‘core’ variant was designed by Zhang et al. for increased binding to 
deubiquitinase USP7, and then subjected to ‘affinity maturation’, in which random surface 
mutations were incorporated and variants screened for enhanced binding99. Structures of the 
‘core’ and ‘affinity matured’ variants were solved through room temperature X-ray 
crystallography, allowing for the elucidation of conformational heterogeneity in several 
regions, including the hinge-like β1β2 loop. The ‘core’ variant possessed substantial 
heterogeneity in this region, while the ‘affinity matured’ variant did not, due to the introduction 
of stabilising interactions. The deliberate introduction of conformational flexibility through the 
rational selection of ‘core’ mutations was proposed to disrupt the natural dynamics of protein, 
allowing the variant to sample a broader ensemble of sub-states, (some of which are valuable 
in binding the target USP7), while the ‘affinity maturation’ freezes out non-functional states, 
resulting in a stabilised, specialised variant.  
These works highlight the importance of detailed conformational analysis in protein 
engineering; rational mutagenesis can have far-reaching effects, shifting the equilibria between 
sub-states, and molecular evolution or affinity maturation can proceed through indirect 
alteration of conformational populations.  
The intersection of conformational dynamism, epistasis, and molecular evolution is a complex 
but fundamentally important space. To be best equipped to design and engineer new 
generations of biocatalysts, the interplay of these factors must be established and understood. 
The directed evolution experiment carried out by Tokuriki et al. is unique in its scope; 18 
rounds of selection, later extended to 22 rounds, has resulted in the isolation of 22 variants 
along the trajectory, meaning that subtle alterations to function can be identified through 
structural analysis of these intermediates. The role that conformational dynamics plays in the 
enhancement of promiscuous function can be best understood by the analysis of extant proteins, 
like these 22 variants. 
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Chapters 2 and 3 of this thesis address some of these points of intersection between directed 
evolution, conformational dynamics, and epistasis. The role of conformational dynamics in the 
PTE to AE trajectory presented in Tokuriki et al. is established, and reveals that the 
optimisation of an alternative activity proceeds through the initial incorporation of destabilising 
mutations, and then subsequent ‘freezing out’ of non-productive conformations. The epistatic 
ratchet is investigated in the context of enzymes, through the analysis of structural data 
acquired for the ‘reversal’ of the Tokuriki et al. trajectory. Finally, epistatic constraints on 
evolution and the ‘repeatability’ of evolution between two known phenotypes are investigated 
through the development of a new PTE to AE trajectory, containing initial constraints on 
sequence space that result in a new binding mode of the substrate and the loss of function of 
an entire loop region that was essential in the old trajectory.  
PART 2 
1.4 The Application of Biocatalysis 
Biocatalysts possess a strange dichotomy, in that the very features that make them desirable 
tools in synthesis, industry, and medicine, are also often the factors that limit their application.  
Most often, enzymes have evolved their high turnover numbers and specificities in 
physiological environments; neutral pHs, moderate temperatures, aqueous reaction media, and 
standard atmospheric pressure. In the case of naturally occurring extremophiles, enzyme 
function may be optimised for much higher or lower temperatures100,101, substantial salt 
concentrations102, or unusual pH values103,104, but typically, the limitations of naturally 
occurring catalysts reflect the mild environments in which they evolved. Enzymes in solution 
have a limited lifespan; enzyme longevity is rarely a necessity in vivo. Enzymes therefore often 
require specialised storage, typically refrigeration or lyophilisation, the latter of which can be 
destabilising. 
Protein engineering seeks to address these shortcomings. Rational mutagenesis or directed 
evolution can be used to enhance thermostability, substrate preference, or activity in organic 
solvents. Despite advances in these methods, several barriers to efficient application of 
biocatalysts remain. One of these is the practical issue of introducing an enzyme to a reaction 
mixture, and removing it afterwards. The appeal of an enzyme catalyst lies in its capacity to 
turn over numerous reactions before being depleted, but the separation of catalyst from product 
in large scale processes is a barrier to application of even the most precision-engineered 
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proteins. For an enzyme to be used to its full efficiency, it needs to be recyclable and readily 
removed from a reaction mixture. The immobilization of enzymes on solid supports aims to 
address these shortcomings.  
1.5 Enzyme Immobilisation 
In 1916, Nelson and Griffin observed that invertase retained its enzymatic function after having 
been absorbed on charcoal or aluminium hydroxide105. Over a century later, researchers 
continue to seek flexible, reliable, and applicable methods of immobilising biocatalysts. This 
has led to the advent of functional materials, blending the fields of biochemistry, materials 
chemistry, and systems engineering. Enzymes have been immobilised on beads that can be 
filtered out of reaction mixtures106; incorporated into membranes that can be washed and 
reused107; and mounted in columns over which substrates are passed108.  
In addition to the practical issues surrounding removal of catalysts from reaction mixtures, 
enzyme immobilisation also addresses several other shortcomings of biocatalysts. Immobilised 
enzymes have been demonstrated to have greater tolerance to organic solvents109, enhanced 
lifespans110, and in some cases, higher activity than enzymes in free solution111. 
Methods of immobilisation are varied (Table 1.1). Covalent attachment involves the chemical 
crosslinking of natural sidechains or of a modified enzyme surface to a solid support. Covalent 
attachment can be either site-specific - for example, relying on a novel chemical functionality 
introduced through unnatural amino acid incorporation - or not site-specific, utilising the 
reactivity of amines, thiols, and carboxylic acids. Site-specific covalent immobilisation is 
typically regarded to be superior, as the orientation of the immobilised enzyme on the solid 
support can affect the activity of the resulting construct112. While covalent crosslinking is 
robust, it has several disadvantages. Covalent attachment can require multiple chemical steps 
in order to prepare the enzyme or medium for immobilisation, and often requires the application 
of harsh chemicals that can destabilise the enzyme, reducing the overall efficiency of the 
immobilisation process. Typically, covalent attachment is irreversible, meaning that once the 
immobilised enzyme is depleted, the solid media cannot be readily recycled, or will require 
priming before the addition of new enzyme. 
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Method of immobilisation Advantages Disadvantages References 
Polymer/matrix 
encapsulation 
Access to functional nanomaterials, one 
system can be applied to numerous enzymes 
Reduction of catalytic efficiency, mechanical 
stability of media can vary 
113–116 
Covalent crosslinking of 
natural amino acids 
Easy to exploit amine/thiol/carboxyl 
reactivity, robust attachment 
Requires chemical treatment of enzyme/support, 
often irreversible 
117–119 
Covalent crosslinking of 
unnatural amino acids 
Robust attachment, site-directed 
immobilisation 
Requires chemical treatment of enzyme/support, 
often irreversible 
120 
Physical adsorption 
(hydrophobic supports, 
physical channels/pores) 
Lipophilic enzymes more likely to retain 
activity, high surface area of channels/pores 
maximises adsorption 
Limited scope for soluble enzymes, enzyme 
leakage/leaching from media, limited 
recyclability of media 
121,122 
Affinity tags Single-step purification, site-directed immobilisation 
Interactions too weak (hexahistidine), or not 
readily reversible (streptavidin/biotin) 
123,124 
Enzyme/binding domain 
fusions Moderate attachment, single step purification 
Requires optimisation of fusion construct, 
expression system 
125–127 
Ionic adsorption Rapid immobilisation and desorption in mild conditions Enzyme leakage/leaching from media 
125,127–129 
 
Table 1.1 | Methods of enzyme immobilisation, and their advantages and disadvantages.  
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Affinity tags typically reserved for protein purification have found use in non-covalent site 
specific immobilisation. While traditional hexahistidine tags lack the affinity for long-term 
immobilisation of protein on Ni-NTA resin, work by Khan et al. has shown that a ‘double’ 
hexahistidine motif increases binding affinity by an order of magnitude, improving its 
application to this kind of attachment124. The biotin/streptavidin system has also been used to 
immobilise an enzyme with moderate success – biotinylated aldo/keto reductase (AKR1A1) 
retained activity for 1 week on streptavidin templates – and further demonstrated the 
importance of site-specificity to this sort of immobilisation123.  
Physical adsorption or entrapment allows for enzymes to be incorporated into polymer 
matrices, gels, or metal-organic frameworks. In recent work by Feng et al., metal-organic 
frameworks containing single-molecule traps were designed for the immobilisation of three 
enzymes; horseradish peroxidase, cytochrome c oxidase, and microperoxidase122. The 
networks of organic linkers, metal ions, and coordinated water molecules provided sufficient 
physical interactions for the immobilisation of the enzymes, while having minimal negative 
effect on catalytic efficiency. In fact, KM was observed to decrease in each case. 
Ionic immobilisation has also been investigated as a method of attaching an enzyme to solid 
media. The advantages of ionic immobilization are its simplicity, speed and reversibility; 
adsorption onto ion exchange resin is rapid, and commercially available resins can have high 
enzyme loading capacities. These resins, typically used for purification of proteins, allow for 
quick adsorption and desorption of enzymes; gradually increasing the ionic strength of the 
purification buffer results in bound proteins being eluted according to their isoelectric points130. 
This rapid desorption, while beneficial for recycling of media, also represents the main 
disadvantage of ionic immobilization; the propensity of enzymes to leach out of charged media 
with prolonged use. This can be addressed by altering the surface properties of the enzyme to 
be immobilized. 
1.6 Charge Engineering 
The surface chemistry of proteins is crucial to their intermolecular interactions and stability. 
Numerous studies investigating the relationship between surface charge and tendency of a 
protein to aggregate have determined that the greater a protein’s net charge is, the less likely it 
is that aggregation will occur. Examples of this phenomenon include intrinsically disordered 
proteins, which typically have primary structure consisting of numerous similarly charged 
residues and very few hydrophobic residues. This results in a partially or completely unfolded 
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native state, but high solubility131. The practice of storing protein solutions at a pH either 
substantially higher or lower that the molecule’s isoelectric point, or in specific concentrations 
of salt, relies on the same reasoning; a protein is least soluble when its net charge is closest to 
zero132. The inverse corollary often means that screens for the crystallisation of proteins are set 
up at or around the isoelectric point of the protein, where solubility is lowest, encouraging the 
formation of crystalline solids. Thus, altering the surface charge of a protein is an effective way 
to adjust inter- and intra-molecular interactions.  
In studies by Lawrence et al., it was demonstrated that dramatically increasing the surface 
charge of Green Fluorescent Protein (GFP) conferred resilience against protein unfolding and 
aggregation133. Most notably, upon heating their supercharged GFP variant, GFP(+36), to 100 
°C, no aggregation was observed, and 62% of initial fluorescence was recovered upon cooling 
(Figure 1.7). The lab-stabilised variant of GFP, stGFP, used as a starting point for the 
engineering of GFP(+36), showed a significant loss in solubility and irreversible loss of 
fluorescence under the same conditions. GFP(+36) also showed a remarkable resilience against 
chemical denaturation. 
 
Figure 1.7 | a) Comparison of stGFP and the supercharged variants after heating to 100 °C and subsequent 
cooling, b) Fraction of stGFP and supercharged variants aggregated on addition of 40% TFE. Figure adapted 
from Lawrence et al.133 
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This substantial increase in resilience to aggregation and inactivation is observed in chemical 
modification experiments performed by Shaw et al.134, albeit with a super-anionic protein. In 
this study, samples of α-amylase were treated with acetic anhydride resulting in the acetylation 
of 17 of the 28 lysine residues in the protein. This acetylation saw an increase in negative net 
charge of approximately 17 units compared to the unmodified α-amylase. When incubated with 
common industrial surfactants, the acetylated α-amylase was not inactivated. 
Perriman et al. present further studies involving chemical modification of enzyme surfaces to 
yield highly charged proteins. Chemically cationized ferritin was produced through the 
coupling of N,N-dimethyl-1,3-propanediamine (DMPA) to negatively charged surface residues 
via 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC). The addition of 10 DMPA 
molecules to each of the 24 subunits of ferritin resulted in an increased positive surface charge, 
which served as the basis for addition of anionic polymer surfactants135. When lyophilised and 
heated, the surfactant-enzyme complexes melted, forming novel ‘liquid-phase’ protein which 
remained stable up to 405 °C. Experiments with chemical cationization and surfactant addition 
to myoglobin yielded similar increases in thermostability, as well as improved refolding136. 
These works establish the alteration of enzyme surface properties as not only viable, but often 
advantageous.  
The use of surface modification to enhance ionic immobilization of enzymes has been 
investigated in several studies. One example is the use of the Zbasic2 domain by Bolivar et al. to 
mount D-Amino acid oxidase from Trigonopsis variabilis (TvDAO) on a derivatized 
mesoporous glass125. The cationic Zbasic2 domain, co-opted from staphylococcal protein A by 
Gräslund et al.137, allowed for the simultaneous purification and immobilisation of TvDAO on 
anionic glass beads. The immobilized enzyme had enhanced resistance to bubble aeration, and 
was demonstrated to retain activity for approximately 12 hours of conversion in batch. In work 
by Montes et al. the surface of a penicillin G acylase (PGA) was modified genetically, with the 
aim of reducing the isoelectric point of the enzyme such that it could be reversibly immobilized 
on modified anion exchange resin129. The construct demonstrated enhanced stability to 
dioxane, which, while not a particularly polar solvent (relative polarity = 0.164138), goes some 
way to illustrating the effectiveness of hydrophilic microenvironments in protecting enzymes 
from the damaging effects of organic solvents.  
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1.7 Hydrogels in Biocatalysis 
The incorporation of enzymes into hydrogels has a number of advantages; hydrogels can act 
as a matrix for physical adsorption139; the protective effect of a hydrophilic microenvironment 
can permit exposure of the adsorbed enzyme to organic solvents140; and the properties of the 
hydrogel can be tuned to the desired application141. The most commonly used 
purification/immobilization hydrogel is one comprising crosslinked agarose beads 
(Sepharose). While readily applied in research applications like affinity chromatography, there 
are several significant drawbacks of these polymers; agarose beads are susceptible to 
compression and crushing under high flow rates and pressures, and do not tolerate many 
organic solvents142,143. These factors impose serious limitations on a Sepharose-based 
immobilization system, particularly in industrial or synthetic contexts in which high flowrates 
and organic solvents can be necessary.  
For application in industry, hydrogels can be contained within non-compressible porous 
ceramic beads. This results in a robust material, resistant to the high pressures and mechanical 
forces that accompany reactions performed in flow. Encapsulated hydrogels have a greater 
surface area for enzyme adsorption than a traditional non-porous bead, so biocatalyst loadings 
can be increased. For therapeutic applications, however, biocompatible hydrogels are 
necessary. Amino acid based hydrogels have been shown to spontaneously self-assemble and 
have potential for therapeutic application, as they can more closely mimic the environment of 
the cell144. The incorporation of enzymes into these self-assembling hydrogels could allow for 
precision delivery of enzymatic therapeutics. However, these applications require robust 
immobilization of the protein in the hydrogel to minimize leaching, particularly in therapeutic 
settings in which specific localisation of the enzyme:hydrogel construct would be vital. The 
combination of surface engineering, ionic immobilization, and the utilization of charged, 
biocompatible hydrogels, is therefore an interesting area of study. 
While Montes et al. demonstrated the adsorption of an anionic PGA variant onto chemically-
modified Sepharose, work presented in Chapter 4 of this thesis focuses on the modification of 
arPTE for incorporation into novel anionic biogenic hydrogels. Further, the increased surface 
charge of the presented arPTE (pI = 10.01) puts it in the top 0.0001% of soluble proteins in the 
E. coli proteome, resulting in a single-step purification from cell lysate that could be readily 
scaled up without reduction in the resolution of the purification. A moderately anionic protein, 
like the PGA presented in Montes et al. (pI = 4.3) may become difficult to separate from 
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endogenous E. coli proteins - which are predominantly acidic - on large scales, increasing the 
cost of application to industry. The immobilized arPTE variant was also subjected to rigorous 
testing of its application to organic synthesis, particularly its resistance to the polar solvent, 
methanol (relative polarity = 0.791138) and its capacity to perform kinetic resolutions in 
continuous flow systems.  
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High fashion garment designed and modelled by Sanjana Alex, inspired by the purification 
and crystallization of phosphotriesterase. Image used with permission. 
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CHAPTER 2:  
MOLECULAR EVOLUTION, DYNAMICS, AND EPISTASIS IN A MODEL 
PHOSPHOTRIESTERASE SYSTEM 
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RESEARCH ARTICLE
Reverse evolution leads to genotypic
incompatibility despite functional and
active site convergence
Miriam Kaltenbach1,2, Colin J Jackson3, Eleanor C Campbell3, Florian Hollfelder2,
Nobuhiko Tokuriki1*
1Michael Smith Laboratories, University of British Columbia, Vancouver, Canada;
2Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom;
3Research School of Chemistry, Australian National University, Canberra, Australia
Abstract Understanding the extent to which enzyme evolution is reversible can shed light on the
fundamental relationship between protein sequence, structure, and function. Here, we perform an
experimental test of evolutionary reversibility using directed evolution from a phosphotriesterase to
an arylesterase, and back, and examine the underlying molecular basis. We find that wild-type
phosphotriesterase function could be restored (>104-fold activity increase), but via an alternative set
of mutations. The enzyme active site converged towards its original state, indicating evolutionary
constraints imposed by catalytic requirements. We reveal that extensive epistasis prevents
reversions and necessitates fixation of new mutations, leading to a functionally identical sequence.
Many amino acid exchanges between the new and original enzyme are not tolerated, implying
sequence incompatibility. Therefore, the evolution was phenotypically reversible but genotypically
irreversible. Our study illustrates that the enzyme’s adaptive landscape is highly rugged, and
different functional sequences may constitute separate fitness peaks.
DOI: 10.7554/eLife.06492.001
Introduction
The controversy surrounding evolutionary reversibility pertains to one of the fundamental questions in
evolutionary biology: the extent to which selection pressure determines evolutionary outcomes
(Teotonio and Rose, 2001;Gould, 2007; Collin and Miglietta, 2008; Lobkovsky and Koonin, 2012).
Also, through understanding reversibility on the levels of both phenotype and genotype, one could
catch a glimpse at the structure of the respective fitness (or adaptive) landscape. The extent of
ruggedness of adaptive landscapes—that is, the prevalence of epistasis, and thus historical
contingency—have recently received considerable attention (Whitlock et al., 1995; Poelwijk et al.,
2007; de Visser et al., 2011; Breen et al., 2012; Harms and Thornton, 2013; McCandlish et al.,
2013; Kaltenbach and Tokuriki, 2014). While the unlikelihood of reversing a historical pathway taken
by evolution has been demonstrated (Bridgham et al., 2009), a large number of sequences can
encode functionally identical proteins (‘genotypic redundancy’) and phenotypic reversion can still
occur via alternative pathways (Clarke, 1985; Lenski, 1988; Crill et al., 2000; Teotonio and Rose,
2000; Kitano et al., 2008). Yet, the evolutionary dynamics underlying phenotypic reversion have not
been addressed. Does phenotypic reversion lead back to the ancestral peak on the adaptive
landscape or to a new peak (Carneiro and Hartl, 2010; Lobkovsky and Koonin, 2012)? In other
words, to what extent are the sequences of the ancestral and reverse-evolved proteins accessible via
a neutral network—that is, are amino acid exchanges between the two proteins tolerated or result in
loss of function? The inability to exchange amino acids between homologous proteins due to epistasis
represents ‘genotypic incompatibility’ and can result in a non-functional enzyme, a phenomenon
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which can be compared to the ‘Dobzhansky-Muller effect’ of hybrid incompatibility (Orr, 1995;
Kondrashov et al., 2002).
Another important aspect to be explored is the underlying molecular mechanism of phenotypic
reversibility. Restoration of function can either be brought about by the same structure and
mechanism as in the ancestor, or by a distinct, alternative state. Structural convergence would indicate
that functional requirements exist, which deterministically lead to one particular structural solution.
On the other hand, structural divergence would imply the accessibility of various solutions that can
bring about efficient catalysis. Thus, understanding the molecular basis for (ir)reversibility and (in)
compatibility would provide valuable insights into protein sequence-function-structure relationships.
What are the molecular requirements for a specific function? What structural changes are required to
switch from one function to another? Identifying such changes, which are often based on subtle
effects (e.g., on mutations occurring in remote locations, or mutations which only show a favorable
effect in combination), remains a great challenge in protein science. What is the molecular basis
underlying mutational epistasis, which leads to alternative evolutionary outcomes?
Directed evolution is a powerful tool to address these questions and explore adaptive landscapes
because it allows the study of evolution in a highly controlled setup (Peisajovich and Tawfik, 2007;
Romero and Arnold, 2009; Kawecki et al., 2012). High selection pressure can prevent fixation of
neutral, functionally irrelevant mutations, resulting in an adaptive trajectory without mutational noise.
All evolutionary intermediates (the ‘molecular fossil record’) are obtained, so the evolutionary
dynamics and their molecular basis can be characterized in detail. Performing evolution in both the
forward and reverse direction and comparing the changes in each direction provides a unique handle
for identifying such effects. Understanding these phenomena would improve our ability to design and
engineer novel proteins in the laboratory.
eLife digest Enzymes in bacteria and other organisms are built following instructions contained
within each cell’s DNA. Changes in the DNA, that is to say, mutations, can alter the shape and activity
of the enzymes that are produced, which can ultimately affect the ability of the organism to survive
and reproduce. Mutations that are beneficial to the organism are more likely to be passed on to
future generations, which can lead to populations changing over time.
The DNA sequences that an organism carries are referred to as its ‘genotype’ and the resulting
physical characteristics of the organism are known as its ‘phenotype’. Studies of evolution tend to
focus on how particular species or molecules become more different over time. However, one area
that remains controversial is whether it is possible for evolution to be reversed so that an organism or
molecule returns to a previous form.
An enzyme called PTE is said to have phosphotriesterase activity because it catalyzes this
particular type of chemical reaction. Recently, a group of researchers used a method called ‘directed
evolution’ to demonstrate that it is possible for PTE to evolve in a way that means it loses its
phosphotriesterase activity and becomes able to catalyze a different type of chemical reaction. Here,
Kaltenbach et al.—including some of the researchers from the previous work—investigated whether
it was possible to use the same method to reverse this evolution and restore the enzyme’s original
activity.
The experiments show that reverse evolution is possible as phosphotriesterase activity was
restored to the PTE enzyme from the previous study. However, although the phenotype of the final
enzyme matched that of the original PTE enzyme, the genotypes did not match as the DNA
sequences of the genes that encode these enzymes differ. The DNA does not revert to its original
sequence because the effect of individual mutations on the phenotype depends on what other
mutations are present. For example, as the enzyme evolved its new activity, additional mutations
accumulated that did not alter enzyme activity. During the reverse evolution experiment, some of
these mutations could have started to exert influence on the phenotype so that different mutations
were required to restore the phosphotriesterase activity.
In the future, Kaltenbach et al.’s findings may aid efforts to engineer artificial enzymes for use in
medicine or industry.
DOI: 10.7554/eLife.06492.002
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Here, we experimentally test the reversibility of enzyme evolution and investigate its molecular
basis. We previously evolved the enzyme PTE, a phosphotriesterase, into an arylesterase (Roodveldt
and Tawfik, 2005; Tokuriki et al., 2012; Wyganowski et al., 2013). In this work, we applied
a selection pressure to restore the original phosphotriesterase activity. We characterized the entire
trajectory including both the forward and reverse process in terms of phenotypic reversibility (function
or enzymatic activity), genotypic irreversibility (sequence), as well as in terms of the underlying
molecular basis (structure and mechanism). We find that PTE has a rugged adaptive landscape on
which the accessibility of functional mutations is severely limited, and describe the mechanisms that
lead to genotypic irreversibility and incompatibility.
Results
Phenotypic reversibility in the laboratory evolution of PTE
We previously reported the laboratory evolution of PTE (wtPTE) into a highly efficient arylesterase for
2-naphthyl hexanoate (2NH) (Roodveldt and Tawfik, 2005; Tokuriki et al., 2012;Wyganowski et al.,
2013). In the course of the trajectory, the original phosphotriesterase activity decreased drastically
(104-fold) although no selection pressure was applied against it. In this work, we first completed the
functional transition by further decreasing the remaining phosphotriesterase activity (∼10-fold) by four
additional rounds of directed evolution for maintaining arylesterase but reducing phosphotriesterase
activity (Supplementary file 1). Briefly, libraries were generated by error-prone PCR and transformed
into Escherichia coli (BL21 (DE3)). As a pre-screen for arylesterase activity, protein expression was
induced in the bacterial colonies on agar plates, and a mixture of the substrate 2NH and a product
stain (Fast Red) was added as previously described (Figure 1A) (Roodveldt and Tawfik, 2005;
Tokuriki et al., 2012; Wyganowski et al., 2013). Upon hydrolysis of 2NH, Fast Red forms a red
complex with the naphtholate leaving group, meaning colonies that develop a red color contain active
arylesterase variants. In each round, 2000–10,000 colonies were screened in this fashion, theoretically
covering most single point mutations in the 330 amino acid PTE gene. Positive colonies were then
re-grown and re-assayed in 96-well plates and initial rates of both 2NH and paraoxon hydrolysis were
determined in clarified lysate. In our experience, activity increases >1.3-fold compared to the
respective parent yielded reliably improved variants. The variant with the largest improvement in
initial rate was then used as the template for the next round of error-prone PCR or several variants
were subjected to DNA shuffling. To buffer the destabilizing effects of functional mutations and
minimize reductions in soluble protein expression levels, we used GroEL/ES overexpression as
previously described (Supplementary file 1) (Tokuriki and Tawfik, 2009; Wyganowski et al., 2013).
In total, with 22 rounds of ‘forward evolution’, the accumulation of 26 mutations from wtPTE resulted
in a highly efficient and specialized arylesterase (AE) with a ∼105-fold increase in arylesterase
rates (kcat/KM for 2NH >106 M−1s−1) and an overall ∼105-fold decrease in phosphotriesterase activity
(kcat/KM for paraoxon ≈102 M−1s−1, Figure 1B,C). Because selection was specific for arylester
hydrolysis until round 18, the change in phosphotriesterase activity was stochastic: many mutations
decreased phosphotriesterase activity (11 mutations), some were neutral (nine mutations), and others
increased phosphotriesterase activity (six mutations). Starting from AE, we then performed the
reverse evolution to restore phosphotriesterase activity using an experimental setup equivalent to the
forward process (Figure 1A) with the following modifications: the pre-screen was carried out using
a fluorogenic phosphotriester as a surrogate for paraoxon (Supplementary file 1) and then validated
in 96-well format as described above. The selection criterion was now an increased initial rate of
paraoxon hydrolysis. In our evolutionary model system, variant fitness is defined as the level of
enzymatic activity in cell lysate. All variants were also purified and the kinetic parameters determined,
which correlated well with lysate activity (Figure 1—figure supplement 1, Supplementary file 2).
The restoration of phosphotriesterase activity in the reverse evolution followed a pattern similar to
that observed for arylesterase activity in the forward evolution: increasing smoothly and gradually
through the stepwise accumulation of mutations (Figure 1B,C). Moreover, it followed a ‘diminishing
returns’ pattern characteristic for the development of a function under selection—that is, the activity
gain per mutation gradually decreased in later stages of the functional transition, where fitness
reached a plateau (Figure 1B) (Stebbins, 1944;MacLean et al., 2010; Chou et al., 2011; Khan et al.,
2011; Tokuriki et al., 2012). Furthermore, trade-offs between the two activities were weak in the
early rounds of evolution, resulting in a generalist, bifunctional intermediate (Aharoni et al., 2005;
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Khersonsky and Tawfik, 2010). In the forward evolution, trade-offs then became stronger, leading to
specialization of the arylesterase. The reverse evolution, however, retained characteristics of
a generalist: the large increase in phosphotriesterase activity (>104-fold) was accompanied by only
a small (five-fold) reduction in arylesterase activity. A possible reason for this is that the reverse
evolution is still at an early phase of the functional transition after 12 rounds (vs. 22 in the forward
evolution). Because we were unable to isolate any variant with further improved phosphotriesterase
activity, it might be necessary to impose a negative selection pressure to specialize the enzyme. The
molecular basis of substrate binding and trade-offs is described further below (see also Figure 2 and
Figure 1. Activity and sequence changes of PTE over the evolution. (A) Overview of the experimental evolution.
Libraries were generated and transformed into Escherichia coli. Proteins were expressed and screened for paraoxon
and/or 2NH hydrolysis in bacterial lysates. Several thousand variants were screened per round, theoretically
covering most single point mutations in the ∼1000 bp PTE gene. Details are given in Supplementary file 1.
(B) Activity changes during the forward (screening for arylesterase hydrolysis) and reverse evolution (screening for
re-increase in phosphotriesterase hydrolysis). Steady-state kinetic parameters for all variants are provided in
Supplementary file 2A. (C) Type, position, and order of occurrence of the 33 mutations obtained in the evolution.
Mutations are shown relative to wtPTE (GenBank accession number KJ680379) with lower case italics denoting
the amino acid found in wtPTE. Note that wtPTE was obtained in previous screens for improved expression levels in
E. coli and contains six mutations relative to the naturally occurring PTE (I106L, F132L, K185R, D208G, R319S)
(Roodveldt and Tawfik, 2005; Tokuriki et al., 2012). The following mutations occurred in individual variants, but
were not fixated after DNA shuffling: R7a: a204G, R7c: a102V, R19: a78T, v143A, t311A, revR1: c59Y, s238R, revR5:
i176V, revR8a: d264E, revR8b: i296V. All additional variants characterized and sequenced in each round are shown in
Supplementary file 1.
DOI: 10.7554/eLife.06492.003
The following figure supplement is available for figure 1:
Figure supplement 1. Correlation between activities measured in cell lysate and using purified enzyme for all
variants selected over the evolution (Supplementary file 2).
DOI: 10.7554/eLife.06492.004
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Figure 2—figure supplement 1). Overall, we obtained a new efficient, enzyme (neoPTE) on par with
wtPTE (kcat/KM>106 M−1s−1 for paraoxon in both cases). The recovery of identical phosphotriesterase
rates in neoPTE compared to wtPTE establishes that evolution of the phenotype was fully reversible.
Genotypic irreversibility and constraints underlying phenotypic
reversion
To examine the genetic changes causing phenotypic reversion, the sequence of all evolutionary
intermediates was determined. Only five of the 26 mutations that accumulated in the forward
evolution were reverted to the original sequence (‘reversions’, A49v, I172t, Q180h, L271f, M314t,
Figure 1C; amino acids shown in lower case italics denote the wtPTE state, while amino acids not
present in the wild type are shown in capital letters). Nine additional ‘new mutations’ accumulated,
two of which occurred in positions that were mutated in the forward evolution (V130M—originally leu,
I306M—originally phe), and seven were in positions that were not previously mutated (p135S, y156H,
g174D, a203E, m293K, s258N, s308C). Overall, neoPTE is separated further from wtPTE (28 out of
Figure 2. Reshaping of the PTE active site over the evolution. (A)WtPTE (PDB ID: 4PCP) features an active site which
is well adapted for paraoxon hydrolysis, but suboptimal for 2NH. (B) In the forward evolution, selection for
arylesterase activity leads to several changes in the binding pocket from wtPTE to AE (PDB ID: 4PCN). (C) The
reverse evolution leads to restoration of the ancestral state in neoPTE (PDB ID: 4PBF). The four regions of change are
highlighted in different colors. Top row: the 2NH analogue (yellow) was modeled into the three structures by
superposition with PTE-R18 in complex with the analogue (PDB ID: 4E3T) (Tokuriki et al., 2012). Bottom row: the
paraoxon analogue diethyl 4-methoxyphenyl phosphate (yellow) was modeled into the structures by superposition
with Agrobacterium radiobacter PTE in complex with the analogue (PDB ID: 2R1N) (Hong and Raushel, 1996).
Amino acids found in wtPTE are shown in lower case italics.
DOI: 10.7554/eLife.06492.005
The following figure supplements are available for figure 2:
Figure supplement 1. Details of the active site changes.
DOI: 10.7554/eLife.06492.006
Figure supplement 2. Overlay of electron density maps for the active sites of (A) wtPTE (salmon) and AE (cyan) and
(B) wtPTE (salmon) and neoPTE (magenta).
DOI: 10.7554/eLife.06492.007
Figure supplement 3. Development of B-factors over the evolution.
DOI: 10.7554/eLife.06492.008
Figure supplement 4. Linear free energy relationships of wtPTE, AE, and neoPTE.
DOI: 10.7554/eLife.06492.009
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333 amino acids) than AE from wtPTE (26 amino acids). Additional rounds of evolution failed to yield
more reversions or activity increases (Supplementary file 1). In the forward evolution, the loss of
phosphotriesterase activity was largely a side product of the property under selection, the increase in
arylesterase activity. Therefore, not all mutations decreased phosphotriesterase activity (Figure 1B),
and it is not surprising that phenotypic reversion did not require full genotypic reversion. However,
a number of mutations that did contribute to decreasing phosphotriesterase in the forward process
were also not reverted. Moreover, the new mutations are located in the same mutational clusters seen
in the forward evolution (Figure 1C), indicating they may be alternative solutions to the same
functional requirement and replace reversions, as detailed further below. Taken together, although
the phenotype was reversible, PTE evolution was genotypically irreversible, but an alternative
trajectory was readily taken.
The active site converged towards its original state in the reverse
evolution
To unravel the molecular basis of the observed genotypic irreversibility, we solved crystal structures
of wtPTE, AE, and neoPTE (Supplementary file 3). We compared the structures and modeled both
a paraoxon and a 2NH analogue into each active site (by superposition with structures containing
these analogues [Hong and Raushel, 1996; Tokuriki et al., 2012]). The phosphotriester paraoxon is
characterized by tetrahedral ground-state geometry and P–O cleavage proceeds via a trigonal
bipyramidal transition state. The arylester 2NH is planar and C–O bond hydrolysis proceeds via
a tetrahedral transition state. The structural comparison indicates that AE adapted to the planar
substrate 2NH in the forward evolution, but that this came at a cost of phosphotriesterase activity, as
the bulky paraoxon is no longer efficiently recognized (Figure 2). We identify several regions of the
active site that may be responsible for the functional transition (Figure 2 and Figure 2—figure
supplement 1). First, a binding pocket for the naphthyl leaving group of 2NH was excavated through
the combined action of h254R and d233E (Figure 2A,B, green region) (Hong and Raushel, 1996;
Tokuriki et al., 2012). Leaving group coordination was further improved through a subtle ∼1.0 A˚
shift of Trp131 (Figure 2A,B, purple region). Moreover, the pocket was elongated through the f306I
mutation (Figure 2A,B, pink region) and narrowed by l271F (Figure 2A,B, orange region), resulting
in better accommodation of the long hexanoate chain of 2NH. These changes may lead to the
reduction of phosphotriesterase activity through loss of interactions (either shape complementarity,
hydrophobicity, or π-π stacking) in several regions and steric hindrance in others, as described in
further detail below (Figure 2—figure supplement 1). Additionally, the distance between the two
active site zinc ions decreased from 3.8 A˚ to 3.3 A˚ (Figure 2A,B, light blue region and Figure 2—figure
supplement 1). The observed structural changes are subtle, at the sub-angstrom scale, and their
contributions to catalysis unquantified. However, the dispersion precision indicator (DPI; Cruickshank,
1999) for each of the structures is less than one-tenth of an angstrom, meaning that the observed
distance changes (including the 0.5 A˚ shift in the metal position) are significant (Figure 2—figure
supplement 2).
In neoPTE, the part of the active site necessary for phosphotriesterase activity has converged
back towards its original state. The regions of suboptimal binding were re-optimized for paraoxon
and the metal distance was restored to the 3.8 A˚ (Figure 2C). Moreover, the pattern of loop
flexibility that is characteristic of wtPTE was also restored in neoPTE (Figure 2—figure supplement
3). Furthermore, we measured linear free energy relationships for wtPTE, AE, and neoPTE for both
arylester and phosphotriester hydrolysis (Figure 2—figure supplement 4), that is, the dependence
of the catalytic parameters kcat/KM on the pKa of the leaving group. For phosphotriester hydrolysis
by wtPTE, a break in pKa dependence around 7 is consistent with the rate-limiting step changing on
either side of this break (Hong and Raushel, 1996; Tokuriki et al., 2012). By contrast, AE shows
a continuous, linear dependence over the whole pKa range, indicating that the rate-limiting step
does not change. In neoPTE, the pattern characteristic for wtPTE was restored. Together with the
observed structural convergence, the simplest assumption must be that the very similar active site
environment enables similar residue contributions to catalysis in wt- and neoPTE on phospho-
triesterase activity. However, active site convergence is not complete, as the naphthyl binding
pocket remains intact (Figure 2C, green region, Arg254 and Glu233), which likely explains why
neoPTE is still bifunctional.
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It should be pointed out that, at this stage, we do not know the extent to which the modification of
each structural element contributes to the overall >104-fold activity change. Also, we cannot exclude
the existence of alternative substrate binding modes from our model, as well as the role protein
dynamics play in the functional switch. However, in the combined forward and reverse evolution,
which involved a change in catalytic activity of >104 M−1s−1 in each direction, only four mutations were
located in the active site. Instead, most functional mutations occur in more remote positions.
Therefore, it is likely that fine-tuning of the active site by these remote mutations contributes
significantly to the activity changes. Taken together, the restoration of all structural elements key for
phosphotriesterase activity as well as the catalytic mechanism occurred despite the alternative
genotypic trajectory, suggesting that biophysical requirements exist for this particular active site
shape, and that phosphotriesterase activity may otherwise be inefficient.
To further investigate whether mutational accessibility is dictated by the necessity for structural
convergence to the wild-type active site, a parallel evolutionary experiment was performed. In this
experiment, we attempted to restore phosphotriesterase activity by a trajectory containing only new
mutations. To this end, we sequenced the improved variants after each round and removed all those
containing reversions. This trajectory only resulted in a 70-fold improvement in five rounds (Figure 3A),
after which the activity plateaued and no further improved variants could be found. This failure to reach
wild-type activity levels without reversions, as well as the fact that three out of the five new mutations
obtained (p135S, a203E, s308C, Figure 3B) were identical to the successful trajectory containing
reversions, emphasizes that the number of adaptive trajectories that lead to a wild-type level fitness
peak from AE are highly limited. However, trajectories involving neutral mutations, or trajectories which
do not pass through the best variant in each round but through less improved intermediates, may exist.
It is likely that a wild-type-like paraoxon binding pocket is compulsory to achieve efficient
phosphotriesterase activity, and only a small set of mutations (e.g., reversions or the combination of
reversions and new mutations that we identified) can provide such a solution.
Figure 3. An alternative experimental evolution, where fixation of back-to-wild-type reversions was prohibited, failed
to restore the original level of PTE activity. (A) Activity changes in the alternative trajectory. After five rounds, PTE
activity plateaued at a 65-fold improvement (trajectory 2), 340-fold lower than the main trajectory (trajectory 1).
(B) Mutations accumulated in the alternative trajectory. All clones containing reversions, which occurred frequently,
were removed after sequencing and thereby prohibited from fixating. Three of the five new mutations also fixated in
the main trajectory. The mutations c59Y and s238R occurred in variants revR1 and revR2b, but were not fixated after
DNA shuffling. Amino acids found in wtPTE are shown in lower case italics. All additional variants characterized and
sequenced in each round are shown in Supplementary file 1.
DOI: 10.7554/eLife.06492.010
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Emergence of sequence incompatibility between the two PTEs
Next, we set out to answer the question how the two enzymes exhibiting identical phosphotriesterase
activity, wt- and neoPTE, are connected on the adaptive landscape. If they populate the same fitness
plateau, amino acid exchanges between them should be neutral. On the other hand, a loss of function
upon interconversion between amino acids would indicate genotypic incompatibility (Kondrashov
et al., 2002; Lunzer et al., 2010;Wellner et al., 2013), meaning that the two enzymes occupy distinct
positions on the landscape that are poorly connected through a neutral network. To this end, we
characterized the effect of all 28 single point exchanges separating the two enzymes in each
background (56 mutants in total, Figure 4 and Supplementary file 2). Mutations are considered non-
neutral if they cause a >1.3-fold change in phosphotriesterase activity in lysate compared to the parent
background because, in our screening system, this cut-off enabled us to reliably identify improved
variants. Moreover, we have performed a statistical analysis of the mutational effects, which confirms
that a >1.3-fold change is significant (p-values <0.05) in almost all cases (statistics are provided in
Figure 4—source data 1 and Supplementary file 2B). According to this analysis, only eight of 28
exchanges were compatible; they were neutral in both backgrounds (Figure 4A). The remaining 20
positions showed incompatibility, 15 of which were partially incompatible, as the exchange was neutral
in one background but deleterious in the other (Figure 4B,C). Five exchanges were completely
incompatible; they severely decreased activity in both backgrounds (Figure 4D). Taken together,
despite >90% sequence identity between wt- and neoPTE, the reverse trajectory led to a functional
sequence that is poorly connected with the original one. It remains unknown whether the two
sequences comprise completely separate peaks on the adaptive landscape or are connected through
a neutral network, that is, if the neutral exchanges would permit the subsequent occurrence of initially
deleterious exchanges. However, because >70% of the mutated positions cause incompatibility, only
one out of the 54 exchanges confers higher fitness, and this exchange (neoPTE + f306M) would require
two simultaneous base changes, it is unlikely that an evolutionary transition between the two could
easily occur by adaptive or strong purifying selection.
Mutational epistasis underlies genotypic irreversibility
To understand how convergence to the original function and architecture was achieved despite
genotypic irreversibility and incompatibility, we performed a comprehensive mutational analysis. All
33 mutated positions were examined in the background of the three enzymes (wtPTE, AE, and
neoPTE), and in the background in which they originally occurred in the evolution (i.e., in the different
rounds) to identify mutations that are epistatic—that is, change their effect depending on the genetic
background (Figure 5 and Supplementary file 2). To determine whether or not the measured
changes were significant, the same stringent cut-off as described above for the comparison between
wt- and neoPTE was applied (statistics are provided in Supplementary file 2B–G). Furthermore, we
analyzed the crystal structures to determine which mutations caused the divergence and convergence
of the active site configuration.
The analysis revealed extensive epistasis during the forward and reverse evolution. In the forward
evolution, the effect of mutations is significantly altered after their fixation due to epistasis caused by
mutations subsequently accumulated in the trajectory. For example, some mutations initially increased
(t172I in round 6 and l271F in round 14) or were neutral to (l130V in round 14) phosphotriesterase
activity when they occurred in the trajectory, and were thus unfavorable to revert as their reversion
would not change (V130l) or decrease (I172t, F271l) activity (Figure 6A). However, reversion of these
mutations became possible (i.e., would lead to an increase in activity) in the background of AE
(Figure 6A). On the contrary, h254R decreased phosphotriesterase activity when it occurred in round
1 and therefore its reversion (R254h) would initially be favorable. However, the effect of this reversion
switched to unfavorable (R254h) when it was tested in AE (Figure 6B). Moreover, mutations in the
forward evolution had a permissive effect on the accumulation of new mutations and, in this way,
opened up a path towards the alternative trajectory taken in the reverse process; all new mutations had
a neutral or negative effect on phosphotriesterase activity in the genetic background of wtPTE
but most of them become positive in AE (Figure 6C); for example, AE-s308C (6.4-fold), AE-V130M
(5.4-fold) and AE-p135S (2.9-fold). Because these mutations can compete with the most favorable
reversions (>1.3–8-fold effect, Supplementary file 2), they were selected in the early rounds of the
reverse evolution, laying the foundation for the alternative trajectory.
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In the reverse evolution, the active site architecture necessary for phosphotriesterase activity was
restored largely through new mutations, which restricted the reversion of mutations accumulated in
the forward evolution. Overall, nine of the 10 reversions that were initially favorable in the background
of AE lost their favorable effect in neoPTE because of epistasis during the reverse evolution
(Figure 7A). We were able to trace the molecular basis of this effect in several cases as described in
the following. First, f306I enlarged the active site in the forward evolution, resulting in a loss of shape
complementarity to paraoxon. In the reverse evolution, the nearby s308C offsets this effect by
increasing the hydrophobicity of the pocket (Figure 2, Figure 7C, Figure 2—figure supplement 1A).
Figure 4. Genotypic incompatibility between wtPTE and neoPTE. (A–D) The effect of the 28 amino acid exchanges
separating the two enzymes was tested in the background of wtPTE and neoPTE, respectively. Activities are given
relative to the parent mutational background, wtPTE or neoPTE. Amino acids found in wtPTE are shown in lower
case italics. Color code as in Figure 1. (A) Compatible exchanges, neutral in both backgrounds. (B, C) Partially
incompatible exchanges, neutral in one background but deleterious for another. (D) Mutually incompatible
exchanges. Mutations causing a >1.3-fold change compared to the respective parent mutant (dotted line) are
considered non-neutral. p-values compared to each parent (Supplementary file 2B) and p-values for the effect of
each mutation Figure 4—source data 1 in the two backgrounds were calculated. Note that the effect of i313F,
which causes a significant decrease in wtPTE, is statistically not significant between wtPTE and neoPTE.
DOI: 10.7554/eLife.06492.011
The following source data is available for figure 4:
Source data 1. Comparison of the effect of mutations in wt- and neoPTE.
DOI: 10.7554/eLife.06492.012
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The redundancy of the mutations f306I and s308C was also evidenced by combinatorial mutational
analysis; incorporation of s308C restricts subsequent reversion of I306f due to sign epistasis
(Figure 7B). While this reversion would have been favorable in isolation, phosphotriesterase activity of
the double mutant AE-I306f-s308C is reduced compared to AE-s308C. Second, the active site was
narrowed in the forward evolution by l271F and several other mutations in loop7/8 including l272M
and i313F (Figure 7C and Figure 2—figure supplement 1B), causing steric hindrance for paraoxon.
The pocket was re-opened initially by the reversion F271l. Subsequently, the new mutation s258N
destabilized and altered the conformation of loop 7 and further enlarged the pocket (Figure 2,
Figure 2—figure supplement 1B). We also observed that incorporation of s308C and F271l restricted
the reversion of both l272M and f313I (M272l and I313f, Figure 7B). Third, the active site was
reshaped by a subtle ∼1.0 A˚ shift of Leu106 and Trp131, which was likely triggered by a cluster of
remote mutations occurring in the same loops (s102T, l130V, m138I, s137T, and v140M, Figure 7D,
and Figure 2—figure supplement 1C). In the reverse evolution, these residues are shifted back to
their original positions through two new remote mutations, p135S and V130M (Figure 7D). Again, the
two mutations are redundant and mutually exclusive; p135S restricts the reversion of m138I (I138m,
Figure 7B). Fourth, the distance between the two active site zinc ions decreased from 3.8 to 3.3 A˚ in
the forward evolution through displacement of the metal-chelating His201 and the β-metal
(Figure 7E), which was likely triggered by the combined action of several remote mutations in loops
4 and 5 (t172I, q180H, t199I, and a204G, Figure 2). In the reverse evolution, the positions of His201
and the β-metal, as well as the original inter-metal distance of 3.8 A˚, were restored through the
reversion I172t and formation of a new hydrogen bonding network with two additional new
mutations, a203E and g174D (Figure 7E). These examples demonstrate that rewiring the
intramolecular interaction network of the protein can result in the same physical solution in key
elements in the active site. Rewiring occurs because new mutations act as ‘epistatic ratchets’
Figure 5. Changes in phosphotriesterase activity upon mutations in five different backgrounds: wtPTE in the forward
evolution, AE in the reverse evolution, and neoPTE. Thirty-three positions were mutated in the entire evolution, two
of which (130 and 306) were mutated to two different amino acids. Amino acids found in wtPTE are shown in lower
case italics. Numbers indicate the fold change in activity caused by a mutation in a certain background
(Supplementary file 2B–F). Mutations causing a >1.3-fold change compared to the respective parent mutant are
considered non-neutral. p-values compared to each parent were calculated (Supplementary file 2B,D,F). The
mutations T341i in AE, l140M and t199I in the forward evolution, and V49a and s258N in the reverse evolution are not
significant (p-values >0.05). Therefore, out of 144 mutations, only five show a >1.3-fold effect, but are statistically not
significant. Boxes that are crossed out indicate that a mutation did not occur in this background. For direct
comparison, the activity changes resulting from a mutation are adjusted to the same direction—from the amino acid
found in AE to the respective other amino acid (label at the top). To illustrate, the effect of R254h was measured as
follows: AE and neoPTE contain Arg254, and thus the effect of R254h is directly calculated based on the comparison
between AE and AE-R254h (Fold changeR254h = ActicityAE-R254h/ActivityAE) and between neoPTE and neoPTE-R254h
(Fold changeR254h = ActicityneoPTE-R254h/ActivityneoPTE). However, because wtPTE and the forward evolution
background already contain His254, the effect of introducing this amino acid has to be calculated ‘in reverse’ by first
assuming to remove this mutation and then adding it back in, that is, based on the comparison between wtPTE-
h254R and wtPTE (Fold changeR254h = ActicitywtPTE/ActivitywtPTE-h254R). All mutational effects that were calculated in
this ‘reverse’ way are underlined. Note that wtPTE-h254R is identical to the round 1 variant and therefore the effect in
the forward evolution is the same as in the wtPTE background. Because R254h did not occur in the reverse evolution,
no effect could be calculated in this background and the respective box is crossed out.
DOI: 10.7554/eLife.06492.013
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(Bridgham et al., 2009) for potential reversions, restricting their fixation and thus leading to the
incompatible new enzyme neoPTE.
Discussion
Our work demonstrated that a >104-fold loss in phosphotriesterase activity, which accompanied the
functional transition to a distinct chemical reaction—arylester hydrolysis—via accumulation of 26
mutations, is readily restored when the selection pressure is reverted. Phenotypic reversal has been
observed in previous cases (Clarke, 1985; Lenski, 1988; Crill et al., 2000; Teotonio and Rose, 2000;
Kitano et al., 2008), supporting the notion that the phenotype is largely subject to deterministic
forces. The likelihood of evolutionary reversibility depends on the complexity of the system and the
distance in sequence and function from the ancestor, and it is possible that starting from a more
distantly evolved arylesterase would have failed to restore phosphotriesterase function. Moreover, we
modulated protein stability throughout the entire trajectory using overexpression of GroEL/ES to
avoid evolutionary dead ends caused by stability bottlenecks (Socha and Tokuriki, 2013;
Wyganowski et al., 2013). In the absence of chaperones, adaptation may have occurred through
a different pathway. Another limitation of our work is that we only examined two evolutionary
trajectories (the main trajectory and the trajectory without reversions). One could imagine conducting
multiple parallel evolutionary experiments to shed light on the repeatability of the trajectory taken,
but unfortunately our screening system is not amenable to such a throughput. Nevertheless, our
experiment shows that the genotype is subject to strong constraints: an alternative mutational
Figure 6. Epistasis between mutations in the forward evolution restricts some reversions while permitting others as
well as new mutations. (A) Several reversions change their effect from unfavorable upon their initial occurrence in the
forward evolution to favorable in AE. (B) Other reversions change their effect from favorable to unfavorable. Note
that, in the forward evolution, mutations occurred in the opposite direction as shown (l130V, t172I, l271F, and h254R),
but are given in the same direction as AE for direct comparison. Phosphotriesterase activity was too low to be
determined in AE + R254h, but at least 10-fold reduced. (C) The effect of new mutations changes from wtPTE (small
panel) to AE (large panel). Relative activities were calculated by comparing a variant containing a certain mutation
with one lacking only this mutation. Mutations causing a >1.3-fold change compared to the respective parent
mutant (dotted line) are considered non-neutral. p-values compared to each parent (Supplementary file 2B) and p-
values for the effect of each mutation in the two respective backgrounds shown in each panel were calculated
(Figure 6—source data 1, 2). Note that the mutation m293K, which causes a significant increase in AE, does not
have a significantly different effect in the two backgrounds. Amino acids found in wtPTE are shown in lower case
italics. Color code as in Figure 1. All other mutational effects in the different backgrounds are given in Figure 5 and
Supplementary file 2.
DOI: 10.7554/eLife.06492.014
The following source data are available for figure 6:
Source data 1. Comparison of the effect of mutations in the forward evolution and in AE (panels A, B).
DOI: 10.7554/eLife.06492.015
Source data 2. Comparison of the effect of mutations in wtPTE and AE (panel C).
DOI: 10.7554/eLife.06492.016
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pathway was taken which prevented retracing of the original pathway. Genotypic irreversibility was
caused by several factors. First, because selection in the forward evolution was only for increased
arylesterase activity (except in rounds 19–22), the effect of the mutations on phosphotriesterase
activity was stochastic: most decreased phosphotriesterase activity, some did not affect it, and some
increased phosphotriesterase activity. Therefore, even if one were to revert the mutations in the
reverse order of their occurrence (from rounds 22 back to 1), the lack of continuous activity increases
Figure 7. Convergence to the original active site configuration in the reverse evolution through rewiring of the
molecular interaction network leads to genetic incompatibility. (A, B) Epistasis during the reverse evolution causes
irreversibility and incompatibility. (A) The activity change of mutations that were favorable in the initial stage of
reverse evolution, but not reverted. neoPTE background: small panel; AE background: large panel. Color code as in
Figures 1, 2. Mutations causing a >1.3-fold change compared to the respective parent mutant (dotted line) are
considered non-neutral. p-values compared to each parent (Supplementary file 2B) and p-values for the effect of
each mutation in the two respective backgrounds shown in each panel were calculated (Figure 7—source data 1).
(B) Combinations of mutations that constrained the evolutionary trajectory due to sign epistasis. Phosphotriesterase
activity is shown on a linear scale. p-values are given in Supplementary file 2G. Note that the two mutants AE +
F271l + s308C and AE +M272l + s308C have non-significant p-values compared to the ‘double mutant’ in this series,
AE + F271l +M272l + s308C. However, determination of kcat/KM values confirms sign epistasis in this series (see also
Supplementary file 2G). (C–E) Amino acid changes in the forward (left panel) and reverse evolution (right panel).
(C) Reorganization of loops 7 and 8. A new mutation, s258N, caused the reorganization (see also Figure 2—figure
supplement 1A,B). (D) Different combinations of remote mutations in loop 3 resulted in identical positioning of
Leu106, Trp131, and Leu132 in wtPTE and neoPTE (see also Figure 2—figure supplement 1C). (E) Rewiring the
interaction network in neoPTE by remote mutations in loops 4 and 5 led to β-metal displacement (see also
Figure 2—figure supplement 1D). Amino acids found in wtPTE are shown in lower case italics.
DOI: 10.7554/eLife.06492.017
The following source data is available for figure 7:
Source data 1. Comparison of the effect of mutations in wtPTE and AE (panel A).
DOI: 10.7554/eLife.06492.018
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would prevent a gradual adaptive trajectory. Second, by the end of the forward evolution, several new
mutations able to increase paraoxonase activity emerged due to epistasis. The fixation of these
mutations then acts as an epistatic ratchet (Bridgham et al., 2009) that prevents reversions.
Therefore, as soon as the first new mutation accumulates, the trajectory deviates further from the
original path.
Our work suggests that only certain sets of mutations are able to cause phenotypic reversal.
Although genotypic redundancy was observed, the presence of at least some reversions was essential
for complete restoration of catalytic activity, and several new mutations were shared between the two
trajectories examined. Similarly, other experimental evolution studies that examined parallel
evolutionary trajectories starting from the same sequence often resulted in accumulation of the
same mutations (Bull et al., 1997; Salverda et al., 2011; Dickinson et al., 2013; Khanal et al., 2014).
These observations indicate that a number of functional mutations accessible from a particular starting
point are highly limited, and that the genotype is also subjected to deterministic forces to some
extent. In our case, the limited accessibility to functional mutation can be explained by the
requirement to adapt the wild-type active site configuration in order to obtain efficient
phosphotriesterase hydrolysis. Recent work by Harms et al. showed that the accessibility of functional
and permissive mutations on hormone receptors is also strongly constrained by biophysical require-
ments imposed on the binding pocket as well as by protein dynamics (Harms and Thornton, 2014).
Understanding such biophysical requirements and, in the case of enzymes, imperatives of chemical
reactivity, is essential to develop our knowledge of evolutionary dynamics and constraints, although the
exact nature of such requirements may be unique to each protein.
In the case of PTE, the combination of multiple subtle changes is required to fulfill these biophysical
requirements and completely switch the enzyme’s ability to recognize two different substrates
(paraoxon vs. 2NH: tetrahedral vs. planar, P–O bond vs C–O bond cleavage, trigonal bipyramidal
vs. tetrahedral transition state geometry). All but four of the 33 mutations occur in locations remote
from the active site and act by fine-tuning rather than directly changing the active site configuration.
Some changes occur at the sub-A˚ level (e.g., the shift in Trp131, Leu132, and the β-metal), and
possibly act by influencing the dynamics of the active site loops. It may be that only remote mutations
can achieve such subtle optimization. A mutation directly in the active site would result in a larger,
more disruptive change (e.g., even a single additional carbon center would fill an additional 4 A˚
radius) and therefore be unable to provide the necessary fine-tuning. Other directed evolution studies
also observed the accumulation of remote mutations (Morley and Kazlauskas, 2005), suggesting that
fine-tuning of the active site may be a common strategy to implement a new function.
Our work reveals that the adaptive landscape of PTE is highly rugged: even single amino acid
changes can regulate activities upwards or downwards and also predetermine the potential effect of
subsequent mutations. As discussed above, because multiple mutations can directly or indirectly
affect the same key component for catalysis, their effects are likely to be epistatic. Therefore, the
alternative trajectory is caused by epistasis between mutations: frequently, those mutations that
accumulate first have a permissive or restrictive effect on subsequent mutations. Overall, >70% of
mutations have highly variable effects on phosphotriesterase activity, depending on the genetic
background (26 out of 33 positions, Figure 5), and ∼40% showed sign epistasis (7 out of 33). The role
of epistasis in natural evolution has recently received much attention, but its extent and prevalence
are still under debate (Whitlock et al., 1995; Poelwijk et al., 2007; de Visser et al., 2011; Breen
et al., 2012; Harms and Thornton, 2013;McCandlish et al., 2013; Kaltenbach and Tokuriki, 2014).
Our findings suggest a high frequency of strong epistatic interactions during functional adaptation
and therefore support the view that epistasis is paramount in shaping evolution. However, while
restrictive mutations block many of the possible evolutionary trajectories, as has been previously
emphasized, permissive mutations simultaneously open up new pathways, avoiding ‘evolutionary
dead-ends’ and contributing to the diversity of enzyme homologs found in nature.
Moreover, our study demonstrates how genotypic irreversibility leads to the emergence of
a functional sequence incompatible with the original one (Kondrashov et al., 2002;Maheshwari and
Barbash, 2011), and implies the importance of evolutionary contingency on the genotypic level.
In nature, the environment never ceases to change and a temporary relaxation in selection pressure
(i.e., the level and type of nutrients or toxins) followed by re-adaptation (through both reversions and
new compensatory mutations) may be common (Akashi et al., 2012). Higher levels of organization
(such as metabolic or regulatory networks) might be subject to similar contingency; restoration of
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a certain function may be achieved by alternative mutations in other parts of the protein structure, in
other domains, or in a different protein altogether. If the mutations are mutually exclusive, sequence
incompatibilities may arise rapidly. Therefore, in addition to proposed mechanisms such as genetic
drift (Akashi et al., 2012), genotypic irreversibility may contribute to the prevalence of incompatibility
between orthologous enzymes (Lunzer et al., 2010; Kvitek and Sherlock, 2011; Corbett-Detig
et al., 2013; Wellner et al., 2013; Schumer et al., 2014; Shafee et al., 2015).
Finally, our observations have important implications for the engineering of highly efficient
enzymes—for example, how fine-tuning of multiple active site regions can confer significant activity
changes, and how context-dependent such changes are. As our understanding of protein sequence-
structure-function relationships grows, further rational and computational approaches need to be
developed to address the role of remote mutations and epistasis to enhance our ability to create
tailor-made proteins.
Materials and methods
Error-prone PCR
Error-prone PCR libraries were generated using nucleotide analogues (8-oxo-2′-deoxyguanosine-5′-
triphosphate [8-oxo-dGTP] and 2′-deoxy-P-nucleoside-5′-triphosphate [dPTP]) or Mutazyme (GeneMorph
II Random Mutagenesis kit, Agilent, Santa Clara, CA, United States). A typical protocol using nucleotide
analogues can be found in Tokuriki and Tawfik (2009). A typical protocol using Mutazyme starts with
a 50 μl PCR reaction containing 50 ng of pET-Strep-PTE template and 0.8 μM of outer primers (forward
TTCCCCATCGGTGATGTC, reverse GTCACGCTGCGCGTAAC). Cycling conditions were: initial de-
naturation at 95˚C for 2 min followed by 10 cycles of denaturation (30 s, 95˚C), annealing (30 s, 63˚C) and
extension (1 min, 72˚C), and a final extension step at 72˚C for 10 min. Plasmid was removed by treatment
with Dpn I (NEB, Ipswich, MA, United States). The PCR product was purified using the QIAquick PCR
purification kit (Qiagen, Netherlands), and amplified further with BIOTAQ DNA polymerase (Bioline,
United Kingdom) using inner primers (forward ACGATGCGTCCGGCGTA, reverse GCTAGTTATTGCT
CAGCG) and starting from 20 ng of template in a 100 μl reaction volume. Cycling conditions were: initial
denaturation at 95˚C for 2 min followed by 20 cycles of denaturation (30 s, 95˚C), annealing (1 min, 58˚C)
and extension (30 s, 72˚C), and a final extension step at 72˚C for 2 min. This gave an average of two amino
acid substitutions per gene.
DNA shuffling
PTE genes of selected variants were amplified by PCR from pET-Strep-PTE plasmids using the outer
primers and BIOTAQ DNA polymerase. Cycling conditions were: initial denaturation at 95˚C for
2 min followed by 25 cycles of denaturation (30 s, 95˚C), annealing (1 min, 63˚C) and extension (1 min,
72˚C), and a final extension step at 72˚C for 2 min. PCR products were purified using the QIAquick
PCR purification kit and mixed at equal amounts. Before the preparative digest, conditions were
optimized by digesting 1 μg of template DNA with a range of DNase I concentrations (Fermentas,
Waltham, MA, United States). DNase digest buffer (10×) consists of 0.5 M Tris-HCl pH 7.5
supplemented with 0.5 mg/ml BSA. In addition, reactions contained 10 mM MnCl2. Reactions were
incubated for 10 min at 37˚C, stopped by addition of 1/5 vol of stop buffer (30 mM EDTA pH 8.0, 30%
glycerol and ≈0.6× of a DNA loading buffer) and analyzed by agarose gel electrophoresis in TBE
buffer (2% agarose gel, 45 mM Tris, 45 mM boric acid, and 1 mM EDTA pH 8.0; for all other agarose
gel electrophoresis procedures, we used 1% agarose gels and TAE buffer, which is 40 mM Tris, 20 mM
acetic acid, and 1 mM EDTA pH 8.0). Reactions were scaled up to 10–15 μg of DNA and the digest
repeated at the appropriate DNase dilution to give fragments in the range of 50–150 bp. Fragments
were purified by gel extraction and 60–80 ng used in a 20 μl assembly PCR. This PCR was performed
with Herculase I (Stratagene, La Jolla, CA, United States). Cycling conditions were: initial denaturation
at 96˚C for 90 s followed by 35 cycles of denaturation (30 s, 94˚C), annealing (incremental 3˚C steps from
65˚C down to 41˚C, 90 s each) and extension (2 min, 72˚C), and a final extension step at 72˚C for 10 min.
Full-length assembly products were amplified using the inner primers and BIOTaq DNA polymerase
under the following cycling conditions: initial denaturation at 95˚C for 2 min followed by 25 cycles of
denaturation (30 s, 95˚C), annealing (1 min, 58˚C) and extension (1 min, 72˚C), and a final extension step
at 72˚C for 2 min. The amount of assembly product used as template for this reaction was varied and
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product formation verified by 1% agarose gel electrophoresis. Fractions containing product were
pooled and purified using the QIAquick PCR purification kit.
Construction of single and double mutants
Mutants were constructed by site-directed mutagenesis as described in the QuikChange Site-Directed
Mutagenesis manual (Agilent).
Cloning
PCR products and pET-Strep-ACP vector were digested with Fermentas FastDigest Nco I and Hind
III (or Kpn I, see Supplementary file 1) for 1 hr at 37˚C. The vector was treated with CIP (calf-
intestinal alkaline phosphatase, NEB, Ipswich, MA, United States) for an additional hour and
subsequently insert and vector were purified from 1% agarose gel using the QIAquick gel extraction
kit followed by the Qiagen PCR purification kit. Ligations were performed at a vector:insert mass
ratio of 1:1 using T4 DNA ligase (NEB, Ipswich, MA, United States) supplemented with 0.5 mM ATP
(NEB, Ipswich, MA, United States) for 2 hr at 22˚C or 16˚C overnight. Prior to transformation,
reactions were purified by ethanol/glycogen (Fermentas, Waltham, MA, United States) precipitation.
Transformation into electrocompetent E. cloni 10G (Lucigen, Middleton, WI, United States) yielded
at least 105 colonies.
Pre-screen on agar plates
Plasmids were extracted and re-transformed into E. coli BL21 (DE3) containing pGro7 plasmid for
overexpression of the GroEL/ES chaperone system. Transformation reactions were plated on an
average of 10 agar plates (140 mm diameter) containing 100 μg/ml ampicillin (or 50 μg/ml kanamycin,
see Supplementary file 1) and 34 μg/ml chloramphenicol such that each plate contained 200–1000
colonies, leading to a final library size of 2000–10,000 variants. Colonies were transferred onto
nitrocellulose membrane (BioTrace NT Pure Nitrocellulose Transfer Membrane 0.2 μm, PALL Life
Sciences, Port Washington, NY, United States), which was then placed onto a second plate
additionally containing 1 mM isopropyl β-D-1-thiogalactopyranoside (IPGT) 200 μM ZnCl2 (to ensure
availability of Zn2+ ions necessary for enzymatic activity), and either 20% (wt/vol) arabinose for chaperone
overexpression or 20% (wt/vol) glucose for repression of chaperone expression. After expression
overnight at room temperature for plates containing arabinose or for 1 hr at 37˚C for plates containing
glucose, the membrane was placed into an empty petri dish. For low activity levels of the parent gene
where a maximum signal is desirable, cells were lysed prior to the activity assay by alternating three times
between storage at −20˚C and 37˚C. For higher activities, the lysis step was omitted, making it easier to
differentiate between different colonies. For the activity assay, 20–25 ml of 0.5% Agarose in 50 mM Tris-
HCl buffer, pH 7.5 containing 200 μM 2NH (Sigma, St. Louis, MO, United States) and Fast Red (Sigma, St.
Louis, MO, United States) was poured onto the membrane. Red color developed within 30 min. To
screen for phosphotriesterase activity, the buffer contained varying concentrations of fluorogenic
phosphotriester instead of 2NH/Fast Red as indicated in Supplementary file 1. Turnover of
O-fluoresceinyl-O,O-diethyl-thiophosphate (fluoresceinyl-DETP, excitation 495 nm, emission 520 nm)
was detected in a Typhoon 9400 scanner (GE Healthcare, Wauwatosa, WI, United States) after an
appropriate incubation time (0–3 hr). In the case of 7-O-diethylphosphoryl-3-cyano-4-methyl-7-
hydroxycoumarin (Me-DEPCyC), activity was detected in an agarose gel imager (excitation 365 nm)
using a SYBR Safe filter.
Screens in 96-well plates
Colonies exhibiting high enzymatic activity identified in the pre-screen were picked and re-grown in four
to six 96-deep well plates overnight at 30˚C, leading to a library of 400–600 pre-selected variants. Wells
contained 200 μl lysogeny broth (LB) supplemented with 100 μg/ml ampicillin and 34 μg/ml
chloramphenicol. Subsequently, deep well plates containing 500 μl LB per well supplemented with
ampicillin, chloramphenicol, and 20% (wt/vol) arabinose or glucose (depending on whether
chaperone overexpression was to be induced or repressed) were inoculated with 25 μl of pre-
culture and grown for 2–3 hr at 37˚C until the OD600 reached ∼0.6. Expression of PTE variants was
induced by adding IPTG to a final concentration of 1 mM and cultures were incubated for an
additional 2 hr at 30˚C or for 1 hr at 37˚C in rounds aimed at reducing chaperone dependence. Cells
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were spun down at 4˚C at maximum speed (3320×g) for 5–10 min and the supernatant was removed.
Pellets were frozen for a minimum of 30 min at −80˚C and subsequently lysed by addition of 200 μl 50 mM
Tris-HCl pH 7.5 supplemented with 0.1% (wt/vol) Triton-X100, 200 μM ZnCl2, 100 μg/ml lysozyme, and ∼1
μl of benzonase (25 U/μl, Novagen, Madison, WI, United States) per 100 ml. After 30 min of lysis at room
temperature, cell debris was spun down at 4˚C at 3320×g for 20 min. Depending on the activity level of the
library, clarified lysate was diluted prior to the activity assay to obtain a good signal in the initial linear
phase of the reaction. Reactions were performed in transparent 96-well plates containing 200 μl per well
(20 μl lysate + 180 μl of 200 μM substrate in 50 mM Tris-HCl, pH 7.5 supplemented with 0.02% Triton-X100
in the case of paraoxon and 0.1% in the case of 2NH/FR). Paraoxon hydrolysis was monitored at 405 nm;
2NH hydrolysis was monitored at 500 nm via complex formation with Fast Red. Improvements >1.3-fold
relative to the previous round were considered significant. The best clones were picked and re-grown in
triplicate. The observed initial rates were normalized to cell density (determined by the OD600) and the
average values determined. Approximately 10 improved variants were sequenced after each round.
A description of each directed evolution round including selection criteria, the mutations found in each
sequenced variant, and mention of the variants chosen as templates for the next library generation can be
found in Supplementary file 1.
Purification of Strep-tagged proteins for enzyme kinetics
pET-Strep-PTE plasmids were transformed into E. coli BL21 (DE3) and grown at 37˚C in TB medium
containing 100 μg/ml ampicillin and 200 μM ZnCl2. Expression was induced with 0.4 mM IPTG when
cell density reached an OD600 of 0.6 units and cells grown overnight at 20˚C. Cells were harvested by
centrifugation at 3320×g and 4˚C for 10 min, resuspended and lysed for 1 hr at room temperature
using a 1:1 mixture of B-PER Protein Extraction Reagent (Thermo Scientific, Waltham, MA, United
States) and 50 mM Tris-HCl buffer, pH 7.5 containing 200 μM ZnCl2, 100 μg/ml lysozyme and ∼1 μl of
benzonase per 100 ml. Cell debris was removed by centrifugation at 30,000×g and 4˚C for 45 min and
the clarified lysate passed through a 45 μm filter before loading onto a Strep-Tactin Superflow High
capacity column (1 ml column volume). After several washes with 50 mM Tris-HCl buffer, pH 7.5
containing 200 μM ZnCl2, Strep-PTE variants were eluted in the same buffer containing 2.5 mM
desthiobiotin according to the manufacturer’s instructions (IBA BioTAGnology, Germany). Protein was
dialyzed overnight against 50 mM Tris-HCl buffer, pH 7.5 containing 100 mM NaCl and concentrated
if necessary. This protocol was adapted for purification in 96-well format by using AcroPrep 96 Filter
Plates (Pall Life Sciences, Port Washington, NY, United States) according to the manufacturer’s
instructions. Lysates were clarified using Lysate Clearance plates (3 μm GxF, 0.2 μm Supor) and
transferred to filter plates (0.45 μm GHP) containing 50 μl Strep-tactin resin per well. Wells were
washed 3× with 50 mM Tris-HCl pH 8.5 containing 100 mM NaCl and 200 μM ZnCl2 and 3× with pH
7.5 buffer. After elution, samples were concentrated and elution buffer removed using ultrafiltration
plates (Omega 10K membrane).
Kinetic characterization of variants
Paraoxon, 2NH, and Fast Red were purchased from Sigma (St. Louis, MO, United States). Substrates for
linear free energy relationships were gifts from Dan Tawfik’s laboratory and their synthesis is described in
Khersonsky and Tawfik (2005). Absorbance wavelengths and extinction coefficients are given in
Supplementary file 2. For determination of initial rates in lysate, cells were grown and assayed in at least
duplicate as described under the section ‘Screens in 96-well plates’. The experiment was repeated and
the average change relative to the respective parent variant and the standard deviation were
determined (Supplementary file 2). A Student’s t-test was performed to obtain p-values. Where
applicable, p-values were also calculated to determine whether the effect of a certain mutation in two
different backgrounds (rather than compared to the parent mutant lacking this mutation) is significant.
For determination of initial rates using purified enzyme, variants were expressed and purified in 96-well
format in at least duplicate and assayed as described above in ‘Screens in 96-well plates’. For
determination of Michaelis–Menten parameters, reactions were performed in triplicate at a range of
substrate concentrations (0–2000 μM). Reactions were initiated by addition of 180 μl of substrate
solution (in 50 mM Tris-HCl, pH 7.5 supplemented with 0.02–0.1% Triton X-100) to 20 μl of enzyme in 50
mM Tris-HCl, pH 7.5 supplemented with 200 μM ZnCl2 and 0.02% Triton X-100. Data were fit to
Michaelis–Menten kinetics in Kaleidagraph.
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Purification of untagged proteins for crystallization
AE and neoPTE genes were cloned into pET32-trx plasmid without Strep-tag using FastDigest NcoI
and HindIII as described above, transformed into E. coli BL21 (DE3), and grown for 72 hr at 30˚C in TB
medium containing 100 μg/ml ampicillin and 500 μM ZnCl2. Cells were harvested by centrifugation at
3320×g and 4˚C for 10 min, resuspended in 20 mM Tris-HCl pH 8 containing 100 μM ZnCl2 and lysed
by sonication (OMNI Sonic Ruptor 400, Thermo Scientific, Waltham, MA, United States, 3× 30 s on/60
s off, amplitude 40%). Cell debris was removed by centrifugation at 30,000×g and 4˚C for 45 min and
lysate filtered through 45 μm filters (Millipore). The lysate was loaded onto two HiPrep Q FF columns
(GE Healthcare, Wauwatosa, WI, United States) in series. PTE elutes in the flow through as well as the
early wash fractions. Active fractions were pooled and passed through a 45 μm filter. The sample was
concentrated over a Millipore spin column (MWCO 30,000) and purified by gel filtration (HiLoad 16/60
Superdex 200 prep grade, GE Healthcare, Wauwatosa, WI, United States). Protein was concentrated
to 12 mg/ml and stored at 4˚C.
Crystallization, data collection and structure determination
Crystals of wtPTE, AE, and neoPTE were obtained by vapor diffusion from a solution containing
protein (10 mg/ml) plus 20–30% wt/vol 2-methane-4-pentane diol (MPD), buffered to pH 6.5 by 0.1
M sodium cacodylate, as described previously (Tokuriki et al., 2012). Serial microseeding was
performed to increase crystal size (Bergfors, 2003). Crystals grew to approximately 200
micrometers and were soaked in 40% MPD, 0.1 M sodium cacodylate as cryoprotectant for
5–10 min and then flash-cooled to 100 K in the gaseous nitrogen cryostream of a cooling device
(Oxford Cryosystems, United Kingdom). Data were collected from frozen crystals on beamline MX1
of the Australian Synchrotron (AS). The data were indexed and integrated by XDS (Kabsch, 2010)
and Aimless (Evans and Murshudov, 2013), with data cut-off being made at the highest resolution
that retained a mean half dataset correlation coefficient (CC1/2) of at least 0.5 in the outer shell
(Supplementary file 3) (Karplus and Diederichs, 2012). Although all three crystals were
crystallized in the same conditions, neoPTE crystallized in a different space group with different
unit cell dimensions (p65, with a h, −h−k, l merohedral twin operator, vs C2221). A starting model
for refinement (R18; PDB ID: 4E3T) (Tokuriki et al., 2012) was used to provide initial phases.
Structures were refined with phenix.refine (Afonine et al., 2012) and validated with molprobity
(Chen et al., 2010), as implemented in the phenix software suite (Supplementary file 3) (Adams
et al., 2010).
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Supplementary	file	1	for Kaltenbach	at	al.,	Reverse	evolution	leads	to	genotypic	
incompatibility	despite	functional	and	active-site	convergence 
Description	of	the	directed	evolution	rounds	
	Supplementary	 File	 1A.	 Library	 creation	 and	 screening	 conditions	 for	 rounds	 19-22	 of	 the	
forward	evolution	and	all	rounds	of	the	reverse	evolution.	Rounds	1-18	have	been	described	in	
(Tokuriki	et	al.,	2012).	
[a] To	avoid	cross-contamination	between	 libraries,	 the	second	trajectory	 library	was	placed	 into	a	pET-
Strep	 vector	with	 kanamycin	 resistance	 from	 round	 rev3b.	 Additionally,	 the	HindIII	 restriction	 site	was
replaced	by	a	KpnI	site	from	round	rev5b	to	prevent	cross-contamination	during	cloning.
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[b] Fluoresceinyl-DETP:	O-fluoresceinyl-O,O-diethyl-thiophosphate,	Me-DEPCyC:	7-O-diethylphosphoryl-3-
cyano-4-methyl-7-hydroxycoumarin.
Information	about	Supplementary	Files	1B-V.	These	files	give	an	overview	of	all	selected	
clones.	 For	 activity	 measurements,	 cells	 were	 grown	 in	 triplicate.	 Cell	 lysates	 were	
sufficiently	diluted	to	determine	initial	rates	using	paraoxon	and/or	2NH	as	substrates,	
normalized	 to	 cell	 density	 (determined	 by	 absorption	 at	 600	 nm)	 and	 averaged.	
Activities	 are	 given	 relative	 to	 the	 activity	 of	 the	 parent	mutant	 (columns	 “2NH”	 and		
“paraoxon”).	The	activity	of	the	parent	mutant	is	shown	in	the	first	row	of	each	table	in	
italics.	Specificity	for	2NH	(column	“2NH/paraoxon”)	is	given	as	the	ratio	of	2NH	activity	
to	 paraoxon	 and	 is	 not	 normalized	 to	 the	 parent	 mutant.	 Chaperone	 dependence	
(column	 “+GroEL/-GroEL”)	 is	 the	 ratio	 of	 the	 activity	 measured	 in	 the	 presence	 of	
GroEL/ES	to	the	activity	in	the	absence	of	GroEL/ES	and	is	also	not	normalized.	Note	that	
data	from	different	tables	is	not	directly	comparable	as	lysates	were	diluted	to	different	
extents	in	different	rounds	(ranging	from	no	dilution	to	5	×	104-fold)	depending	on	the	
activity	 of	 the	 variants.	 Mutations	 are	 given	 relative	 to	 the	 parent	 mutant	 unless	
otherwise	 indicated.	 Enriched	 mutations	 are	 shown	 in	 grey	 boxes.	 For	 the	 reverse	
evolution,	all	changes	 in	previously	mutated	positions	are	shown	in	bold,	and	back-to-
ancestor	mutations	are	additionally	written	in	small,	italic	letters.	
Forward	evolution	
Round	1-18.	These	rounds	have	been	described	in	detail	in	the	Supporting	Information	
of	reference	(Tokuriki	et	al.,	2013).	
Round	19.	The	 library	was	created	by	error-prone	PCR	 from	PTE-R18	using	mutazyme	
and	screened	for	increased	specificity	for	2NH.	
Supplementary	 File	 1B.	 Activity,	 selectivity	 (2NH/paraoxon),	 and	 mutations	 of	 round	 19	
variants.	
[a] This	variant	contained	only	synonymous	mutations.
2NH/
paraoxon
R18 1.0 1.0 1.5
19_1 0.2 0.5 3.4 m314T r356Q STOP365
19_2 0.6 1.2 2.8 [a]
19_3 0.4 1.2 4.6 v183A i288V i341T
19_4 "R19" 0.1 0.7 11.9 a74T v143A q180H t311A
19_5 0.1 0.5 9.4 l132F t177I p342S
19_6 0.04 0.3 11.6 g101M
19_7 0.1 0.6 7.2 v183E
19_8 0.5 1.1 3.7 m317L
19_9 0.3 0.9 4.1 t45A v183L
19_10 0.2 0.5 3.5 l113M e144V t202A
Variant paraoxon 2NH Mutations
50
Round	20.	The	library	was	created	by	DNA	shuffling	of	the	10	round	19	variants	
(Supplementary	File	1B)	and	screened	for	increased	specificity	for	2NH.	
Supplementary	 File	 1C.	 Activity	 (relative	 to	 R19),	 selectivity	 (2NH/paraoxon),	 and	 mutations	
(relative	to	R18)	of	round	20	variants.	
Round	21.	The	 library	was	created	by	error-prone	PCR	 from	PTE-R20	using	mutazyme	
and	screened	for	increased	specificity	for	2NH.	
Supplementary	File	1D.	Activity,	selectivity	 (2NH/paraoxon),	chaperone	dependence	(+GroEL/-
GroEL),	and	mutations	of	round	21	variants.	
[a] n.d.:	Activity	 in	the	absence	of	GroEL/ES	was	not	detected;	therefore,	chaperone	dependence	could
not	be	determined.
[b] This	variant	contained	only	synonymous	mutations.
Round	22.	The	library	was	created	by	error-prone	PCR	from	PTE-R21	using	mutazyme	
and	screened	for	reduced	chaperone	dependence.	
2NH/
paraoxon
R19 1.0 1.0 1.7
20_1 0.2 0.6 4.7 v183E v292H m317L p342S
20_2 0.2 0.6 5.8 q180H s238C
20_3 "R20" 0.2 0.7 6.2 t45A e144V q180H
m314T i341T
20_4 0.2 0.6 5.1 t45A q180H
20_5 0.2 0.6 5.5 v183E m317L
20_6 0.2 0.7 3.9 e144V v183A m317L
20_7 0.4 0.9 5.4 r36Q v183E
20_8 0.2 0.7 5.6 t45A q180H m317L
20_9 0.3 0.9 6.7 t45A v183E
20_10 0.3 1 5.3 v183L m317L
20_11 0.3 1 3.6 m314T
2NH MutationsVariant paraoxon
2NH/ +GroEL/
paraoxon -GroEL
R20 2.7 12.3 4.6 17.3
21_1 "R21" 0.5 1 8.1 6.4 s102T
21_2 0.8 1 5.8 18.4 t361A
21_3 0.9 1 5.3 18.4 [b]
21_4 0.3 0.6 9.9 n.d.[a] y156N a193T
s238N y292H l362M
21_5 0.4 0.7 8.4 n.d.[a] a126P g261D
Variant paraoxon 2NH Mutations
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	Supplementary	File	1E.	Activity,	selectivity	(2NH/paraoxon),	chaperone	dependence	(+GroEL/-
GroEL),	and	mutations	of	round	22	variants.	
[a] These	variants	contained	only	synonymous	mutations.
Round	 23-25.	 Three	 additional	 rounds	 of	 forward	 evolution	 were	 performed,	 but	 no	
variants	 with	 further	 reduced	 phosphotriesterase	 activity	 could	 be	 found	 without	
compromising	arylesterase	activity.	
Reverse	evolution	
Round	rev1.	The	library	was	created	by	error-prone	PCR	from	AE	using	mutazyme	and	
screened	for	increased	phosphotriesterase	activity.	
	Supplementary	File	1F.	Phosphotriesterase	activity	and	mutations	of	round	rev1	variants.	
Round	 rev2.	 The	 library	 was	 created	 by	 DNA	 shuffling	 of	 9	 round	 rev1	 variants	
(Supplementary	File	1F)	and	4	round	25	variants	 (Supplementary	File	1G)	and	screened	
for	increased	phosphotriesterase	activity.	
2NH/ +GroEL/
paraoxon -GroEL
R21 15.7 41 0.4 3.1
22_1 1.1 1.1 0.4 3.4 [a]
22_2 1.1 1.2 0.4 3 [a]
22_3 0.6 1.1 0.2 3.9 e263Q
22_4 0.5 1 0.1 2.9 r363Q
22_5 "AE" 3.5 0.9 0.3 1.5 v176M
22_6 0.8 1.2 0.3 3.3 [a]
22_7 0.9 1 0.4 2.7 r363Q
Variant paraoxon 2NH Mutations
AE 1.0
rev1_1 3.1 M176A s308I
rev1_2 4.6 I172t
rev1_3 4 I172t s222N
rev1_4 "revR1" 9.9 c59Y s238R s308C
rev1_5 9.2 f104Y q290H
F313i T314S
rev1_6 5.4 I172t
rev1_7 6.3 V130M
rev1_8 1.7 d35G s308N
rev1_9 2.2 h257L
MutationsVariant paraoxon
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Supplementary	 File	 1G.	 Activity,	 selectivity	 (2NH/paraoxon),	 and	 mutations	 of	 round	 25	
variants.	
Supplementary	File	1H.	Phosphotriesterase	activity	and	mutations	of	round	rev2	variants.	
Round	 rev3.	 The	 library	 was	 created	 by	 error-prone	 PCR	 from	 PTE-revR2	 using	
mutazyme	and	screened	for	increased	phosphotriesterase	activity.	
Supplementary	File	1I.	Phosphotriesterase	activity	and	mutations	of	round	rev3	variants.	
2NH/
paraoxon
AE 1.0 1.0 1.3
25_1 2.4 0.2 0.1 d121G i284V k285N I172t m293K
25_2 1.8 0.2 0.1 I172t l283S
25_3 15.2 0.3 0 s308C
25_4 4.5 0.4 0.1 t234I M272l k175M k339Q
Variant paraoxon 2NH Mutations
AE 1.0
rev2_1 151 V130M I172t s308C
rev2_2 151.7 V130M I172t s308C
rev2_3 145.7 a92T V130M I172t s308C T341i
rev2_4 136 i37V I172t s205G s308C d232G
rev2_5 124.7 k82R V130M I172t s308C
rev2_6 "revR2" 142 V130M I172t s308C
rev2_7 172.7 V130M I172t s308C
rev2_8 141.7 V130M I172t s308C
rev2_9 173.3 V130M I172t s308C i328V
rev2_10 168.7 V130M I172t s308C
rev2_11 160.3 V130M I172t m293K s308C
rev2_12 164.3 V130M I172t s308C
rev2_13 160.7 V130M I172t s308C
rev2_14 46.3 f104Y I172t s308C
rev2_15 49 f104Y I172t s308C
rev2_16 55 f104Y I172t s308C
paraoxon MutationsVariant
revR2 1.0
rev3_1 3.5 [a]
rev3_2 "revR3" 6.5 F271l
rev3_3 5.3 t137S h257P i296V
rev3_4 4.7 [a]
rev3_5 4.3 t177S F271l
rev3_6 4.4 [a]
rev3_7 4.6 p135S
rev3_8 3.6 [a]
rev3_9 5.1 p135S
rev3_10 3.4 i44V
rev3_11 1.8 [a]
rev3_12 3 [a]
rev3_13 1.7 r85G
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Round	 rev4.	 The	 library	 was	 created	 by	 DNA	 shuffling	 of	 13	 round	 rev3	 variants	
(Supplementary	File	1I)	and	screened	for	increased	phosphotriesterase	activity.	
Supplementary	File	1J.	Phosphotriesterase	activity	(relative	to	revR3)	and	mutations	(relative	to	
revR2)	of	round	rev4	variants.	
Round	 rev5.	 The	 library	 was	 created	 by	 error-prone	 PCR	 from	 PTE-revR4	 using	
mutazyme	and	screened	for	reduced	chaperone	dependence.	
	Supplementary	 File	 1K.	Phosphotriesterase	 activity,	 chaperone	 dependence	 (+GroEL/-GroEL),	
and	mutations	of	round	rev5	variants.	
revR3 1.0
rev4_1 1.8 i44V F271l s276P
T314m t350I
rev4_2 1.6 M176A t202S F271l i296V
rev4_3 1.4 p135S F271l
rev4_4 2.8 V49a T137s F271l
rev4_5 1.4 i44V F271l I296V l362M
rev4_6 1.3 p135S F271l
rev4_7 2 V49a p135S r189Q i296V T314m
rev4_8 "revR4" 2.7 p135S F271l T314m
rev4_9 1.9 F271l T314m
rev4_10 1.3 F271l
rev4_11 3.7 p135S F271l T314m
rev4_12 2.2 p135S F271l T314m
rev4_13 1.8 p135S r88L F271l s276P
rev4_14 1.3 F271l
paraoxon MutationsVariant
+GroEL/
-GroEL
revR4 1.0 7.6
rev5_1 1.9 6.7 g174D a347T
rev5_2 1.8 7.2 k175N STOP366C
rev5_3 1.5 8.5 t52A
rev5_4 "revR5" 1.6 4.6 m293K
rev5_5 1 4.1 a347E
rev5_6 0.5 2.3 t345S
rev5_7 4.3 6.4 M176v a203E
Variant paraoxon Mutations
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Round	 rev6.	 The	 library	 was	 created	 by	 DNA	 shuffling	 of	 the	 7	 round	 rev5	 variants	
shown	 in	 Supplementary	 File	 1K	 and	 an	 additional	 10	 unsequenced	 variants	 and	
screened	for	reduced	chaperone	dependence.	
Supplementary	File	1L.	Phosphotriesterase	activity	 (relative	 to	 revR5),	chaperone	dependence	
(+GroEL/-GroEL),	and	mutations	(relative	to	revR4)	of	round	rev6	variants.	
Round	 rev7.	 The	 library	 was	 created	 by	 error-prone	 PCR	 from	 PTE-revR6	 using	
mutazyme	and	screened	for	increased	phosphotriesterase	activity.	
Supplementary	File	1M.	Phosphotriesterase	activity	and	mutations	of	round	rev7	variants.	
[a] These	variants	contained	only	synonymous	mutations.
+GroEL/
-GroEL
revR4 0.4 10.3
revR5 1.0 9.2 m293K
rev6_1 1.0 6.6 a203E m293K
rev6_2 1.1 8.7 a203E
rev6_3 0.8 6.9 t52A i167V a203E
rev6_4 "revR6" 0.7 6.9 a203E
rev6_5 0.8 6.8 a203E m293K t345S
rev6_6 1.2 8.7 k175E a203E
rev6_8 1.2 10 a203E
rev6_10 1.8 12.7 a203E
rev6_11 1.1 9.7 t173A a203E A203E
paraoxon MutationsVariant
revR6 1.0
rev7_1 "revR7a" 1.5 H180q s258N
rev7_2 1.2 [a]
rev7_3 1.4 [a]
rev7_4 "revR7b" 2.4 g174D
rev7_5 1.2 [a]
rev7_6 1.3 [a]
rev7_7 0.9 M130V l237S
Variant paraoxon Mutations
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Round	 rev8.	 The	 library	 was	 created	 by	 error-prone	 PCR	 from	 PTE-revR7a	 and	 PTE-
revR7b	using	deoxynucleotide	analogues	and	screened	for	increased	phosphotriesterase	
activity.	
	Supplementary	File	1N.	Phosphotriesterase	activity	(relative	to	revR7a)	and	mutations	(relative	
to	revR6)	of	round	rev8	variants.	
Round	rev9.	The	library	was	created	by	error-prone	PCR	from	5	revR8	variants	(rev8_1,	
3,	5,	revR8a,	and	revR8b)	using	deoxynucleotide	analogues	and	screened	for	increased	
phosphotriesterase	activity.	
	Supplementary	File	1O.	Phosphotriesterase	activity	(relative	to	revR8b)	and	mutations	(relative	
to	revR6)	of	round	rev9	variants.	
Round	 rev10.	 The	 next	 library	 was	 made	 by	 error-prone	 PCR	 from	 PTE-revR9	 using	
deoxynucleotide	analogues.	Because	no	improved	variants	were	identified,	a	pool	of	the	
best	228	clones	(with	phosphotriesterase	activities	≥	0.5-fold	relative	to	PTE-revR9)	was	
taken	into	the	next	round.	
Round	 rev11.	 Error-prone	 PCR	 (deoxynucleotide	 analogues)	was	 performed	on	 top	of	
the	plasmid	mix	 from	 round	 rev10	and	 screened	 for	 reduced	 chaperone	dependence.	
Again,	no	 improved	variants	were	 identified,	 and	135	clones	 (with	phosphotriesterase	
activities	≥	0.5-fold	relative	to	PTE-revR9)	were	taken	into	the	next	round.	
revR7a 1.0
rev8_1 1.1 g174D
rev8_2 1.1 g174D
rev8_3 1.3 I138m H180q s256N
e344D
rev8_4 1 g174D
rev8_5 0.8 V144A H180q
s258N
rev8_6 "revR8a" 2 g174D s258N i296V
rev8_7 1.3 g174D
rev8_8 1.4 g174D n265S
rev8_9 "revR8b" 2 y156H g174D H180q d264E
paraoxon MutationsVariant
revR8a 1.0
rev9_1 1.9 I138m g174D H180q s258N
i296V
rev9_2 "revR9" 2.0 y156H g174D H180q s258N
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Round	rev12.	Screening	of	a	new	error-prone	library	(deoxynucleotide	analogues)	using	
the	 plasmid	 mix	 from	 round	 rev11	 yielded	 one	 variant	 with	 increased	
phosphotriesterase	activity	 (1.3-fold	 relative	 to	PTE-revR9),	which	contained	 the	back-
mutation	 V49A	 and	 a	 new	 mutation	 in	 a	 known	 position,	 I306M.	 This	 variant	 is	
“neoPTE”.		
Round	rev13-14.	To	corroborate	that	no	further	improvements	could	be	found,	a	rev13	
library	was	constructed	by	error-prone	library	(deoxynucleotide	analogues)	using	a	mix	
of	168	plasmids	including	neoPTE	from	round	rev12.	No	significantly	improved	variants	
were	found.	The	best	variants	had	neoPTE-like	activity	and	showed	enrichment	of	I306M	
and	a	high	 fraction	of	 synonymous	mutations,	 indicating	 that	no	 functional	mutations	
could	be	found.	To	confirm	whether	the	mutation	V49a	was	also	relevant	or	hitchhiking,	
neoPTE	 was	 back-shuffled	 with	 revR8x	 (round	 rev14).	 All	 variants	 kept	 the	 I306M	
mutation,	and	all	but	1	the	V49a	reversion.	
Supplementary	File	1P.	Phosphotriesterase	activity	and	mutations	of	round	rev13	variants.	
[a] This	variant	contained	only	synonymous	mutations.
Supplementary	File	1Q.	Phosphotriesterase	activity	and	mutations	of	round	rev14	variants.	
[a] Because	mutations	are	given	relative	to	neoPTE,	the	table	shows	that	Ser258	and	Ala49	were	present
in	all	but	the	indicated	variants.
neoPTE 1.0
rev13_1 1.1 I306M
rev13_2 1 I306M
rev13_3 1 e81G w302R I306M a355V
rev14_4 1.2 I306M
rev13_5 1.2 [a]
rev13_6 1.2 I306M
rev13_7 1.1 I306M
rev13_8 1.1 I306M
rev13_9 1 i284V I306M
Variant paraoxon Mutations
neoPTE 1.0
rev14_1 1.2
rev14_2 1
rev14_3 0.7 N258s[a] d264E
rev14_4 1.5
rev14_5 1.2
rev14_6 1.3
rev14_7 1.4
rev14_8 1.7
rev14_9 1.2 a49V[a]
paraoxon MutationsVariant
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Reverse	 evolution:	 Alternative	 trajectory	 excluding	 back-to-ancestor	
mutations	
In	 this	 trajectory,	 variants	 with	 improved	 phosphotriesterase	 activity	 were	 only	
accepted	as	templates	for	library	generation	for	the	next	round	if	they	did	not	contain	
any	back-to-ancestor	mutations.	
Round	 revR1b.	 The	 first	 library	 was	 identical	 to	 round	 rev1.	 However,	 instead	 of	
shuffling	 selected	 clones,	only	PTE-revR1	was	 chosen	 for	 the	next	 round	as	 it	 exhibits	
the	 greatest	 increase	 in	 phosphotriesterase	 activity	 and	 lacks	 back-to-ancestor	
mutations.	
Round	 revR2b.	 The	 library	 was	 created	 by	 error-prone	 PCR	 from	 PTE-revR1	 using	
mutazyme	and	screened	for	increased	phosphotriesterase	activity.	
Supplementary	File	1R.	Phosphotriesterase	activity	and	mutations	of	round	rev2b	variants.	
Round	revR3b.	The	library	was	created	by	DNA	shuffling	of	AE,	rev2B_6	and	revR2b,	and	
screened	for	increased	phosphotriesterase	activity.	
	Supplementary	File	1S.	Phosphotriesterase	activity	(relative	to	revR2b)	and	mutations	(relative	
to	AE)	of	round	rev3b	variants.	
revR1 1.0
rev2b_1 4.2 p354S I172t
rev2b_2 2.7 H180q
rev2b_3 1.6 i167V s224T I172t i333V
rev2b_4 1.8 T314m
rev2b_5 3.2 V130l
rev2b_6 1.3 l146I t173S
rev2b_7 "revR2b" 2.1 p135S
rev2b_8 1.6 i37V d121N M176I M272l
rev2b_9 3.7 E233d
paraoxon MutationsVariant
revR2b 1.0
rev3b_1 "revR3b" 1.9 p135S q290R s308C
rev3b_2 1.5 p135S t173S s238R s308C
p135S s308C p342S
rev3b _3 1.7 v101A p135S s308C
rev3b _4 1.6 c59Y p135S s308C
rev3b _5 1.5 c59Y p135S g162E t173S s308C
rev3b _6 1.5 p135S s238R s308C
rev3b _7 1.6 p135S s238R s308C
rev3b _8 2.8 T102s p135S s308C
rev3b _9 1.7 p135S s238R s308C
Variant paraoxon Mutations
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Round	revR4b.	The	library	was	created	by	error-prone	PCR	from	revR3b,	rev3b_2,	and	7	
using	deoxynucleotide	analogues	and	screened	for	reduced	chaperone	dependence.	
Supplementary	 File	 1T.	 Phosphotriesterase	 activity	 (relative	 to	 rev4b_0),	 chaperone	
dependence	 (+GroEL/-GroEL),	 and	 mutations	 (relative	 to	 AE+P135S+S308C)	 of	 round	 rev4b	
variants.	
[a] Round	 rev4b	was	 initially	 conducted	 in	 the	presence	of	 chaperones,	but	no	 improved	variants	were
found.	 Because	 chaperone	 dependence	 was	 high	 in	 many	 clones,	 this	 round	 was	 repeated	 without
chaperones	 and	 a	 clone	 from	 the	 first	 try	 with	 phosphotriesterase	 activity	 similar	 to	 revR3b	 and	 low
chaperone	dependence	(“rev4b_0”)	used	for	comparison.
Round	 revR5b.	 The	 library	 was	 created	 by	 error-prone	 PCR	 from	 PTE-revR4b	 using	
mutazyme	and	screened	for	increased	phosphotriesterase	activity.	
	Supplementary	File	1U.	Phosphotriesterase	activity	and	mutations	of	round	rev5b	variants.	
Round	rev6b.	PTE-rev5b	was	used	as	template	for	error-prone	PCR	to	give	library	rev6b.	
All	 clones	 with	 improved	 phosphotriesterase	 carried	 back-to-ancestor	 mutations	
(Supplementary	File	1V).	Library	creation	was	repeated	but	again,	the	screen	yielded	no	
improved	 variants	 devoid	 of	 back-mutations	 (not	 shown).	 Therefore,	 this	 trajectory	
reached	an	activity	plateau	in	round	rev5b.	
	Supplementary	 File	 1V.	Phosphotriesterase	 activity,	 chaperone	 dependence	 (+GroEL/-GroEL),	
and	mutations	of	round	rev6b	variants.	
+GroEL/
-GroEL
rev4b_0 [a] 1.0 4.2
rev4b_1 1.0 3.4 i167V I306L q290R
rev4b_2 "revR4b" 0.9 3.8 q290R t345A
rev4b_3 1.4 13.2 f270L q290R
paraoxon MutationsVariant
revR4b 1.0
rev5b_1 1.8 M272l
rev5b_2 1.4 r85I d105H
rev5b_3 "revR5b" 2.7 a203E
rev5b_4 2.4 M272l
rev4b_5 1.4 I172S
Variant paraoxon Mutations
revR5b 1.0
rev6b_1 1.5 v84A H180q
rev6b_2 2.3 H180q
rev6b_3 1.7 T314m T341S
rev6b_4 3.5 I172S
rev6b_5 2.4 V130l l362M
rev6b_6 1.1 l113M
paraoxon MutationsVariant
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Supplementary	file	2	for Kaltenbach	at	al.,	Reverse	evolution	leads	to	genotypic	
incompatibility	despite	functional	and	active-site	convergence 
Kinetic	parameters	of	all	variants	
Information	about	Supplementary	Files	2A-G.	These	files	give	an	overview	of	the	kinetic	
parameters	 of	 all	 PTE	 variants.	 Lysate	 measurements:	 Cells	 were	 grown	 in	 at	 least	
duplicate	 and	 lysates	 sufficiently	 diluted	 (~1-10,000-fold)	 to	 determine	 initial	 rates	 of	
paraoxon	and/or	2NH	hydrolysis	at	a	substrate	concentration	of	200	μM,	normalized	to	
cell	 density,	 corrected	 for	 the	 dilution	 factor,	 and	 averaged.	 This	 experiment	 was	
repeated	twice	and	the	combined	average	determined.	Purified	enzyme	measurements:	
Variants	were	purified	in	at	least	duplicate	in	a	96-well	format	and	sufficiently	diluted	(~ 
0.1	 nM	 -	 10	 μM)	 to	 determine	 initial	 rates	 of	 paraoxon	 and/or	 2NH	 hydrolysis	 at	 a	
substrate	 concentration	 of	 200	 μM,	 corrected	 for	 the	 dilution	 factor,	 and	 averaged.	
Selected	variants	were	purified	on	a	larger	scale	to	determine	initial	rates	over	a	range	
of	 substrate	 concentrations	 and	 calculate	Michaelis	Menten	 parameters.	 For	 back-to-
wild-type	mutations,	wild-type	amino	acid	is	shown	in	lower	case	italics.	
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Supplementary	File	2A.	Enzymatic	activities	of	selected	variants	from	the	forward	and	reverse	
evolution	in	lysate	and	using	purified	enzyme.		
[a] Note	that	the	kinetic	parameters	from	variant	wtPTE	to	R18-1	were	published	in	(Tokuriki	et	al.,	2012).
[b] Cells	 were	 grown	 in	 at	 least	 duplicate	 and	 lysates	 sufficiently	 diluted	 to	 determine	 initial	 rates	 of
paraoxon	 and/or	 2NH	 hydrolysis	 at	 a	 substrate	 concentration	 of	 200	 μM,	 normalized	 to	 cell	 density,
corrected	 for	 the	dilution	 factor,	 and	averaged.	 The	experiment	was	 repeated	 twice	and	 the	 combined
average	determined.	[c]	For	better	comparison,	wtPTE	was	repuried	and	remeasured	in	parallel	with	the
reverse	evolution	variants	(wtPTE-2).	[d]	For	better	comparison,	PTE-R18	was	repurified	and	remeasured
in	parallel	with	the	subsequent	variants	(R18-2).
lysate[a] lysate[a]
relative to wtPTE kcat [s-1] KM [µM] kcat/KM [M-1s-1] relative to wtPTE kcat [s-1] KM [µM] kcat/KM [M-1s-1]
wtPTE-1[c] 0 1.0 (1.3±0.1)!103 57±5 2.3!107 1.0 0.035±0.002 83±19 420
R1 1 0.08±0.003 62±3 7±1 8.9!106 6.6±1.5 0.27±0.01 250±30 1.1!103
R2a 2 0.071±0.007 160±50 13±3 1.2!107 430±80 2.9±0.1 220±10 1.3!104
R2b 2 0.049±0.023 440±10 18±1 2.4!107 (2.1±0.6)!103 24±3 150±30 1.6!105
R3 3 0.082±0.014 200±60 21±3 9.5!106 430±90 3.3±0.1 230±20 1.4!104
R4 4 0.014±0.004 300±10 250±20 1.2!106 (5.6±3.8)!103 54±2 120±20 4.5!105
R5a 5 0.024±0.003 60±1 310±20 1.9!105 (1.3±0.7)!104 65±3 120±10 5.4!105
R5b 5 0.022±0.003 63±1 67±4 9.4!105 (7.1±3.8)!103 54±1 110±10 4.9!105
R6 6 0.03±0.004 65±2 120±20 4.6!105 (1.5±0.7)!104 130±10 190±20 6.8!105
R7a 7 0.015±0.006 20±4 120±2 1.7!105 (1.7±0.9)!104 110±10 160±10 6.9!105
R7b 7 (7.1±0.2)!10-3 53±3 430±60 1.2!105 (2.3±1.1)!104 74±2 130±10 5.7!105
R7c 7 (8.2±0.4)!10-3 17±1 180±10 9.4!104 (8.3±3.7)!103 28±1 120±10 2.3!105
R8 8 (3.2±0.5)!10-3 10±1 300±80 3.3!104 (6.1±2.2)!104 73±2 140±10 5.2!105
R9 9 (1.5±0.3)!10-3 11±1 320±10 3.5!104 (7.1±3.1)!104 350±10 110±10 3.2!106
R10 10 (2.0±0.01)!10-3 5.7±0.2 240±20 2.4!104 (1.0±0.4)!105 650±20 190±10 3.4!106
R11a 11 (1.2±0.3)!10-3 4.2±0.1 250±20 1.7!104 (1.0±0.5)!105 340±10 160±10 2.1!106
R11b 11 (2.0±0.3)!10-3 4.2±0.1 240±20 1.8!104 (1.3±0.3)!105 250±10 110±10 2.3!106
R12 12 (2.0±0.1)!10-3 6.4±0.1 240±10 2.7!104 (1.4±0.4)!105 400±10 140±10 2.9!106
R13a 13 (1.6±0.1)!10-3 17±0.1 480±10 3.5!104 (2.4±0.7)!105 420±20 120±10 3.5!106
R13b 13 (1.0±0.2)!10-3 2.2±0.1 360±40 6.1!103 (1.2±0.6)!105 470±10 100±10 4.7!106
R14 14 (1.6±0.1)!10-3 0.8±0.02 640±50 1.3!103 (2.3±1.0)!105 490±10 88±22 5.6!106
R18-1[d] 18 (9.9±1.3)!10-5 0.73±0.1 (1.3±0.2)!103 560 (3.3±0.9)!105 880±30 63±9 1.4!107
R18-2[d] 18 0.69±0.03 480±50 1.4!103 500±30 89±10 5.7!106
R19 19 (2.0±0.4)!10-5 0.15±0.01 (1.0±0.1)!103 150 (1.9±0.6)!105 390±10 200±10 1.9!106
R20 20 (2.0±0.1)!10-5 0.11±0.02 750±250 150 (2.3±0.8)!105 560±20 110±20 7.6!105
R21 21 (9.1±0.1)!10-6 0.07±0.02 (1.1±0.1)!103 68 (1.6±0.6)!105 150±10 130±10 1.1!106
AE 22 (1.0±0.01)!10-5 0.12±0.01 (1.2±0.1)!103 100 (1.7±0.6)!105 870±50 130±20 6.5!106
revR1 rev1 (1.0±0.1)!10-4 0.85±0.02 790±40 1.1!103 (9.7±5.3)!104 670±10 140±10 4.7!106
revR2 rev2 (2.4±0.1)!10-3 13±1 350±10 3.7!104 (6.1±1.5)!104 500±30 38±9 1.3!107
revR3 rev3 (9.4±4.0)!10-3 34±1 200±10 1.7!105 (8.9±3.7)!103 99±2 150±10 6.6!105
revR4 rev4 0.016±0.003 34±1 90±4 3.7!105 (8.3±3.3)!103 69±1 120±10 5.8!105
revR5 rev5 0.033±0.018 24±1 88±4 2.7!105 (1.2±0.3)!104 77±2 200±20 4.0!105
revR6 rev6 0.04±0.01 28±1 74±2 3.8!105 (1.9±0.6)!104 280±10 130±10 2.1!106
revR7a rev7 0.075±0.024 35±1 73±2 4.7!105 (2.4±0.5)!104 300±10 140±10 2.1!106
revR7b rev7 0.06±0.005 340±10 91±2 3.7!106 (1.2±0.5)!104 240±1 160±4 1.5!106
revR8a rev8 0.089±0.001 140±10 66±2 2.0!106 (1.9±0.7)!104 230±10 140±4 1.7!106
revR8b rev8 0.082±0.01 48±1 140±10 3.5!105 (1.6±0.4)!104 70±1 170±10 4.2!105
revR9 rev9 0.014±0.003 420±10 110±10 3.9!106 (2.1±0.3)!104 200±1 170±10 1.2!106
neoPTE rev12 0.022±0.05 270±10 130±10 2.1!106 (3.4±1.2)!104 110±10 180±20 6.1!105
wtPTE-2[c] 0 360±10 65±5 5.5!106 0.026±0.001 210±20 120
Variant Round
Paraoxon 2NH
purified[b] purified[b]
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Supplementary	File	2B.	Kinetic	parameters	of	wtPTE,	AE,	and	neoPTE	variants	(Figure	4-7)	in	
lysate	and	using	purified	enzyme.
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[a] For	comparison,	the	effect	of	each	mutation	is	given	in	the	same	direction,	e.g.	A45t	means	the	effect
of	introducing	Thr	into	each	background	(AE-A45t,	neoPTE-A45t).	When	the	amino	acid	in	question	(Thr	in
this	 case)	 is	 already	present	 in	 a	 certain	background,	 the	 effect	 is	 calculated	 as	 its	 reintroduction	 after
removal	(reversion	of	wtPTE-t45A	to	wtPTE).
[b] Cells	were	 grown	 in	 at	 least	 duplicate	 and	 lysates	 sufficiently	 diluted	 (~1-10,000-fold)	 to	determine
initial	rates	of	paraoxon	hydrolysis	at	a	substrate	concentration	of	200	μM,	normalized	to	cell	density,	and
corrected	for	the	dilution	factor.	This	experiment	was	repeated	twice	and	the	average	change	relative	to
the	respective	parent	variant	(wtPTE,	AE,	and	neoPTE)	and	the	standard	deviation	were	determined.	A	t-
test	 was	 performed	 to	 obtain	 p-values.	 Only	 mutants	 with	 an	 average	 >1.3-fold	 difference	 from	 the
respective	 parent	 mutant	 AND	 a	 p-value	 <0.05	 are	 considered	 significant.	 Non-significant	 values	 are
underlined.	Note	that	the	only	>1.3	fold	change	with	non-significant	p-value	is	AE+T341i	(1.4-fold,	p-value
0.15).
[c] Variants	were	purified	 in	at	 least	duplicate	 in	a	96-well	 format	and	sufficiently	diluted	 to	determine
initial	 rates	 of	 paraoxon	 hydrolysis	 at	 a	 substrate	 concentration	 of	 200	 μM,	 corrected	 for	 the	 dilution
factor,	averaged	and	the	standard	deviation	determined.
[d] Phosphotriesterase	activity	was	too	low	to	be	determined.
[e] No	standard	deviation	is	given	because	only	a	single	measurement	is	shown.
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Supplementary	File	2C.	Kinetic	parameters	of	additional	variants	made	to	determine	mutational	
effects	over	the	forward	evolution	 in	 lysate	and	using	purified	enzyme.	The	mutational	effects	
are	 given	 in	 Figure	 5	 and	 6	 and	 were	 calculated	 by	 comparing	 each	 variant	 to	 its	 parent	
indicated	in	the	name	(e.g.	R8+I138M	to	R8)	and	as	shown	in	Supplementary	File	2D.	The	effect	
of	all	mutations	not	listed	could	be	calculated	directly	by	comparing	variants	from	the	forward	
evolution	as	shown	in	Supplementary	File	2D.	
[a] Cells	were	 grown	 in	 at	 least	 duplicate	 and	 lysates	 sufficiently	 diluted	 (~1-10,000-fold)	 to	 determine
initial	rates	of	paraoxon	hydrolysis	at	a	substrate	concentration	of	200	μM,	normalized	to	cell	density,	and
corrected	for	the	dilution	factor.	This	experiment	was	repeated	twice	and	the	average	change	relative	to
the	 respective	 parent	 variant	 AE	 and	 the	 standard	 deviation	 were	 determined.	 P-values	 are	 shown	 in
Supplementary	File	2D.
[b] Variants	were	purified	 in	at	 least	duplicate	 in	a	96-well	 format	and	sufficiently	diluted	 to	determine
initial	 rates	 of	 paraoxon	 hydrolysis	 at	 a	 substrate	 concentration	 of	 200	 μM,	 corrected	 for	 the	 dilution
factor,	averaged	and	the	standard	deviation	determined.
lysate[a] purified[b]
relative to AE [1/sec]
AE 1 0.015±0.003
R8+I138m 850±280 5.8±1.0
R8+I199t 190±40 3.4±0.4
R18+V49a 9.1±0.1 0.073±0.001
R18+E77k 10±1 0.079±0.004
R18+M140l 14±8 0.12±0.06
R18+F313i 100±10 0.83±0.04
R20+A45t 1.5±0.2 0.022±0.013
R20+T137s 2.6±0.1 0.023±0.002
R20+V144e 2.3±0.2 0.021±0.001
R20+H180q 8.9±0.7 0.30±0.01
R20+T314m 2.6±0.1 0.029±0.001
R20+T341i 2.4±0.1 0.022±0.001
Variant
Paraoxon
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Supplementary	 File	 2D.	 Mutational	 effects	 over	 the	 forward	 evolution	 in	 lysate	 and	 using	
purified	enzyme.	
[a] Cells	were	 grown	 in	 at	 least	 duplicate	 and	 lysates	 sufficiently	 diluted	 (~1-10,000-fold)	 to	 determine
initial	rates	of	paraoxon	hydrolysis	at	a	substrate	concentration	of	200	μM,	normalized	to	cell	density,	and
corrected	for	the	dilution	factor.	This	experiment	was	repeated	twice	and	the	average	change	relative	to
the	 respective	 parent	 variant	 (shown	 in	 the	 column	 “Calculation”)	 and	 the	 standard	 deviation	 were
determined.	A	t-test	was	performed	to	obtain	p-values.	Only	mutants	with	an	average	>1.3-fold	difference
from	the	respective	parent	mutant	AND	a	p-value	<0.05	are	considered	significant.	Non-significant	values
are	underlined.	Note	that	l140M	and	t199I	have	a	>1.3	fold	effect	but	non-significant	p-values.
lysate[a] T-test[a]
relative to parent p-value
t45A 1.3±0.1 0.72 R20 / R20+A45t
a49V 1.1±0.1 0.14 R18 / R18+V49a
k77E 1.0±0.1 0.58 R18 / R18+E77k
a80V 1.3±0.4 0.19 R10 / R9
s102T 0.51±0.07 1.7×10-4 R21 / R20
s111R 0.80±0.15 0.03 R12 / R11b
l130V 1.0±0.1 0.68 R14 / R13a
s137T 0.74±0.07 1.1×10-3 R20 / R20+T137s
i138M 0.36±0.1 2.0×10-3 R8 / R8+I138m
l140M 0.74±0.05 0.41 R18 / R18+M140l
e144V 0.84±0.08 0.04 R20 / R20+V144e
t172I 2.2±0.4 4.4×10-3 R6 / R5b
v176M 1.0±0.1 0.72 AE / R21
q180H 0.18±0.02 4.9×10-5 R20 / R20+H180q
t199I 1.6±0.6 0.06 R8 / R8+I199t
a204G 1.2±0.2 0.10 R12 / R11a
d233E 0.45±0.04 0.01 R2b / R1
h254R 0.072±0.022 3.0×10-5 R1 / wtPTE
s269T 1.8±0.3 4.4×10-3 R6 / R5a
l271F 1.9±0.1 3.0×10-6 R14 / R13b
l272M 0.48±0.16 6.4×10-3 R9 / R8
i274S 1.0±0.2 0.78 R3 / R2a
i313F 0.10±0.01 7.8×10-9 R18 / R18+F313i
m314T 0.73±0.07 1.0×10-3 R20 / R20+T314m
i341T 0.80±0.08 3.3×10-3 R20 / R20+T341i
CalculationMutation
Paraoxon
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Supplementary	File	2E.	Kinetic	parameters	of	additional	variants	made	to	determine	mutational	
effects	over	 the	 reverse	evolution	 in	 lysate	and	using	purified	enzyme.	The	mutational	effects	
are	 given	 in	 Figure	 5	 and	 7	 and	 were	 calculated	 by	 comparing	 each	 variant	 to	 its	 parent	
indicated	in	the	name	(e.g.	revR3+T172I	to	revR3)	and	as	shown	in	Supplementary	File	2F.	The	
effect	 of	 all	mutations	 not	 listed	 could	 be	 calculated	 directly	 by	 comparing	 variants	 from	 the	
reverse	evolution	as	shown	in	Supplementary	File	2F.	
[a] Cells	were	 grown	 in	 at	 least	 duplicate	 and	 lysates	 sufficiently	 diluted	 (~1-10,000-fold)	 to	 determine
initial	rates	of	paraoxon	hydrolysis	at	a	substrate	concentration	of	200	μM,	normalized	to	cell	density,	and
corrected	for	the	dilution	factor.	This	experiment	was	repeated	twice	and	the	average	change	relative	to
the	 respective	 parent	 variant	 AE	 and	 the	 standard	 deviation	 were	 determined.	 P-values	 are	 shown	 in
Supplementary	File	2F.
[b] Variants	were	purified	 in	at	 least	duplicate	 in	a	96-well	 format	and	sufficiently	diluted	 to	determine
initial	 rates	 of	 paraoxon	 hydrolysis	 at	 a	 substrate	 concentration	 of	 200	 μM,	 corrected	 for	 the	 dilution
factor,	averaged	and	the	standard	deviation	determined.
lysate[a] purified[b]
relative to AE [1/sec]
AE 1.0 0.015±0.003
AE+s308C 6.6±0.9 0.059±0.001
revR3 900±260 7.6±1.7
revR3+t172L 220±20 3.0±0.1
revR3+M130V 170±40 1.1±0.1
revR3+p135S 400±170 9.9±5.0
revR3+T314m (1.3±0.5)!103 19±5
revR4 (1.4±0.5)!103 23±5
revR6+K293m (3.9±2.0)!103 32±13
revR9 (1.8±1.1)!104 100±10
revR9+D174g (7.0±4.0)!103 70±14
revR9+q180H (6.3±2.0)!103 55±5
revR9+N258s (9.2±4.9)!103 69±13
revR9+H156y (1.4±0.4)!104 70±21
neoPTE+a49V (1.5±0.6)!104 140±20
neoPTE+M306I (1.8±0.1)!103 92±29
neoPTE (2.0±0.8)!104 110±40
Paraoxon
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Supplementary	File	2F.	Mutational	effects	over	the	forward	evolution	in	lysate	and	using	
purified	enzyme.	
[a] Cells	were	 grown	 in	 at	 least	 duplicate	 and	 lysates	 sufficiently	 diluted	 (~1-10,000-fold)	 to	 determine
initial	rates	of	paraoxon	hydrolysis	at	a	substrate	concentration	of	200	μM,	normalized	to	cell	density,	and
corrected	for	the	dilution	factor.	This	experiment	was	repeated	twice	and	the	average	change	relative	to
the	 respective	 parent	 variant	 (shown	 in	 the	 column	 “Calculation”)	 and	 the	 standard	 deviation	 were
determined.	A	t-test	was	performed	to	obtain	p-values.	Only	mutants	with	an	average	>1.3-fold	difference
from	the	respective	parent	mutant	AND	a	p-value	<0.05	are	considered	significant.	Non-significant	values
are	underlined.	Note	that	V49a	and	s258N	have	a	>1.3	fold	effect	but	non-significant	p-values.
lysate[a] T-test[a]
relative to parent p-value
V49a 1.7±0.3 0.12 neoPTE+a49V / neoPTE
V130M 5.4±1.6 4.9!10-5 revR3 / revR3+M130V
p135S 1.1±0.4 0.83 revR3 / revR3+p135S
y156H 1.3±0.8 0.42 revR9 / revR9+H156y
I172t 4.1±1.2 3.5!10-3 revR3 / revR3+t172L
g174D 2.6±1.6 0.04 revR9 / revR9+D174g
H180q 2.9±1.8 0.03 revR9 / revR9+q180H
a203E 2.9±1.2 5.4!10-3 revR6+K293m / revR4
s258N 2.0±1.2 0.09 revR9 / revR9+N258s
F271l 2.9±0.8 4.9!10-4 revR3 / revR2
m293K 0.9±0.4 0.8 revR6 / revR6+K293m
I306M 11±5 8.2!10-3 neoPTE / neoPTE+M306I
s308C 6.6±0.9 7.4!10-8 AE+s308C / AE
T314m 3.4±1.2 2.4!10-4 revR4 / revR3+p135S
Mutation
Paraoxon
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Supplementary	 File	 2G.	 Kinetic	 parameters	 of	 variants	 made	 for	 combinatorial	 mutational	
analysis	(Figure	7)	in	lysate	and	using	purified	enzyme.	
[a] Cells	were	 grown	 in	 at	 least	 duplicate	 and	 lysates	 sufficiently	 diluted	 (~1-10,000-fold)	 to	 determine
initial	rates	of	paraoxon	hydrolysis	at	a	substrate	concentration	of	200	μM,	normalized	to	cell	density,	and
corrected	for	the	dilution	factor.	This	experiment	was	repeated	twice	and	the	average	change	relative	to
the	parent	variant	AE	and	the	standard	deviation	were	determined.	A	t-test	was	performed	to	obtain	p-
values.	Only	mutants	with	an	average	>1.3-fold	difference	 from	the	respective	parent	mutant	AND	a	p-
value	<0.05	are	considered	significant.	Non-significant	values	are	underlined.
[b] Fold	 changes	 between	 the	 single	 and	 double	 mutants	 of	 each	 series	 shown	 in	 Figure	 7B	 (e.g.,
AE+p135S	differs	by	4.3-fold	from	the	double	mutant	AE+p135S+I138m,	AE+I138m	differs	by	2.6-fold).	A	t-
test	was	performed	to	obtain	p-values.	Note	that	the	two	mutants	AE+F271l+s308C	and	AE+M272l+s308C
have	non-significant	p-values	compared	to	the	“double	mutant”	in	this	series,	AE+F271l+M272l+s308C.
[c] Values	 for	 AE+F271l	 are	 compared	 to	 the	 double	mutant	 AE+F271l+F313l.	 Values	 for	 AE+s308C	 are
compared	to	the	double	mutant	AE+I306f+s308C.
[d] AE+F271l+s308C	and	AE+M272l+s308C	are	 “single	mutants”	of	 the	parent	AE+s308C	and	 values	 are
compared	to	the	“double	mutant”	AE+F271l+M272l+s308C.
[e] Variants	 were	 purified	 to	 determine	 initial	 rates	 of	 paraoxon	 hydrolysis	 over	 a	 range	 of	 substrate
concentrations	and	calculate	Michaelis	Menten	parameters.
lysate[a] T-test[a] single/ T-test[b]
relative to AE p-value double[b] p-value kcat [s-1] KM [µM] kcat/KM [M-1s-1]
AE 1.0 0.12±0.01 (1.2±0.1)!103 100
AE+p135S 2.4±0.1 5.4!10-10 4.3 1.0!10-10 0.26±0.01 740±110 350
AE+I138m 1.4±0.2 6.4!10-4 2.6 3.0!10-6 0.20±0.01 (1.3±0.1)!103 150
AE+F271l 7.0±0.8 5.8!10-9 1.8[c] 2.2!10-5 [c] 0.37±0.01 970±50 380
AE+I306f 1.5±0.3 6.8!10-4 0.4 1.2!10-7 0.21±0.01 (1.2±0.2)!103 170
AE+s308C 5.8±0.3 8.4!10-13 1.7[c] 4.3!10-8 [c] 0.42±0.02 460±50 910
AE+F313I 7.4±0.7 1.2!10-9 1.9 4.6!10-6 1.0±0.01 (1.6±0.1)!103 650
AE+p135S+I138m 0.6±0.1 6.9!10-6 0.052±0.002 760±80 68
AE+F271l+s308C 19±9 5.4!10-4 1.8[d] 0.25 5.2±0.1 870±30 6.0!103
AE+M272l+s308C 15±2 1.6!10-8 1.4[d] 0.06 3.0±0.1 930±50 3.2!103
AE+F271l+F313I 4.0±0.6 2.2!10-7 0.13±0.01 620±50 200
AE+I306f+s308C 3.5±0.3 7.8!10-10 0.64±0.03 (1.2±0.1)!103 540
AE+F271l+M272l+s308C 10±3 1.3!10-4 1.8±0.1 (1.5±0.1)!103 1.2!103
Variant
Paraoxon
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Supplementary	 File	 2H.	Absorption	wavelength	 λ,	 extinction	 coefficient	 ελ,	 and	 leaving	 group	
pKa	values	for	substrates	used	for	kinetic	analysis.	Values	were	taken	from	(Khersonsky	and	Tawfik,	
2005).	
[a] Extinction	 coefficients	 are	 given	 for	 a	 pathlength	 of	 0.58	 cm,	which	 results	 from	 a	 200	 μL	 reaction
volume	in	a	96-well	plate.
[b] 2NH	was	not	used	for	linear	free	energy	relationship	analysis.
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Substrate ! [nm] "! [M-1][a] pKa
Phosphotriesters
Paraoxon 405 10510 7.14
2,4-dinitrophenyl diethyl phosphate 360 9160 4.08
2-fluoro 4-nitrophenyl diethyl phosphate 395 11080 5.45
3-fluoro 4-nitrophenyl diethyl phosphate 390 11676 5.94
2,6-difluorophenyl diethyl phosphate 270 950 7.3
4-cyanophenyl diethyl phosphate 275 7495 7.95
diethyl phosphate acetophenone 320 8080 8.05
3-fluorophenyl diethyl phosphate 270 656 9.28
Arylesters
2-naphthyl hexanoate (2NH) 320 800 [b]
4-nitrophenyl acetate 405 10510 7.14
4-acetoxy benzaldehyde 330 12620 7.66
4-cyanophenyl acetate 275 7495 7.95
4-acetoxy acetophenone 320 8080 8.05
3-nitrophenyl acetate 340 840 8.39
3-cyanophenyl acetate 295 1610 8.61
4-chlorophenyl acetate 280 838 9.38
Phenyl acetate 270 700 10
3,4-dimethyl phenyl acetate 276 850 10.36
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Supplementary	file	3	for Kaltenbach	at	al.,	Reverse	evolution	leads	to	genotypic	
incompatibility	despite	functional	and	active-site	convergence 
Crystallographic	information	
Supplementary	File	3A.	Data	collection	and	refinement	statistics	for	structures	reported	 in	
this	work.	
[a] Values	in	parenthesis	are	for	the	highest-resolution	shell.
[b[	Rmerge(I)	=	(Σhkl	Σj	|Ihkl,j	-	áIhklñ|)/(Σhkl	Σj	 Ihkl,j)	where	áIhklñ	 is	the	average	intensity	of	j	symmetry-related
observations	of	reflections	with	Miller	indices	hkl.
[c] CC1/2	=	percentage	of	correlation	between	intensities	from	random	half-datasets.
[d] Rwork	 =	 Σhkl|F(obs)-F(calc)|/Σhkl|F(obs)|;	 5%	of	 the	data	 that	were	excluded	 from	 the	 refinement	were
used	to	calculate	Rfree.
wtPTE AE neoPTE
Wavelength (Å) 0.9537 0.9537 0.9537
Resolution range (Å) [a] 43.16-1.63 (1.68-1.63) 39.44-1.54 (1.60-1.54) 48.33-1.9 (1.94-1.9)
Space group P 21 21 2 P 21 21 2 P 65
Unit cell
  a, b, c (Å) 86.14, 86.33, 88.72 85.9, 86.27, 88.68 123.7, 123.7, 112.13
  a, b, g (°) 90, 90, 90 90, 90, 90 90, 90, 120
Total reflections 598370 (60391) 707292 (70797) 841841 (46861)
Unique reflections 83078 (8191) 97912 (9642) 76542 (4520)
Multiplicity 7.2 (7.4) 7.2 (7.3) 11.0 (10.4)
Completeness (%) 99.98 (99.99) 99.97 (100.00) 100 (100)
Mean <I/s(I)> 13.19 (2.35) 11.44 (1.52) 14.6 (2.4)
Wilson B-factor 17.33 15.17 14.4
Rmerge(I)[b] 0.101 (0.7993) 0.1111 (1.237) 0.163 (1.322)
CC1/2[c] 0.998 (0.83) 0.998 (0.694) 0.996 (0.684)
Rwork/R free[d] 0.1789/0.2190 0.1703 (0.2051) 0.1405 (0.1728)
No. of non-hydrogen atoms 5791 5964 5591
  macromolecules 5394 5389 5216
  ligands 14 44 30
  water 383 531 345
Protein residues 659 655 660
R.m.s deviations
Bond lengths (Å) 0.009 0.015 0.006
Bond angles (°) 1.18 1.55 0.97
PDB ID 4PCP 4PCN 4PBF
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The remarkable catalytic power of enzymes is thought to derive from the preorganization of enzyme active sites, which allows them to stabilize the transition states (TSs) of chemical 
reactions and lower the activation energy, thereby increasing the 
rate1–4. Although it is recognized that active site residues need to 
be precisely positioned for efficient TS stabilization5, recent studies 
have described a link between active site dynamics and catalysis of 
the chemical step6,7. Separate from the discussion of protein dynam-
ics and the chemical step, several studies have observed enzymes 
undergoing conformational change throughout their catalytic 
cycle8–11, adopting various configurations that are suited to differ-
ent roles, such as substrate binding, catalysis and product release. 
Despite substantial work, several questions still remain relating to 
the role of protein dynamics in enzyme function, and it remains a 
controversial topic12–14.
Although the majority of the studies that have investigated struc-
tural protein dynamics examined extant and specialized enzymes15,16, 
some studies highlight a potential role for structural dynamics in 
the molecular evolution of enzymes8,11,17, demonstrating that the 
equilibrium between sub-states can be modified by mutagenesis11,18. 
It is also suggested that conformational plasticity and changes in 
the conformational landscapes of proteins contribute to catalytic 
promiscuity and the diminishing returns observed during protein 
specialization19–21. Despite substantial evidence from these studies 
that suggests that protein dynamics are under evolutionary selec-
tion, little is understood of the molecular basis for the evolution of 
protein dynamics or how they could affect activity. Indeed, recent 
work shows that excessive structural mobility can actually impede 
enzyme evolution, providing some balance to the generally positive 
view of protein dynamics in activity and evolution22.
An evolutionary process can only be understood if we can exam-
ine the intermediate states that together comprise the trajectory. 
Laboratory (directed) evolution is invaluable to the study of molecular 
evolution because it permits the isolation of every intermediate 
along a trajectory and the use of high selective pressure to minimize 
the level of noise, or neutral variation, in the sequence. Bacterial 
phosphotriesterases (PTEs) catalyze the hydrolysis of organophos-
phates at rates limited by product release, which involves opening 
of an active site loop (loop 7)11,23. We have previously reported the 
laboratory evolution from wild-type PTE (round 0; R0) to an effi-
cient and specialized arylesterase (AE; R22), in which a 109-fold 
switch in the ratio of catalytic specificities (measured by compari-
son of kcat/KM) was achieved over 22 generations (Supplementary 
Results, Supplementary Table 1 and Supplementary Fig. 1)21,24. 
More recently, we carried out the same experiment in reverse24, i.e., 
we evolved AE back into an efficient PTE (neoPTE) over 12 gen-
erations (Rev12). These experiments provide us with a ‘molecular 
fossil record’ that we can use to determine the biophysical changes 
that are causally related to the change in function. Previous struc-
tural analysis, comparing the start (PTE: R0), end (AE: R22) and 
restored (neoPTE: Rev12) points, shows that the overall structures 
are nearly identical in terms of enzyme ground state (EnzGS) struc-
ture. The relative activities of R0 and R18 have been investigated 
computationally through analysis of the altered active sites, showing 
that differences between the active sites of the two enzymes largely 
account for the changes in activation energy25. However, the process 
by which these new active sites were established, and the biophysical 
basis for their gradual optimization, cannot be understood without 
analysis of the structures and dynamics of the intermediate states.
In this work, we analyzed nine crystal structures that are rep-
resentative of several intermediate points and end points along the 
trajectory, as well as three rationally designed variants. Altogether, 
this data set reveals the destabilizing effects that many mutations 
can have and how these can be repaired in subsequent generations, 
evolutionary pressure to ‘freeze out’ or minimize unproduc-
tive motions, and specific conformational sampling of unique 
1Research School of chemistry, Australian national university, canberra, Australia. 2Michael Smith laboratories, university of british columbia, vancouver, 
british columbia, canada. 3department of biochemistry, university of cambridge, cambridge, uK. 4biomedicine discovery institute, Monash university, 
clayton, victoria, Australia. 5department of biochemistry and Molecular biology, Monash university, clayton, victoria, Australia. 6institut de biologie 
Structurale, university Grenoble Alpes, commissariat à l’energie Atomique and centre national de la Recherche Scientifique, Grenoble, France.  
7these authors contributed equally to this work. *e-mail: colin.jackson@anu.edu.au or tokuriki@msl.ubc.ca
the role of protein dynamics in the evolution of 
new enzyme function
eleanor Campbell1,7, Miriam Kaltenbach2,3,7, Galen J Correy1, paul d Carr1, Benjamin t porebski4,5, 
emma K Livingstone1, Livnat afriat-Jurnou1, ashley M Buckle4,5, Martin Weik6, Florian Hollfelder3, 
nobuhiko tokuriki2* & Colin J Jackson1*
Enzymes must be ordered to allow the stabilization of transition states by their active sites, yet dynamic enough to adopt 
alternative conformations suited to other steps in their catalytic cycles. The biophysical principles that determine how specific 
protein dynamics evolve and how remote mutations affect catalytic activity are poorly understood. Here we examine a ‘molecu-
lar fossil record’ that was recently obtained during the laboratory evolution of a phosphotriesterase from Pseudomonas diminuta 
to an arylesterase. Analysis of the structures and dynamics of nine protein variants along this trajectory, and three rationally 
designed variants, reveals cycles of structural destabilization and repair, evolutionary pressure to ‘freeze out’ unproductive 
motions and sampling of distinct conformations with specific catalytic properties in bi-functional intermediates. This work 
establishes that changes to the conformational landscapes of proteins are an essential aspect of molecular evolution and that 
change in function can be achieved through enrichment of preexisting conformational sub-states. 
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conformations that can catalyze either phosphotriester or arylester 
hydrolysis in bifunctional intermediates.
rESulTS
Structure determination and comparison
In addition to the three previously described structures (R0, R22 
and Rev12)24, we selected for structural analysis a series of inter-
mediate variants along the forward (PTE activity with paraoxon to 
AE activity with 2-naphthyl hexanoate (2NH)) and reverse evolu-
tionary trajectories (Supplementary Fig. 1, and Supplementary 
Tables 1 and 2). The end points R0 and R22 are relatively special-
ized catalytic mirror images (kcat/KM for primary activity > 104-fold 
higher than that for secondary activity), R6 and Rev6 represent true 
bi-functional intermediates in that they have approximately equal, 
and substantial, second-order rate constants (kcat/KM ≈ 106 M−1 s−1) 
for both substrates, whereas R1, R2, R8, R18 and Rev12 are vari-
ants with relatively uniform activity increases in between. We solved 
crystal structures of all of these variants, which diffracted to similar 
resolution (1.5−1.9 Å) in the same crystallization conditions, and all 
but Rev12 crystallized in the same space group. This was an impor-
tant aspect of the analysis, allowing direct comparison between the 
structures without confounding due to crystal-packing artifacts.
As noted previously, despite 104-fold and 105-fold changes in 
kcat/KM for the phosphotriester and arylester between R0 and R22, 
respectively, these structures are almost identical to each other (R0 
versus R22; ~90% sequence identity; the maximum r.m.s. displace-
ment over Cα atoms was only 0.4 Å) (Fig. 1a). This is highlighted 
through analysis of a Cα distance matrix between the R0 and R22 
variants (Fig. 1b): in terms of backbone changes, the only substan-
tial difference is a relatively minor shift in the conformation of loops 
4 and 5 and a very slight difference in the conformation of loop 7. 
The shift in loop 5 contributes to additional enzyme−substrate 
interactions (Fig. 1c,d). Other substitutions that contributed to 
the specificity change reshaped the substrate-binding pocket and 
introduced charged groups to the active site (Fig. 1c,d). Briefly, 
Phe306Ile slightly widened the binding pocket for the aryl side 
chain of 2NH, Leu271Phe reduced available space for an ethyl side 
chain of paraoxon and His254Arg introduced a cation-π interac-
tion with the naphthol leaving group of 2NH. These substitutions 
were, individually, only responsible for no more than an ~3-fold 
improvement in the kcat/KM, or a cumulative ~12-fold increase, i.e., 
~1% of the final 104-fold increase. Recent structural and compu-
tational analysis of the catalytic mechanism of PTE and AE has 
revealed that small changes in the Zn2+-Zn2+ metal-ion distance also 
occur, although the catalytic effect is unclear25. Thus, the structural 
basis for the scale of the change in function must involve more than 
direct changes to the substrate-binding site. The mean distance of 
the mutations from the active site increased throughout the trajec-
tory, with the first substitutions close to or within the active site, and 
the bulk of subsequent substitutions located at or near the surface 
of the protein (Fig. 1e,f). In fact, specialization for the new activity 
occurred without the addition of any active site substitutions in the 
latter part of the trajectory (R6-R22) (Supplementary Table 1).
changes to the internal protein interaction network
To investigate the interplay between structural and functional 
changes, we analyzed how the substitutions affected the internal pro-
tein interaction network. Comparison between the intramolecular 
interaction networks (hydrogen bonds, salt bridges and hydropho-
bic interactions) using RINalyzer26 revealed that, unlike the average 
atomic positions of the atoms, the intramolecular interaction net-
work of the protein underwent dramatic alterations throughout the 
evolutionary trajectory (Fig. 2). Three areas of the protein are of par-
ticular interest with respect to the change in function: loops 5 and 
7, which overhang the active site from opposite sides, and Arg254, 
which forms cation-π interactions with the substrate. Loops 4 and 5 
are the only loops that underwent substantial Cα backbone altera-
tion throughout the evolutionary trajectory. Loop 7 has previously 
been shown to undergo functionally important conformational 
fluctuations between open (poised for substrate and product dif-
fusion) and closed (catalytic) conformations11, and Arg254 is the 
first mutation accumulated in the evolution toward AE activity and 
hydrogen bonds to a backbone carbonyl of loop 7. The residues in 
loop 7 are largely unconnected to the (α/β)8 barrel in R0 (Fig. 2a), 
but they become highly interconnected, for example, via hydrogen 
bonding with Arg254, en route to R22 (Fig. 2b). In R0, the residues 
in loop 5 are highly connected to each other (Fig. 2c), whereas this 
interaction network almost completely disappears by R22, with few 
intra-loop interactions remaining (Fig. 2d). Thus, while the aver-
age positions of the backbone and side chain atoms in the protein 
changed little over the evolutionary trajectory, the intramolecular 
interaction network has undergone substantial reorganization.
Structural dynamics are altered through evolution
We investigated the hypothesis that altered conformational 
dynamics are under evolutionary selection by solving structures of 
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Figure 1 | locations and effects of substitutions that accumulated  
across the evolutionary trajectory. (a) R0 is shown as a gray cartoon, and 
R22 as a blue cartoon. loops 4, 5 and 7 are shown to overhang the active 
site from each side. the only substantial conformational changes between 
R0 and R22 were in loops 4, 5 and 7. (b) A c-α distance matrix between the 
R0 and R22 variants highlights the absence of conformational differences 
outside of loops 4, 5 and 7. s.d., standard deviation of distances among 
equivalenced residue pairs. (c) the structure of R0 with phosphotriester 
docked (superimposed from 2R1n) shows the absence of any interaction 
with loop 5. (d) the structure of R22 with docked arylester tS analog shows 
the close contacts between new loop 5 configuration and the substrate. 
(e) the substitutions are scattered throughout the protein, but the first 
substitutions, in both the forward and reverse trajectory, are located closest 
to the active site, whereas the latter substitutions are frequently located on 
the surface. (f) the mean distance of the substitutions from the active site
increases quickly at the start, but begins to plateau by R22.
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five intermediates between R0 and R22 (R1, R2, R6, R8 and R18), 
and focusing on the three functionally relevant areas: Arg254, loop 7 
and loop 5. The mobility of loops 4, 5, and 7 changed substantially 
across the evolutionary trajectory in a manner that was consistent 
with the observed changes to the intermolecular interaction network; 
namely, loop 7 became more stable upon gaining additional intra-
molecular interactions, whereas the loss of interactions destabilized 
loop 5 (Fig. 3a,b and Supplementary Fig. 2). Moreover, the level 
of disorder in each region changed gradually over the course of 
the evolutionary trajectory, i.e., there was a consistent directional 
change in terms of the stability of these loops and it was not a 
random fluctuation. An analysis of the pathways of communication 
between loops 5 and 7, which can be used to assess the strength 
of the allosteric interaction between them27,28, showed substantial 
change between R0 and R22 (Supplementary Fig. 3). In R0 there is 
an optimal path extending from Ala204 in loop 5 to Ala270 in loop 7, 
via Thr279 and Leu283 in the rear of the protein, with suboptimal 
paths extending through His254 and Asp232, consistent with a 
widely distributed network involving substantial motion of loop 7. 
In R22, the optimal path has shortened, with the original path, and 
the suboptimal path through His254, being lost (potentially owing 
to the His254Arg substitution), and the previously suboptimal path 
through Asp232 becoming dominant and involving the two substi-
tutions to loop 7 (Leu272Met and Leu271Phe), consistent with the 
observed reduction in the mobility of loop 7.
The active site mutation His254Arg was the first mutation (R1) to 
fixate in the evolution. Arg254 can adopt either bent (Cβ-Cγ-Cδ-Nε 
dihedral angle ~40−70°) or extended (Cβ-Cγ-Cδ-Nε dihedral angle 
~170°) rotamers (Fig. 3c). Both rotamers are compatible with the 
PTE activity, and His254Arg is a naturally occurring polymor-
phism29. In contrast, only the bent conformation is catalytically 
productive for the AE activity, forming cation-π interactions with the 
naphthol leaving group of the arylester. The extended conformation 
is nonproductive and is involved in a steric clash with the arylester 
binding mode21. Both bent and extended conformations of Arg254 
were apparent in R1 and R2 structures, either through inspection 
of electron density maps or through automated fitting of multiple 
conformations with QFit30,31. The bent conformation of Arg254 is 
enriched and stabilized through evolution: the refined occupancy 
increased from 61% (R1) to 100% by R6. The bent conformation 
was further stabilized through the later rounds: when we refined 
the structure with only the bent conformation, the B-factor pro-
gressively decreased from R1 to R22 (Fig. 3d and Supplementary 
Fig. 4). This illustrates that new mutations can arise in structural 
contexts that initially prevent side chains from adopting an optimal 
geometry. The substituted amino acids are likely to be loosely posi-
tioned at first, dynamically sampling a number of nonproductive 
conformations, and their full catalytic effect will only be manifested 
once nonproductive conformations are ‘frozen out’. In this case, the 
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Figure 2 | intermolecular interaction networks in r0 and r22. (a) in R0, 
loop 7 has very few intra-loop bonds and little interaction (electrostatic or 
hydrophobic) with the (α/β)8-barrel body of the protein. (b) by R22,  
a number of new electrostatic interactions form (dashed lines) as well as 
increased hydrophobic interactions (transparent spheres). this includes 
new hydrogen bonds with the (α/β)8-barrel via Arg254. (c) in R0, loop 5 is 
highly interconnected to the (α/β)8-barrel and within itself. (d) by R22 the 
majority of these bonds are lost.
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Figure 3 | changes in protein disorder and conformation across an evolutionary trajectory. (a) A plot of the averaged (A and b chains) main chain 
b-factor of R0, R22 and Rev6, showing level of disorder of loops 5 (200−210) and 7 (257−275). the disorder in loops 5 and 7 of Rev6 began to return to 
the ancestral state (R0). (b) the disorder in loops 4 and 5 increased gradually from R0 to R22, whereas the disorder in loop 7 decreased gradually along 
the trajectory. (c) Arg254 sampled both open and closed conformations in R1. 2mFobs − DFcalc maps are contoured at 1.5σ and shown in blue; mFobs − DFcalc 
difference density contoured at 3σ is shown in green. (d) the changes in disorder of the various loops occurred at different rates along the trajectory 
for different regions. Arg254 (red) peaked in R1 and was stable by R6. loop 7 (cyan) peaked at R2 and continued to decrease to R18. loop 5 (green) 
underwent its most substantial increase between R9 and R18. (e) the conformation of loops 5 (left) and 4 (right) did not substantially change between 
R1 (red), R2 (orange) and R6 (salmon), but shifted by R9 (gray) and R18 (light blue) before adopting the final conformation in R22 (dark blue).
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shift in the conformational equilibrium of Arg254 occurs as a result 
of the Asp233Glu substitution and a series of changes that stabilize 
loop 7, which is discussed in detail below. The major changes in the 
B-factor at position 254 occurred before round 6, when the refined
occupancy of Arg254 reached its maximum.
The rate-limiting fluctuation of loop 7 between open (diffusive) 
and closed (catalytic) conformations in PTE is a specific move-
ment that is essential to the PTE activity11,23 but not the AE activity. 
As with the extended conformation of Arg254, we measured the sta-
bility of the modeled closed conformation by the change in B-factor 
throughout the trajectory (Fig. 3d and Supplementary Fig. 4), i.e., 
if the loop is in a well-ordered, high occupancy, closed conformation 
it will have a lower B-factor than if it is highly disordered. Loop 7 
became more ordered in R1, because a hydrogen bond formed 
between Leu271 of loop 7 and the bent conformer of Arg254 in the 
body of the protein11. However, Arg254 then formed a salt bridge 
with Glu233 in R2, which competes with the hydrogen bond to 
Leu271 formed in R1, reducing the Arg254−loop 7 interaction and 
increasing the disorder of loop 7. A series of mutations (encoding 
substitutions Leu271Phe, Leu272Met, Phe306Ile and Ile313Phe) 
then accumulated over the course of the trajectory, progressively 
stabilizing the closed conformation of loop 7 by increasing the 
hydrophobic contacts between loop 7 and the (α/β)8 barrel of the 
protein (Fig. 2b). Thus, the nonproductive open conformation and 
loop dynamics were reduced through evolution.
The change in B-factor of loop 5, which was also the only region 
to undergo substantial conformational rearrangement (Fig. 3d,e 
and Supplementary Fig. 4), was particularly pronounced. The 
dominant conformation of loop 5 did not change over the first three 
rounds (R0 to R2), yet there was a slight shift in the adjacent loop 4 
(Fig. 3e). This scenario provides sufficient conformational free-
dom for loop 5 to have undergone a small shift over rounds 6−18, 
before it adopted its final structure in R22. In terms of dynamics, 
the B-factor underwent little change over R0 to R6, with the most 
substantial increases in B-factor occurring over the second half of 
the evolution (between rounds 8 and 18). When examined in con-
junction with the change in activity, we observed that the change in 
loop 5 appeared to correspond to the specialization of the enzyme 
for AE from round 7 onward (increase of AE:PTE ratio, largely 
through loss of PTE activity), rather than the initial increases in AE 
activity over the first six generations that yielded the bifunctional 
intermediate R6 (Supplementary Table 1).
The biophysical basis of catalytic promiscuity
It is unclear how proteins, whose genes undergo discreet changes, 
often (although not always) evolve new function in a fluid and 
gradual manner, yielding characteristically smooth transitions such 
as those observed here (Supplementary Fig. 1). A gradual shift in 
the conformational landscape was apparent when we examined the 
bifunctional R6 and Rev6 intermediate variants (Supplementary 
Fig. 1 and Supplementary Table 1). These enzymes were truly 
bifunctional (kcat/KM = 105−106 M−1 s−1 for both PTE and AE activi-
ties), and were more active with either substrate than many natural 
proteins are for their native substrate. The high-resolution diffrac-
tion data we obtained for these intermediate structures allowed 
detailed analysis of the conformational mobility of certain regions. 
First, we observed electron density in Rev6 that was consistent 
with loop 5 sampling both R0-like and R22-like conforma-
tions (Fig. 4a,b). Likewise, anisotropic refinement of the atomic 
displacement parameters illustrated that, although loop 7 in Rev6 
displayed substantial disorder (Fig. 4c), the disorder was directional 
and consistent with the population of molecules in the crystal sam-
pling a range of states between the open and closed conformations 
of this loop11. This was supported by crystallographic ensemble 
refinement (Online Methods, Supplementary Figs. 2 and 5, and 
Supplementary Table 3)32. These results revealed that R6 and Rev6 
are true dynamic intermediates of R0 and R22: whereas the mobil-
ity of loops 4, 5 and 7 was opposite at the start and end points of 
the evolutionary trajectories, R6 and Rev6 exhibited high flexibility 
in both loop 7 and loops 4 and 5, and could sample both R0-like 
and R22-like conformations, suggesting the presence of R0-like and 
R22-like EnzGS conformational sub-states in these enzymes, which 
can rapidly interconvert (Fig. 4d and Supplementary Fig. 6).
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Figure 4 | conformational sampling of PTE-like and AE-like states by 
evolutionary intermediates r6 and rev6. (a) loop 5 can be modeled in 
two conformations: a dominant pte-like conformation that is modeled 
into 2mFobs − DFcalc electron density (blue), contoured at 1.5σ, and a second 
Ae-like conformation that is modeled into mFobs − DFcalc difference density 
(green), contoured at 2.5σ. (b) overlay of the two Rev6 conformations  
of loop 5 (magenta and orange) onto structures of R0 (gray) and R22  
(sky blue). (c) Anisotropic refinement of Rev6, showing the directional 
atomic displacements of the atoms in loop 7, consistent with fluctuation 
between states, rather than random disorder. (d) Flexibility of loop 4, loop 5 
and loop 7 of R0, R6, R22 and Rev6 revealed by ensemble refinement. 
the single line represents the mean cα r.m.s. fluctuation across the five 
replicate refinements with the uncertainty (s.d.) shaded in red.
Table 1 | Kinetic parameters for all rationally designed variants with the arylester 2-napthyl hexanoate
kcat (s−1) KM (mM) kcat/KM (s−1 M−1) substitutions
r0 0.035 ± 0.002 83 ± 19 4.2 × 102
E1a 0.068 ± 0.006 393 ± 61 1.7 × 102 d233e
E1b 0.53 ± 0.06 256 ± 45 2.1 × 103 l271F l272M F306i i313F
r1 0.27 ± 0.1 250 ± 30 1.1 × 103 H254R
E2a 1.1 ± 0.5 374 ± 151 3.0 × 103 d233e l271F l272M F306i i313F
E2b 43 ± 3 124 ± 19 3.4 × 105 H254R l271F l272M F306i i313F
r2 24 ± 3 150 ± 30 1.6 × 105 H254R d233e
E3 55 ± 4 56 ± 10 9.8 × 105 H254R d233e l271F l272M F306i i313F
Assays were performed in 100 mM tris-Hcl, pH 7.5, 100 μM Zncl2 and 0.02% triton X-100 at 20 °c.
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remote mutations control conformational sampling
Although the efficiency of R22 was due to the ability of the active 
site to catalyze the reaction, it was the gradual evolutionary optimi-
zation of the configuration of the active site (via remote mutations; 
Fig. 1e) that allowed it to reach its potential. This evolutionary pro-
cess resulted in the accumulation of a number of mutations around 
Arg254, specifically Glu233 and a cluster of interacting hydropho-
bic mutations in and adjacent to loop 7 (L7; Phe271-Met272-Ile306-
Phe313) (Fig. 2b). We made site-directed mutants to examine the 
impact of these mutations on catalytic activity and loop dynam-
ics (Table 1 and Fig. 5a,b). When we introduced His254Arg (R1), 
Asp233Glu (E1a) or the L7 substitutions (E1b) into R0, they resulted 
in 8-fold, 2-fold and 15-fold improvements in the turnover rate (kcat), 
respectively. The Asp233Glu and L7 mutations combined additively 
(E2a), resulting in a 30-fold (i.e., 2 × 15) improvement. In contrast, 
when we combined His254Arg with either Asp233Glu or L7, we 
observed 90-fold and 160-fold increases in kcat, respectively, reveal-
ing strong epistatic relationships33. When we combined Asp233Glu 
with His254Arg/L7, or L7 with His254Arg/Asp233Glu, we observed 
improvements of only <2-fold, suggesting that these second-shell 
substitutions have the same role: the conformational optimization 
of the bent conformation of Arg254 (Fig. 5c). Crystal structures 
of these variants showed that the B-factor of His at position 254 
increased when Arg was introduced (R1) and was comparably sta-
bilized by either Asp233Glu, or the L7 substitutions. The increased 
stability of the bent conformation correlated with increased turnover 
of the arylester substrate (Fig. 5a). Asp233Glu substitutions resulted 
in a stabilizing salt bridge to the bent conformation21, whereas stabi-
lization of Arg254 by the L7 substitutions was due to stabilization of 
loop 7 via increased van der Waals interactions between loop 7 and 
the rest of the enzyme (Fig. 5d), leading to a more stable hydrogen 
bond between the bent conformation of Arg254 and the carbonyl 
oxygen of the residue at position 271 of loop 7 in its closed con-
formation (Fig. 2b). This Arg254-loop 7 interaction is highlighted 
in the variance of the flexibility of loop 7 over this series of vari-
ants (Fig. 5d): a decrease in the observed B-factors of loop 7 after 
the introduction of Arg254 and the L7 substitutions was in contrast 
to the effects of the Asp233Glu substitution, which resulted in an 
increase in the disorder of this loop, because it distorted the align-
ment of the hydrogen bond between Arg254 at the carbonyl oxygen 
of position 271, weakening it and reducing the stabilizing effect it 
has on loop 7 (Supplementary Fig. 7). Taken together, these results 
are consistent with a model in which most of the mutations that 
accumulate in evolutionary trajectories are remote from the active 
site and have little direct catalytic impact, but serve to optimize the 
conformational landscape of a few catalytically important regions of 
the protein, particularly Arg254 and loop 7 in this example.
DiScuSSioN
New substitutions, such as Arg254, often appear to be conforma-
tionally unstable and can adopt nonproductive rotamers that limit 
their potential catalytic benefit. It is only through minimization 
of unproductive flexibility or dynamics that their full potential is 
realized. Likewise, mobility that might be valuable to an ancestral 
activity (for example, loop 7 with PTE activity) is reduced through 
evolution if it is not beneficial to the new activity. It is also notable 
that the changes to the dynamics of different regions do not occur 
simultaneously. There appears to be a defined order in which these 
changes must occur, i.e., Arg254 is optimized first, followed by 
loop 7. Once Arg254 is stabilized and loop 7 has begun to stabi-
lize, the level of disorder around loop 5 begins to increase (Fig. 3d 
and Supplementary Fig. 4). Such a series of sequential adjustments 
makes biophysical sense given the detrimental effect that simultane-
ous destabilization of all three regions would have on catalytic activ-
ity and structural integrity of the enzyme, i.e., mutants appear to 
survive the mutational destabilization in one site at a time, whereas 
simultaneous acquisition of mutations in three loci would exceed 
the stability threshold. This explanation is consistent with recent 
work showing that excessive dynamics can lead to negative epistasis 
and limit the evolution of a TEM-1 β-lactamase22.
R6 and Rev6 appear to be both bifunctional and multi- 
conformational as they can interconvert between dominant EnzGSs; 
a R0-like EnzGS with loop 5 close to the active site, and R22-like EnzGS 
with loop 5 away from the active site (Fig. 4b). The R0 conformation 
is adept at catalyzing PTE hydrolysis, whereas the R22 conforma-
tion is adept at catalyzing arylester hydrolysis19,25; i.e., the disorder 
or dynamics observed in these intermediates is a reflection of inter-
conversion between two distinct, catalytically relevant, EnzGSs that 
are suited to different reactions. In contrast, in R0 and R22, loop 5 
and loop 7, respectively, are substantially more conformationally 
homogeneous (Fig. 4d and Supplementary Fig. 6). These results 
suggest that the dynamic nature of these proteins is responsible for 
the gradual evolutionary transition and catalytic promiscuity: from 
one gene sequence, multiple enzyme configurations that are opti-
mized for distinct substrates can be attained.
Changes to the active site provide the catalytic potential that 
is optimized through the changes in the conformational distribu-
tion. Thus, these intermediates are not efficient because of their 
dynamics per se; rather, their structural dynamics allow inter-
conversion between two distinct and stable active site configu-
rations. Specialization in evolution is then characterized by a 
drive to minimize, or ‘freeze out’ unnecessary dynamics and 
catalytic promiscuity.
These results show that protein structural dynamics are nuanced: 
one mutation can result in far reaching dynamic effects. It also 
emphasizes that, in this example, structural dynamics themselves 
are not intrinsically beneficial to activity in a general or nonspe-
cific fashion (assuming there is sufficient energy in the system for 
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Figure 5 | Epistatic interactions between mutations that accumulate  
in r22. (a) the kcat values, with 2-naphthyl hexanoate, of the e2b, R2 and 
e3 variants, in which Arg254 is combined with either Asp233Glu, the 
loop 7 substitutions (leu271phe, leu272Met, phe306ile and ile313phe), 
or both, are substantially higher than in variants in which His254Arg is 
not combined with these substitutions. (b) pathways to higher activity 
that proceed through intermediates with Asp233Glu and l7 (but not 
Arg254) gained little activity in round 2. (c) the b-factor of the residue 
at position 254 (His, Arg refined as the bent rotamer) increased in R1, 
and can be stabilized similarly through addition of Asp233Glu, loop 7, or 
both. (d) the b-factor of loop 7 was substantially lower in variants with 
Arg254 (R1, e2b and e3).
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conformational change to occur). This trajectory is marked by strong 
selection against mobility in the key areas of Arg254 and loop 7. 
In this example, where the highly optimized wild-type enzyme has 
considerable mobility, any changes during evolution are highly 
directional and required in a functional role (for example, loop 
7 opening or closing for diffusion or catalysis). Our observations 
establish that changes in the conformational landscape of a protein 
are essential to evolutionary functional change, and strongly suggest 
that enzyme design and engineering will require the development 
of means to tune the conformational landscapes as well as to design 
efficient TS stabilization in the active site. However, these changes 
were attainable by single point mutations to achieve what is, in many 
ways, a simple redistribution of hydrogen bonds and salt bridges 
throughout an otherwise almost identical structure. This suggests 
that substantial changes in function might be achieved through 
dynamic enrichment of pre-existing (but low fractional occupancy) 
catalytic states, rather than direct mutational active site remodeling. 
Instead, positioning of active site features can be achieved through 
optimizing the conformation of the active site residues. Indeed, it 
has previously been shown that the introduction of flexibility is an 
important feature of emerging primordial enzymes34, and it has also 
been observed that if computational enzyme design does not initially 
yield an efficient enzyme, the designed protein can be optimized by 
remote mutations35–38. The observation that most substitutions in 
directed evolution experiments are remote from the active site39 and 
(in this instance) highly epistatic, stabilizing a preorganized active 
site configuration, suggests that laboratory evolution can heuristi-
cally uncover features that mechanistic work would not necessarily 
find, and pave the ground for extrapolation from EnzGS structures to 
mechanisms of TS stabilization. 
received 21 January 2016; accepted 17 June 2016; 
published online 12 September 2016
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Methods and any associated references are available in the online 
version of the paper.
Accession codes. Protein Data Bank: coordinates for the structures 
described in this work have been deposited under the accession 
codes 4PCP (R0), 4XAF (R1), 4XD5 (R2), 4XAG (R6), 4XAY (R8), 
4XAZ (R18), 4PBE (Rev6), 4PBF (Rev12), 4PCN (R22), 4XD6 
(E2a), 4XD4 (E2b) and 4XD3 (E3).
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Construction of combinatorial mutants. Mutants E1a (encoding Glu233Asp), 
E1b (Leu271Phe/Leu272Met/Phe306Ile/Ile313Phe), E2a (Asp233Glu/Leu27
1Phe/Leu272Met/Phe306Ile/Ile313Phe), E2b (His254Arg/Leu271Phe/Leu27
2Met/Phe306Ile/Ile313Phe) and E3 (His254Arg/Asp233Glu/Leu271Phe/Leu
272Met/Phe306Ile/Ile313Phe) were constructed by site-directed mutagenesis 
as described in the QuikChange Site-Directed Mutagenesis manual (Agilent). 
All mutations were confirmed by DNA sequencing. The sequences of E2a and 
E2b were additionally confirmed by X-ray crystallography and inspection of 
difference map peaks.
Enzyme kinetics. For kinetic measurements, all enzymes were purified by strep-
tag affinity chromatography. Plasmids were transformed into Escherichia coli  
BL21 (DE3) and grown at 37 °C in 2YT medium containing 100 μg/mL ampi-
cillin and 200 μM ZnCl2. Expression was induced with 0.4 mM IPTG when 
cell density reached an OD600 of 0.6 and cells were further grown overnight 
at 20 °C. Cells were lysed using B-PER Protein Extraction Reagent (Thermo 
Scientific) and the proteins were purified using strep-tactin affinity columns 
(IBA Lifesciences) according to the manufacturer’s protocol.
Initial rates for 2NH and paraoxon hydrolysis were determined at 12 dif-
ferent substrate concentrations (2 to 2,000 μM in 100 mM Tris-HCl, pH 7.5, 
100 μM ZnCl2 and 0.02% Triton X-100) in a Synergy H1 Hybrid Microplate 
Reader (Biotek). Measurements were performed in triplicate and the average 
values fitted to the Michaelis–Menten equation using KaleidaGraph (Synergy 
Software) (v0 = kcat[E]0[S]0/(KM + [S]0) with v0: initial rate, [E]0: enzyme con-
centration, and [S]0: substrate concentration).
Protein expression and purification. PTE variant expression and purification 
was carried out differently to produce protein for crystallography. First, the 
twelve genes (R0, R1, R2, R6, R8, R18, R22, E2a, E2b and E3) were cloned 
into a tag-less vector (pETMCSIII)40. A single colony of E. coli BL21 (DE3) 
cells transformed with each construct was used to inoculate LB media (5 mL). 
This small scale culture was used to inoculate 1 L of Terrific Broth (TB) media 
supplemented with 100 μM ZnCl2. After incubation at 25 °C for 42 h, cells 
were pelleted by centrifugation (5,000g) and resuspended in buffer A (50 mM 
HEPES, 100 μM ZnCl2, pH 8.0). The resuspended cells were lysed by sonica-
tion (Omni Sonic Ruptor 400), the lysate was sedimented and the superna-
tant filtered before loading onto a DEAE fractogel equilibrated with buffer A. 
The protein did not bind to the resin and was collected in the flow-through 
fraction. The flow-through was then concentrated using a Millipore centrifu-
gal protein concentration device (30 kDa cutoff) and loaded onto a Superdex 
200 Hiload 16/600 column (GE Healthcare) equilibrated with buffer C (20 mM 
HEPES, 50 mM NaCl, 100 μM ZnCl2, pH 8).
Purified PTE variants were concentrated to 10 mg.mL−1 in buffer C. Screens 
were optimized by hanging-drop vapor diffusion at 4 °C. Drops consisting of 
2 μL of reservoir and 1 μL of PTE were equilibrated over a 500 μL reservoir 
using EasyXtal-15-Well Tools (Qiagen). Reservoir solutions were screened 
between 100 mM sodium cacodylate (pH 6.3–6.7), distilled deionized water 
and 20–50% (w/v) 2-methyl-2,4-pentanediol (MPD). Crystals formed in the 
initial screening were manually pulverized for use as microseeds. Six serial 
dilutions of the pulverized crystals were made, from 1/10 to 1/1,000,000 in 
factors of 10. New crystal screens were set up using only sodium cacodylate 
buffer of pH 6.5, and varying MPD concentrations from 12% to 28%. Each well 
contained 1 μL of protein, 1.5 μL of mother liquor and 0.5 μL of microseed 
solution. To obtain crystal structures in the same space group and crystalliza-
tion condition, serial microseeding was used.
X-ray diffraction data collection and refinement. For data collection, crystals 
were soaked in cryobuffer (100 mM sodium cacodylate, pH 6.5, 40% MPD) 
for 2 min before flash-cooling to 100K in a stream of nitrogen gas. PTE dif-
fraction data were collected at the Australian Synchrotron (beamline MX1) at 
a wavelength of 0.9537 Å, or locally on a Marresearch marμX system com-
prising a Xenocs Genix3D Cu high flux generator and a mar345 image plate 
detector. The X-ray diffraction data were indexed and integrated using XDS41 
and merged using AIMLESS as implemented within the CCP4 program suite42. 
Data resolution cut-offs were chosen using half data set correlation coefficients, 
as described by Karplus and Deiderichs43. The structures of PTE and vari-
ants were solved by molecular replacement (PHASER)44 using the R18 struc-
ture (4GY0)21. Refinement was performed using REFMAC and phenix.refine, 
and manual rebuilding was performed using COOT45–47. Automated fitting of 
multiple conformations was carried out with the QFit web-server30, with man-
ual inspection and removal of conformations that were not present in good 
(at least 1.0 σ) electron density.
Computational analysis of protein dynamics. Molecular dynamics simulations 
were carried out on the crystal structures of R0 and R22. All chain termini were 
capped with neutral acetyl and methylamide groups. Completed structures 
were solvated in a cubic simulation box with a minimum distance of 14 Å from 
any protein atom to the box wall, followed by the addition of roughly 150 mM 
NaCl to the aqueous phase, neutralizing the total system charge. Simulation 
systems of R0 and R22 were subjected to energy minimization, followed by a 
three-stage equilibration protocol with positional restraints holding all protein 
atoms at 1,000 kJ mol−1 nm−2, while initializing velocities at 290K and setting 
a temperature reference value of 300K for 100 ps. Restraints were released to 
backbone atoms at 1,000 kJ mol−1 nm−2 for 100 ps and then to Cα atoms at 
100 kJ mol−1 nm−2 for 100 ps. Completed systems were equilibrated and free 
simulation performed at 300K in duplicate for 30 ns, with each replicate starting 
from a different distribution of initial velocities. All simulations were performed 
using GROMACS ver 4.0.7 (ref. 48) in conjunction with the GROMOS 54A7 unit-
ed-atom force field49. Ionizable residues were set to their standard protonation 
states at pH 7. Water was represented explicitly using the simple-point-charge 
(SPC) model50. All simulation systems were equilibrated in an NVT ensemble 
and production runs performed in an NPT ensemble under periodic conditions. 
Temperature was maintained close to its reference value of 300K by V-rescale 
temperature coupling. Pressure was maintained close to a reference value of 
1 atm by isotropic coupling with a Berendsen pressure bath51. Non-bonded 
interactions were evaluated using a twin-range cut-off scheme: interactions fall-
ing within the 8 Å short-range cut-off were calculated every 2 fs whereas inter-
actions within the 14 Å long cut-off were updated every 10 fs, together with the 
pair list. A generalized reaction-field correction was applied to the electrostatic 
interactions beyond the long-range cut-off52, using a relative dielectric permit-
tivity constant of RF = 62 as appropriate for SPC water53. All bond lengths to 
hydrogen atoms were constrained using the P-LINCS algorithm54 and water 
geometry was constrained using the SETTLE algorithm55. A 2 fs time step was 
used for integrating the equations of motion. Analyses of simulations were per-
formed using the tools provided in the GROMACS package ver4.0.7 (ref. 48) and 
custom scripts in conjunction with ProDy56. Principal component analysis was 
performed with the Bio3D package57. Allosteric networks between the ‘source’ 
residue of A203 (loop 5) and the ‘sink’ residue of A270 (loop 7) were identified 
using the Weighted Implementation of Suboptimal Paths (WISP) software58. 
The optimal and 100 suboptimal paths were calculated on the MD simulation 
trajectories of R0 and R22. In each network, residues are linked by persistent 
tertiary contacts between side chains during a simulation. Determination of 
linkage was performed by generation of a correlation matrix of each residue Cα 
atoms within a 4.5 Å cut-off. All paths were visualized in VMD59 and analyzed 
with custom scripts.
To further examine the conformational flexibility of the variants, normal 
mode analysis of elastic network models was performed. Dimeric structures of 
R0 and R22, were submitted to the ElNémo server (http://www.igs.cnrs-mrs.fr/
elnemo/index.html)60 using default parameters. The lowest eigenvalue normal 
modes that involved movement of rigid bodies within each monomer (modes 
7 & 8) were analyzed in detail. The computed B-factors from the normal mode 
analysis were compared against experimentally determined B-factors, yield-
ing correlation coefficients between 0.7 and 0.8. Experimentally determined 
B-factors were compared against each other by refining with a single major 
main-chain conformation, averaging values of two chains within each dimer, 
and normalizing the B-factor, which was achieved by scaling the average 
B-factor of each chain (with the exception of the loops with variable B-factors) 
to achieve a comparable baseline.
Time-averaged ensembles were generated for R0 (4PCP), R6 (4XAG), R22 
(4PCN) and Rev-R6 (4PBE) with phenix.ensemble_refinement implemented 
in PHENIX version 1.9-1692. Initially, the protein and zinc ion coordinates 
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were refined using phenix.refine with default parameters (the ligands MPD and 
CAC were removed). The Rfree of the refined models, and the mFO − DFC differ-
ence density maps, were used to assess the time-averaged refinement protocol. 
To prepare the structures for ensemble refinement, alternate conformations 
were removed and occupancies adjusted to 100% (PDB tools). Hydrogen atoms 
were added (phenix.readyset). Because the carboxylated lysine residues are 
nonstandard, a restraints file was generated (phenix.elbow) with the geometry 
taken from the input PDB file. Each monomer of the crystallographic dimer 
was assigned to a different translation-libration-screw TLS group, with zinc 
cations assigned to the TLS group of the closest protein monomer. Harmonic 
restraints were applied to the zinc cations. A grid search was performed to 
optimize the ensemble refinement simulation parameters pTLS (0.6, 0.7, 0.8 
and 0.9) and TBATH (2K, 5K and 10K). Four additional simulations with the ER 
parameters giving the lowest Rfree were conducted to assess reproducibility, 
with initial velocities assigned with different random seeds. RMSF values 
for the ensembles were calculated with the g_rmsf tool in the GROMACS 
molecular dynamics suit. CCP4 format electron density maps were calculated 
with phenix.density and contoured to comparable e/Å3 levels for comparison. 
All maps and coordinates were visualized using PyMOL version 1.6 (http://
pymol.org). Calculations, modeling and simulations were performed on a 
range of computing resources: 1 ORCHARD 800 core x86 cluster (Monash 
University; X-ray ensemble refinement); 2AVOCA/MERRI (VLSCI 
BlueGene/Q/x86 cluster; atomistic MD).
New data were deposited in the Protein Data Bank.
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Supplementary Figure 1. The mutants studied in this work. The relative catalytic 
specificities (kcat/KM) between R0 and R22 change evenly across the intermediates R1-R18, 
with R6 being bifunctional. The variants obtained through reverse evolution (Rev6, Rev12) 
regain significant phosphotriesterase activity, with Rev6 being similarly bifunctional to R6.  
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Supplementary Results 
Supplementary Figure 2. Distinct disorder and dynamics in R0 and R22. (a) An averaged 
plot (A and B chains) of the main-chain B-factors of R0 and R22 reveals that loops 4 (170-
175) and 5 (200-210) have become disordered, whereas loop 7 (260-275) has attained
greater order. This is portrayed visually (b) as a sausage representation, with increased B-
factor shown as fatter, and redder, sausage. (c) Computed B-factors from normal mode
analysis with an elastic network model show increased movement of loop 5 and reduced
movement of loop 7. This is shown in (d) in a ribbon representation of the lowest
frequenting normal mode (mode 7) in which rigid bodies within the protein began to move
independently, start (blue) to end (red). The reduced motion of loop 7 and the increased
motion of loop 5 are visible. (e) Root mean squared fluctuations of amino acids from
molecular dynamics simulations of R0 and R22 reveal loss of mobility in loop 7 and gain in
mobility of loop 5. (f) Principal component analysis of the dominant motions in R0 and R22
show reduced movement of loop 7 and increased movement of loop 5.
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Supplementary Results 
Supplementary Figure 3. Optimal and suboptimal paths connecting loop 5 and loop 7 in 
R0 and R22. The optimal and suboptimal paths are displayed in blue and red respectively. 
Bold labelled residues are those that have changed between R0 and R22. As structural and 
molecular dynamics analysis revealed striking differences in the mobility of loops 5 (200-210) 
and 7 (260-275) between R0 and R22, we sought to explore respective changes in allosteric 
communication networks. Using the Weighted Implementation of Suboptimal Paths (WISP) 
software (Van Wart et al. 2014), we calculated the optimal (shortest path) and 100 
suboptimal (alternate and longer) pathways. Our analysis reveals that R0 exhibits a 
predominant pathway from A203 > A203 > T234 > L283 > T279 > S276 > A259 >A270, 
with two branching pathways that center on D232 and H254. In contrast, R22 exhibits a 
single major pathway from A203 >T202 >H230 > D232 >R280 >S276 > R275 > G273 > 
F271 > A270.  
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Supplementary Figure 4. A schematic representation of the changes in disorder of the 
various loops along the trajectory for different regions, in which darker color in represents 
greater flexibility. Arg254 (red) peaks in R1 and is stable by R6. Loop 7 (cyan) peaks at R2 
and continues to decrease to R18. Loop 5 (green) undergoes its most significant increase 
between R9 and R18.  
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Supplementary Figure 5.  Optimisation of ensemble refinement empirical parameters. A 
grid-search was conducted for each structure to minimise Rfree by varying the values of pTLS 
and TBATH. The five repeats with the optimised values of pTLS and TBATH are enclosed by red 
lines. Although the choice of pTLS appeared to influence the ensemble Rfree, the value of TBATH 
did not.   
R0 R6 R22 RevR6 
86
Supplementary Results 
Supplementary Figure 6. Comparison of the mFO-DFC difference density between conventional refinement (top) and ensemble refinement (bottom). 
Difference electron maps are contoured at 0.35, 0.35, 0.36 and 0.42 e/Å3 for R0, R6, R22 and Rev6 respectively (the densities are equivalent to 3 σ for the 
single model).  The single structure is shown as a cartoon while the ensembles are shown in line representations with backbone atoms only. The active site 
zinc cations are shown as blue spheres. For ease of interpretation, every second structure from the ensembles is hidden.  
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Supplementary Results 
Supplementary Figure 7. The hydrogen bonding interaction between Arg254 and the 
carbonyl oxygen of the residue at position 271 is weakened through improper alignment 
when Glu233 is present (left), compared with Asp233. 
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Supplementary Table 1. Kinetic parameters and genotype for all variants produced throughed directed evolution. Data from Tokuriki et al. (2012) and 
Kaltenbach et al. (2015). 
Paraoxon 2-Naphthol hexanoate Mutations (vs. R0) 
kcat [s
-1] KM [µM] kcat/KM [M
-1s-1] kcat [s
-1] KM [µM] kcat/KM [M
-1s-1] 
R0 1300 ± 27 57 ± 4.9 2.3 x 107 0.035 ± 0.0017 83 ± 19 4.2 x 102 
R1 62 ± 2.6 7.0 ± 1.4 8.9 x 106 0.27 ± 0.012 250 ± 32 1.1 x 103 H254R 
R2 440 ± 9.9 18 ± 1.4 2.4 x 107 24 ± 2.7 150 ± 25 1.6 x 105 H254R/D233E 
R6 55 ± 2.1 120 ± 17 4.6 x 105 130 ± 3.4 190 ± 20 6.8 x 105 H254R/D233E/F306L/I274S/T172I/S269T 
R8 10 ± 0.55 300 ± 77 3.3 x 104 73 ± 2.0 140 ± 13 5.2 x 105 H254R/D233E/F306L/I274S/T172I/S269T/M138I/T199I 
R18 0.73 ± 0.061 1300 ± 197 5.6 x 102 880 ± 34 63 ± 9 1.4 x 107 
H254R/D233E/F306I/I274S/T172I/S269T/M138I/T199I/I272M/A80V/S111R/A204G/ 
I130V/L271F/A49V/K77E/I140M/I313F 
R22 0.12 ± 0.0034 1200 ± 60 1.0 x 102 870 ± 45 130 ± 22 6.5 x 106 
H254R/D233E/F306I/I274S/T172I/S269T/M138I/T199I/I272M/A80V/S111R/A204G/ 
I130V/L271F/A49V/K77E/I140M/I313F/S137T/Q180H/T45A/E144V/M314T/I341T/S102T/V17
6M 
Rev6 28 ± 0.32 74 ± 2.2 3.8 x 105 280 ± 3.6 130 ± 8 2.1 x 106 
H254R/D233E/F306I/I274S/S269T/M138I/T199I/I272M/A80V/S111R/A204G/ 
I130M/K77E/I140M/A49V/I313F/S137T/T45A/E144V/I341T/S102T/V176M/S308C/P135S/ 
A203E/M293K 
Rev12 270 ± 5.3 130 ± 5.3 2.1 x 106 110 ± 2.3 180 ± 17 6.1 x 105 
H254R/D233E/F306M/I274S/S269T/M138I/T199I/I272M/A80V/S111R/A204G/ 
I130M/K77E/I140M/I313F/S137T/T45A/E144V/I341T/S102T/V176M/S308C/P135S/ 
A203E/M293K/G194D/S258N/Y156H 
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Supplementary Table 2. Data collection statistics for structures described in this work. 
R1 R2 R6 R8 R18 Rev6 
Data collection 
Space group P21212 P21212 P21212 P21212 P21212 P21212 
Cell dimensions   
 a, b, c (Å) 85.7, 85.7, 88.4 85.7, 85.9, 88.4 85.9, 86.3, 88.6 85.8, 85.9, 88.7 86.1, 86.2, 88.9 85.6, 86.0, 89.2 
    α, β, γ  (°) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 
Resolution (Å) 35.71-1.66 
(1.72-1.66) 
44.19-1.85 
(1.92-1.85) 
39.41-1.6 
(1.66-1.6) 
38.41-1.84 
(1.91-1.84) 
39.48-1.55 
(1.61-1.55) 
39.59-1.51 
(1.56-1.51) 
Rsym or Rmerge 0.07831 (0.8946) 0.04736 (0.2506) 0.1212 (1.108) 0.1069 (1.007) 0.08794 (0.9467) 0.08583 (1.023) 
CC1/2 0.999 (0.806) 0.999 (0.906) 0.998 (0.736) 0.999 (0.81) 0.999 (0.792) 0.999 (0.731) 
CC* 1 (0.945) 1 (0.975) 1 (0.921) 1 (0.946) 1 (0.94) 1 (0.919) 
Completeness (%) 99.91 (99.91) 90.54 (57.20) 99.98 (99.99) 99.95 (100.00) 99.98 (99.99) 99.95 (99.75) 
Redundancy 7.3 (7.4) 6.4 (3.7) 7.4 (7.4) 7.4 (7.4) 7.3 (7.3) 7.3 (7.3) 
Refinement 
Resolution (Å) 35.71-1.66 
(1.72-1.66) 
44.19-1.85 
(1.92-1.85) 
39.41-1.6 
(1.66-1.6) 
38.41-1.84 
(1.91-1.84) 
39.48-1.55 
(1.61-1.55) 
39.59-1.51 
(1.56-1.51) 
No. reflections 77440 (7631) 51029 (3184) 87372(8629) 57480 (5673) 96390 (9531) 103658 (10220) 
Rwork / Rfree 0.1794/0.2196 0.1610/0.2037 0.1640/0.2021 0.1759/0.2192 0.1737/0.2060 0.2096/0.2490 
No. atoms 
 Protein 5398 5387 5282 5185 5372 5159 
 Ligand/ion 30 38 41 17 12 17 
 Water 333 384 468 371 581 532 
B-factors
Protein 25.9 23.1 19.9 26.8 20.5 22.2 
Ligand/ion 41.6 40.2 42.7 36.1 45.7 22.4 
Water 29.3 28.5 27.6 31.8 30.6 29.2 
R.m.s. deviations
Bond lengths (Å) 0.016 0.007 0.018 0.007 0.016 0.007 
Bond angles (°) 1.65 1.08 1.78 1.11 1.52 1.11 
*Values in parentheses are for highest-resolution shell.
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Supplementary Table 2 (cont.). Structures of R0, R22 and Rev12 have been published previously (Kaltenbach et al. (2015)). 
E2a E2b E3 
Data collection 
Space group P21212 P21212 P21212 
Cell dimensions   
 a, b, c (Å) 85.7, 85.7, 88.4 85.7, 85.9, 88.4 85.9, 86.3, 88.6 
    α, β, γ  (°) 90, 90, 90 90, 90, 90 90, 90, 90 
Resolution (Å) 35.71-1.66 
(1.72-1.66) 
44.19-1.85 
(1.92-1.85) 
39.41-1.6 
(1.66-1.6) 
Rmerge 0.07283 
(0.4594) 
0.1183 
(0.8233) 
0.0828 
(0.9643) 
CC1/2 0.996 (0.83) 0.996 (0.693) 0.999 (0.806) 
CC* 0.999 (0.952) 0.999 (0.905) 1 (0.945) 
I / σI 22.91 (2.71) 10.48 (1.87) 16.45 (2.31) 
Completeness (%) 90.54 (92.03) 90.45 (91.94) 99.91 (99.94) 
Redundancy 6.4 (3.9) 4.4 (4.2) 7.3 (7.3) 
Refinement 
Resolution (Å) 35.71-1.66 
(1.72-1.66) 
44.19-1.85 
(1.92-1.85) 
39.41-1.6 
(1.66-1.6) 
No. reflections 60062 (6017) 47005 (4690) 91982 (9078) 
Rwork / Rfree 0.2141 / 0.2694 0.1755 / 0.2431 0.1738 / 0.2017 
No. atoms 
 Protein 5132 5164 5126 
 Ligand/ion 46 38 46 
 Water 690 599 672 
B-factors
Protein 22.6 24 22.6 
Ligand/ion 39.1 43.5 43.3 
Water 30.8 32.3 33.8 
R.m.s. deviations
Bond lengths (Å) 0.007 0.007 0.007 
Bond angles (°) 1.13 1.09 1.14 
*Values in parentheses are for highest-resolution shell.
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Supplementary Table 3. Statistics for ensemble refinement of the R0, R6, R22 and Rev6 PTE datasets. 
Data-set 
R0 R6 R22 RevR6 
phenix.ensemble_refinement 
pTLS (%) 90 90 90 90 
TBATH (K) 298 298 290 298 
τX (ps) 0.8 0.8 0.8 0.9
No. of models* 72 ± 8 (77) 73 ± 4 (67) 70 ± 10 (54) 81 ± 7 (74) 
Rwork
* 14.9 ± 0.1 (14.7) 13.9 ± 0.1 (13.8) 14.1 ± 0.1 (14.0) 16.1 ± 0.1 (16.0) 
Rfree
* 19.6 ± 0.2 (19.4) 18.1 ± 0.1 (18.0) 18.0 ± 0.1 (17.9) 20.5 ± 0.2 (20.3) 
RMS (bonds) (Å)* 0.015 ± 0.002 (0.016) 0.016 ± 0.001 (0.016) 0.020 ± 0.001 (0.012) 0.015 ± 0.001 (0.015) 
RMS (angles) (˚)* 2.40 ± 0.02 (2.39) 2.43 ± 0.01 (2.42) 2.62 ± 0.02 (2.00) 2.37 ± 0.01 (2.37) 
* Data is mean ± standard deviation for five repeat refinements. The values in brackets correspond to the ensemble with the lowest Rfree.
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Postcards featuring photograph of a phosphotriesterase crystal, produced for National 
Science Week, 2017. 
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CHAPTER 3:  
REPLAYING THE TAPE OF LIFE – INVESTIGATING THE 
REPEATABILITY OF MOLECULAR EVOLUTION 
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Parallel enzyme evolution reveals distinct molecular mechanisms of adaptation despite 
nearly identical ancestral states. 
Charlotte M. Miton1, Eleanor C. Campbell2, Colin J. Jackson2, Nobuhiko Tokuriki1 
1 Michael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada. 
2 Research School of Chemistry, Australian National University, Canberra, Australia. 
ABSTRACT 
Laboratory directed evolution is a powerful technique that allows the rapid improvement of 
biocatalysts and can also provide valuable insights into the mechanisms by which highly 
efficient catalysts evolve in nature. Numerous factors complicate our working knowledge (and 
thus exploitation) of molecular evolution, and a long-standing question in evolutionary biology 
asks whether adaptation relies on stochastic events due to historical contingency, or if it follows 
a deterministic path imposed by specific molecular or environmental constraints. The 
observation of convergent evolution has led to suggestions that relatives placed under the same 
selection pressure will converge upon a similar genotypic and phenotypic solution. This implies 
that two identical phenotypes under the same selective pressure should follow identical paths 
to the same fitness peak, but how closely related should orthologous proteins be to trigger a 
repeated evolutionary outcome? Is a single amino acid polymorphism enough to impair 
repeatability and predictability along evolutionary trajectories? To explore these questions, we 
‘replayed’ the evolution of a bacterial phosphotriesterase that had been previously evolved 
toward the hydrolysis of an arylester substrate1. Starting from an immediate, nearly neutral 
neighbour, which only differs at the genotype level by a single amino acid mutation (Ser254 
instead of Arg254), and is phenotypically similar, they repeated the laboratory evolution under 
identical experimental conditions. Comparing this trajectory with the previously described PTE 
to AE trajectory has revealed that the initial constraint (a point mutation) has resulted in the 
evolutionary trajectory following a new pathway to reach a distinct fitness peak, featuring a 
different substrate binding mode and vastly altered loop dynamics. This analysis highlights the 
unpredictability of evolution; replaying an evolutionary process from a genotypic ‘neighbour’ 
starting point results in a novel method of adaptation, supporting the hypothesis that adaptive 
evolution relies on historical contingency.  
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INTRODUCTION 
Stephen Jay Gould famously stated that rewinding the ‘tape of life’ and letting it play out again 
would result in a vastly different population of organisms to those we observe today2. His 
assertion was based on the rationale that adaptive evolution is unpredictable, governed by 
stochastic mutational events and further randomised by environmental factors like mass 
extinctions and drastic shifts in climate. This idea has been the topic of much debate, with 
opponents of Gould insisting that adaptive evolution will always converge upon particular 
solutions to selective pressures3. As with many key questions in science, the truth is likely to 
lie somewhere in the middle4,5.  
The exact nature of the repeatability of evolutionary pathways has substantial implications for 
biochemists who strive to understand and design the next generation of enzyme catalysts. Will 
laboratory directed evolution campaigns that start from the same or similar phenotypes always 
result in the same endpoint? Is the pathway between two known phenotypes generally 
repeatable, and if it is, can we exploit the mechanisms of evolution to find shortcuts to more 
efficient catalysts? The existence of convergent evolution suggests that there are a finite 
number of ideal evolutionary solutions, and that the process of natural selection hones in on 
these solutions. Convergent evolution is frequently observed in organisms, e.g. the parallel 
evolution of the focusing eye6, the ‘undulating’ pattern of locomotion in birds and sharks7, and 
even the evolution of problem-solving skills and ‘intelligence’ in distantly related species, like 
apes and crows8. Morphological traits in organisms, however, are typically under the control 
of many genes, meaning that convergence on a particular phenotype can occur via numerous 
pathways, although ‘hotspot’ genes for variation of particular traits have been identified9,10.  
The study of convergent evolution in single proteins can circumvent the confounding effects 
of gene epistasis that arise in the study of organisms. Convergent evolution in molecules is not 
uncommon; the reoccurrence of similar patterns and geometries of active site residues in 
enzymes that catalyse similar reactions suggests that there are also a limited number of ‘best 
solutions’ for a given reactivity11. The convergent evolution of reversible Fe3+ binding between 
ferric-ion-binding protein (FBP) from Haemophilus influenzae and prokaryotic tranferrins 
results in geometrically similar binding sites, and suggests that there are a limited number of 
ways for a protein to acquire this property12. Kinases with different folds have evolved to 
catalyse the phosphorylation of identical substrates13,14, and the Ser-His-Asp triad has evolved 
in a number of distinct folds15. Comparison of serum paraoxonase 1 (PON1) with other 
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organophosphate hydrolases has identified the importance of a hydrophobic binding pocket, a 
feature that has been converged upon in a number of enzymes capable of hydrolysing 
organophosphate compounds16.  
The convergent evolution of proteins towards similar phenotypes could be interpreted as 
evidence of evolutionary determinism; that given enough time, two unrelated (or distantly 
related) proteins under the same selection pressure would come to resemble each other 
genetically and phenotypically. There are, however, numerous factors that complicate the 
evolutionary pathway between two phenotypes; there are typically few mutations that will 
confer the required function without catastrophically disrupting thermostability17; mutational 
bias makes some nucleotide/amino acid substitutions more likely than others, meaning that not 
all pathways between phenotypes are equally likely to be followed18; and epistasis can result 
in evolutionary solutions that are dependent on historical contingency, confounded by neutral 
drift introducing rare permissive substitutions19,20.  These factors, particularly the existence of 
historical contingency, impair the predictability of adaptive evolution of orthologous proteins. 
Different ‘starting points’ are likely to impose different sets of constraints, and the question of 
how different the starting points need to be to result in unique evolutionary trajectories cannot 
be readily answered through the study of extant proteins. 
The use of ancestral protein reconstruction and directed evolution has facilitated the 
exploration of ‘hypothetical’ evolutionary trajectories, allowing the ‘tape of life’ to be 
replayed, albeit on a small scale. The directed evolution of a phosphotriesterase from 
Pseudomonas diminuta (PTE) towards the hydrolysis of an arylester substrate resulted in the 
isolation of a number of evolutionary intermediates, and produced a highly efficient 
arylesterase (AE) in 18 rounds of selection1. In the work presented here, the PTE to AE tape is 
rewound and replayed, this time starting from a phenotypically similar starting point, varying 
by a single amino acid. The kinetic and structural characterisation of evolutionary intermediates 
along this new trajectory reveals that the replayed evolution has followed a new pathway to a 
distinct fitness peak, resulting in altered loop dynamics and a novel substrate binding mode. 
This is indicative of the strong dependence of molecular evolution on historical contingency, 
where a single amino acid substitution fixed at the start of the trajectory can have profound 
effects on the nature of the endpoint. Further, the analysis of each trajectory’s tolerance to the 
other’s substitutions highlights the strong epistasis that governs molecular evolution.   
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RESULTS 
Similarities in the genotypic adaptation lead to a distinct phenotypic improvement 
between the two evolutionary trajectories. PTE-S5, previously described by Roodveldt et 
al., served as the starting point for the original PTE to AE trajectory (henceforth referred to as 
the R-trajectory because of the prominent role of Arg254)21. PTE-S5 will be referred to as 
PTEWT for clarity. In the R-trajectory, the first mutation to be fixed was a naturally occurring 
polymorphism22, His254Arg. Previous studies of the R-trajectory have identified the role of 
this substitution; the flexible arginine residue can adopt a ‘bent’ conformation (Cβ-Cγ-Cδ-Nε 
dihedral angle ~ 40 - 70°), which minimises steric hindrance of 2NH binding, and provides 
stabilising cation-pi interactions with the naphthyl moiety of 2NH1. In fact, subsequent 
mutations in the R-trajectory were found to stabilise this productive ‘bent’ conformation 
through intramolecular hydrogen bonding and electrostatic networks23. Mutagenic scanning of 
position 254 has revealed that it is relatively tolerant to mutation, particularly in terms of the 
promiscuous arylesterase activity (Supplementary Figure 1). 
In order to investigate the reproducibility of the PTE to AE evolutionary pathway, a new 
directed evolution experiment was devised, starting from an ‘immediate neighbour’; the initial 
His254Arg mutation was discarded in favour of point mutation His254Ser, resulting in variant 
S1. S1 is phenotypically similar to PTEWT, showing a 1.4-fold increase in activity with 2NH 
(Figure 3.1). In this sense, it occupies a similar position on the ‘fitness landscape’ as PTEWT, 
more so than other mutants characterised in initial scanning mutagenesis experiments 
(Supplementary Figure 1). S1 was subjected to random mutagenesis, and variants screened 
for activity with 2NH, resulting in the generation of what will be referred to hereafter as the S-
trajectory. Mutagenic libraries were constructed through error-prone PCR and gene shuffling. 
Seven rounds of directed evolution resulted in the isolation of variant S8, which demonstrated 
a 400-fold increase in arylesterase (AE) activity relative to PTEWT (Supplementary Table 2). 
In the R-trajectory, round 8 variant R8 showed a 10,000-fold increase in AE activity, indicating 
that Ser254 is less productive for the evolution of AE activity in this system; the evolution of 
AE activity is immediately constrained by this initial, non-ideal substitution (Figure 3.1). 
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Figure 3.1 | A) Hydrolysis of arylester substrate 2NH by PTE. B) Relative AE activity in both the R-trajectory 
(purple) and S-trajectory (blue).  
The pattern of diminishing returns is apparent in the S-trajectory, as it was in the R-trajectory. 
The R-trajectory showed substantial increases in AE activity for the first eight rounds of 
evolution before an obvious plateau; the nine final substitutions resulted in a cumulative 4.4-
fold improvement1. In the replayed trajectory, this plateau becomes apparent after only two 
rounds of evolution; there is an improvement of 100-fold between S2 and S3, representing the 
largest single improvement in the trajectory, but only 4-fold increase from S3 to S8. This 
suggests that the evolutionary potential of S8 for enhanced AE activity may be exhausted, 
having reached an earlier local maximum on the fitness landscape.  
Excluding the initial 254 point mutation, three of the twelve mutations in the S-trajectory occur 
at sites also mutated in the R-trajectory, although only one of these mutations is identical 
(Table 3.1). Phe306Ile is accumulated in the first round of screening in the S-trajectory (S2), 
where Phe306Leu occurs in the fourth round in the R-trajectory (R4), and is later replaced by 
Ile306 in round seven (R7b). Asp233Ala is fixed in S3. Asp233Glu (R2) played a large role in 
the stabilisation of Arg254 in the initial trajectory. Leu271His is also acquired in S3, where 
Leu271Phe is fixed in later rounds of the R-trajectory (R13). The remaining nine mutations in 
the S-trajectory occur at positions not mutated in the R-trajectory, resulting in a genotypically 
distinct variant.  
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Round Variant Mutations 2NH activity 
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Table 3.1 | The identity of mutations accumulated in the S-trajectory (top) and the relative enhancement of AE 
activity. The mutations acquired in the R-trajectory that shares position and identity to one in the S-trajectory is 
indicated in blue, while those sharing just position are indicated in purple.  
To understand the nature of the constraints on this replayed trajectory, X-ray crystal structures 
of seven variants on the S-trajectory were obtained; S1, S2, S3, S5, S6, S7, and S8 
(Supplementary Table 1). Work previously reported in Campbell et al. links the evolution of 
AE activity in the R-trajectory to the alteration of conformational dynamics in key loop regions, 
specifically loops 4, 5 and 723, so these regions were selected for initial investigation in the S-
trajectory variants (Figure 3.2).  
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Figure 3.2 | The key regions of structural variation in the evolution of arylester activity; residue 254, and loops 
4, 5, and 7.  
The substitutions fixed in the R-trajectory demonstrated a radiating pattern; mutations were 
initially close to the active site but later round substitutions were in outer shells of the protein 
(Figure 3.3). While the S-trajectory comprises fewer substitutions, this pattern is still observed; 
mutations acquired in the last round are distant from the active site. Interestingly, all the 
mutations/positions common to the two trajectories occurred in the first 3 rounds of selection, 
corresponding to the greatest increases in AE activity. This suggests that these positions are 
inherently important in the adaptation to this new activity, although the identities of the residues 
at those sites vary. The last five rounds of evolution on the S-trajectory introduce substitutions 
at positions unaffected in the R-trajectory.  
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Figure 3.3 | The positions of all mutations acquired during the S-trajectory. Left: four mutations occurred at 
positions also mutated in the R-trajectory (purple), and the remaining eight were unique to the S-trajectory (blue). 
Right: the order of accumulation of mutations in the S-trajectory, illustrating that later round substitutions occurred 
at positions remote from the active site. 
Replayed evolution leads to structurally distinct endpoints and substrate binding modes. 
While the endpoints of the R- and S-trajectories are distinct in terms of their arylesterase 
activities, they generally have similar C-α positions. With the exception of several loop regions, 
tertiary structure is well conserved between R18 and S8, with an RMSD of 0.5424. Inspection 
of the active sites of these two evolved variants, however, reveals several distinctions. 
One feature of the R-trajectory is the stabilisation of the productive conformation of Arg254; 
an intricate network of hydrogen bonds not only stabilised the ‘bent’ conformation, but resulted 
in a redundancy such that the key Arg254-stabilising mutation Asp233Glu could be reverted 
without a substantial decrease in AE activity. In this sense, Arg254 was redundantly stabilised, 
particularly by later round mutations that enhanced the connectedness of the hydrogen bonding 
network (Figure 3.4a). This is not observed in the S-trajectory. While Arg254 had a very 
distinct role in the binding and stabilisation of the AE substrate, the role of Ser254, if indeed it 
serves one, is more obscure. Serine is smaller in size and has fewer degrees of conformational 
freedom, so a similar pattern of conformational enrichment was not expected. Rather, it was 
thought that Ser254 might serve as a hub in the centre of a similar hydrogen bonding network 
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to that observed in the initial trajectory. Network analysis using RING 2.0 revealed that Ser254 
remained isolated throughout the S-trajectory; later round mutations did not directly interact 
with the residue (Figure 3.4b)25. This represents a substantial difference between the endpoints 
of these two trajectories; the R-trajectory builds networks and redundancy into the active site 
of the enzyme, while the S-trajectory does not.  
The difference in active site architecture between the two endpoints raised questions about the 
binding mode of the substrate in the S-trajectory. To investigate the effects of Ser254 and the 
S-trajectory on substrate binding, co-crystals of S5 with 2NH transition state analogue
hexyl(naphthalen-2-yloxy)phosphinic acid (HLN) were obtained (Supplementary Table 1).
Screens were also set up in an attempt to co-crystallise S1 with HLN, but the resulting data
showed no evidence of bound TS analogue. Co-crystallisation of S8 and HLN was also
unsuccessful due to slow hydrolysis of HLN; a structure of S8 with hydrolysis product
hexylphosphonic acid was obtained, but the naphthyl moiety could not be visualised. The
presence of HLN in the active sites of S5 was, however, immediately apparent. Interestingly,
the orientation of HLN in the S5 active site was unlike that of HLN in R18; while the alkyl
chain adopted a similar conformation, the naphthyl moiety was modelled in an upright position,
rotated approximately 90° relative to the orientation of HLN in R18 (Figure 3.4c-f).
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Figure 3.4 | a) The productive conformation of Arg254 is enriched over the course of the R-trajectory1,23. Two 
mutations on this trajectory interact directly with the bent conformation of arginine. b) Ser254 remains isolated 
throughout the S-trajectory. No mutations form direct interactions with Ser254, and the trajectory does not result 
in the formation of any new interactions with Ser254. Intramolecular interactions (< 4 Å) are illustrated with dotted 
lines. c) The orientation of HLN in R181. d) Density map (grey mesh, 0.5 σ) for HLN in S5+HLN, and difference 
map of omitted HLN in S5+HLN (green mesh, 2.0 σ). e) The binding orientation of HLN in the R18 active site. 
f) The binding orientation of HLN in S5.
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The substrate binding region features the only mutation acquired that was identical in both 
pathways; Phe306Ile (Figure 3.4e-f). Given how early this mutation was acquired in the S-
trajectory (S2), it would seem that the resulting expansion of the alkyl chain binding pocket is 
vital to the enhancement of 2NH binding affinity. Indeed, the new binding mode observed in 
the S-trajectory differs only in the position of the naphthyl moiety; the alkyl chain binding 
position is conserved between the two trajectories.  
There are a number of key differences in the binding site of S5 relative to R18 that are 
potentially responsible the altered binding mode; the absence of Arg254 eliminates the 
favourable cation-pi interactions that stabilised the ‘straight’ conformation of the bound 
substrate in the R-trajectory, and the lack of some key reshaping residues present in the R-
trajectory (Leu271Phe, and mutations on loops 4 and 5 that reposition loop 5 to better contact 
the substrate) results in an active site less well-suited to the arylester substrate. Also significant 
is the loss of loop 7’s closed conformation; in the R-trajectory, Phe271 (R13) sterically prevents 
the ‘upright’ conformation of HLN observed in S5 (Figure 3.4e). The absence of this closed 
loop conformation (discussed below) opens the active site up, allowing for the unusual 
‘upright’ binding mode (Figure 3.4f). 
The roles of key loops vary between the two evolutionary trajectories. Previous analysis of 
the R-trajectory revealed several changes in loop positions and dynamics throughout the 
evolution of arylesterase activity23. B-factor analysis of S-trajectory variants (Figure 3.5a) 
revealed a number of distinctions from those patterns observed in the R-trajectory. During the 
R-trajectory, the position of loop 5 was observed to change; the tip of loop 5 drew closer to the
active site, resulting in a reshaped binding cavity appropriate for the AE substrate.
Additionally, the disorder/flexibility of loop 5 increased throughout the trajectory, suggesting
it possessed the capacity to adopt multiple conformations. The alteration in position of loop 5
was hypothesised to be involved in the increased specificity for AE substrate, as major changes
in loop position correlated with the reduction of PTE activity, rather than the enhancement of
AE activity.
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 Figure 3.5 | a) Averaged normalised C-α B-factors of S-trajectory variants. b) Averaged normalised B-factors 
of loop 4 and c) loop 5 throughout the S-trajectory. d) Electron density of loop 7 in S2 and e) loop 7 in S3. 
Disorder between Ser258 and Ala270 (orange box) in S3 was too great to facilitate accurate loop building (the 
S2 position of loop 7 is shown for clarity). Maps shown at 0.5σ. 
 
Loop 5 undergoes some positional changes during the S-trajectory, although S8 possesses a 
different final conformation to R18. Loop 5 can, in fact, be modelled into two distinct 
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conformations in S8, with the lower occupancy conformation more closely resembling the 
final position of loop 5 in R18 (Figure 3.6). 
Figure 3.6 | Loops 4 and 5 as modelled in S1 (pale blue), S8 (dark blue) and R18 (purple). Loop 6 omitted for 
clarity. 
Loop 4 also undergoes some change in position; the position of loop 4 in S1 resembles loop 4 
in R18, but adopts a distinct conformation in S8. Analysis of the C-α B-factors of these two 
key loops provides some insight into the changes in loop disorder over the S-trajectory. Unlike 
the R-trajectory, loop 5 does not gain any notable degree of conformational flexibility between 
S1 and S8 (Figure 3.5c). Loop 4, which also gains flexibility in the R-trajectory, does not 
undergo significant change in B-factor throughout the S-trajectory (Figure 3.5b).  
As reported previously, loop 7 undergoes a substantial level of stabilisation over the course of 
the R-trajectory; contacts between Arg254 and the backbone carbonyl of Phe271 link the active 
site to this key loop region23. The loss of mobility of loop 7 throughout the R-trajectory was 
attributed to the ‘freezing out’ of unproductive conformational freedom. While loop 7 adopts 
open and closed conformations associated with the diffusion and hydrolysis of the PTE 
substrate26, the open conformation is no longer required for AE diffusion and thus the motions 
associated with this are diminished to ensure stability of the productive conformation of 
Arg25423. In contrast, loop 7 undergoes major destabilisation over the course of the S-trajectory 
(Figure 3.5a). Normalised C-α B-factors of loop 7 indicate a large increase in 
disorder/flexibility from S1 to S2, and from S3 onwards, the disorder of loop 7 is such that it 
could not be modelled with any confidence (Figure 3.5d-e). 
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The increase in disorder of loop 7 occurs upon the introduction of two substitutions; Asp233Ala 
and Leu271His, both of which are positions mutated in the R-trajectory (Asp233Glu and 
Leu271Phe), and were involved in the intramolecular networks that stabilised loop 7 in that 
original experiment. Asp233Ala eliminates the potential for an intramolecular network linking 
loop 7 to the active site, (previously facilitated through Arg254), and the mutation of 
hydrophobic Leu271 to a charged residue may be responsible for the reduced occupancy of the 
closed loop 7 conformation; position 271 is located at the base of loop 7 and in the R-trajectory, 
forms contacts with the hydrophobic naphthyl moiety of the arylester substrate. The 
introduction of histidine at this position changes the polarity of the binding cavity. It is 
hypothesised that the Leu271His substitution is therefore not involved in substrate binding, and 
is partly responsible for the increased disorder of loop 7.  
Deletion of loop 7 has distinct effects in each trajectory. The disorder/positional variability 
of loop 7 in S3 onwards suggests that it no longer plays a direct role in the binding of the AE 
substrate. To investigate this, several loop-deletion variants were constructed; S1ΔL7, S2ΔL7 
and S5ΔL7 (from the S-trajectory), R1ΔL7, R2aΔL7, R8ΔL7, R14ΔL7 and R18ΔL7 (from the 
R-trajectory), and PTEWTΔL7. The loop 7 deletion in R-trajectory variants was increasingly 
deleterious to AE activity along the evolutionary pathway (Figure 3.7a). Given the established 
role of a stabilised loop 7 in the later round R-trajectory variants, this trend was expected. The 
loop deletion has little effect on AE activity in PTEWTΔL7, but given that this variant has not 
been evolved for enhanced AE activity, its tolerance to this deletion is unsurprising (Figure 
3.7a). In S1ΔL7 and S2ΔL7, the deletion of loop 7 is deleterious for AE activity, but is neutral 
in S5ΔL7 (Figure 3.7a). This supports the hypothesis that loop 7 has become irrelevant to the 
catalytic activity of later round S-trajectory variants, as its removal has no deleterious effects  
X-ray crystal structures of three of these loop-deletion variants (S5ΔL7, R18ΔL7, and 
PTEWTΔL7) were obtained in order to investigate the structural effects of the deletion of loop 
7 (Supplementary Table 1). The truncated loop region was successfully modelled in S5ΔL7 
(Figure 3.7b) and one subunit of PTEWTΔL7. R18ΔL7 did not crystallise in the same unit cell 
dimensions as the other PTE variants; the length of the unit cell was doubled, with four 
monomers modelled into the asymmetric unit. The truncated loop could only be modelled in 
two of the four subunits. This highlights the importance of loop 7 as a crystal packing contact; 
its deletion altered the unit cell despite the use of identical crystallisation conditions to the 
original R18 structure.  
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Figure 3.7 |  a) Relative AE activity of loop deletion variants, indicating little change to PTEWTΔL7 and S5ΔL7, 
but significant loss of activity upon deletion of loop 7 in the R-trajectory. b) Loop 7 in S1 (pale blue), and truncated 
loop 7 in S5ΔL7 (dark blue). The deleted loop region comprises residues 265 – 271. c) Normalised B-factors of 
loops 4 and 5 in S5 (blue) and S5ΔL7 (orange), showing the increase in disorder of loops 4 and 5 upon deletion 
of loop 7. d)  The position of loop 5 in S5 (light blue), S5deltaL7 (orange), and the lower-occupancy position of 
loop 5 in S8 (dark blue). The midpoint of loop 5 (Ser205) is displaced approximately 2.6 Å upon deletion of loop 
7 in S5. e) The single, bent conformation of Arg254 in R18 and f) the partially occupied straight conformation of 
Arg254 in R18ΔL7. Active site residues are illustrated as grey sticks, and Zn2+ ions are modelled as pale orange 
spheres. Map shown at 0.5σ. No difference density was visible for Arg254 in e) or f).  
The deletion of loop 7 in S5ΔL7 exerts some effects on the conformational flexibility of other 
regions of the protein. B-factor analysis of S5 and S5ΔL7 shows an increase in the disorder of 
loops 4 and 5 upon deletion of loop 7 (Figure 3.7c). In addition to this increase in disorder, the 
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position of loop 5 shifts substantially in S5ΔL7 relative to S5. Comparing this loop in S5, 
S5ΔL7, and S8 reveals that the deletion of loop 7 appears to facilitate loop 5 adopting a 
conformation more similar to the lower-occupancy position of the loop in S8, the end point of 
the trajectory (Figure 3.7d). This suggests that the high disorder of loop 7 throughout the S-
trajectory may be important for repositioning loop 5. Deletion of loop 7 from PTEWT appears 
to have no effect on the positions of loops 4 and 5 (Figure 3.8).  
Figure 3.8 | Loops 4 and 5 in PTEWT (brown) and PTEWTΔL7 (green). The truncation of loop 7 has not affected 
the positions of loops 4 and 5. 
Previous structures of R18 feature a single, bent conformation of Arg254 in both subunits, but 
the deletion of loop 7 has resulted in substantial occupancy of the straight conformation, which 
is non-ideal for AE activity, as it sterically prohibits the binding of the AE substrate (Figure 
3.7e-f). Given the degree of connectedness between loop 7 and the bent conformation of 
Arg254 at the conclusion of the R-trajectory, the disruption to the bent conformation is logical. 
Importantly, S5’s tolerance to the loop deletion indicates that the hydrogen bonding network 
that developed in the R-trajectory to link the active site with loop 7 is not present in this 
trajectory; a stark phenotypic difference.  
Swapping key substitutions between trajectories reveals different degrees of mutational 
tolerance in each pathway. Site directed mutagenesis revealed that swapping mutations fixed 
in the S-trajectory into the R-trajectory background is not tolerated: the Arg254Ser substitution 
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on the R18 background causes a 300-fold decrease in arylesterase hydrolysis. However, the 
swap (Ser254Arg) is virtually neutral on the S5 background (<10-fold) (Figure 3.9a). 
Figure 3.9 | a) The effects of swapping Arg/Ser254 on relative arylesterase activity. b) The active site residues of 
R18+254S (grey sticks). Positions of His201, His230, Glu233, and Arg254 in R18 are shown as transparent purple 
sticks. His201 and His230 undergo substantial displacement upon introduction of Ser254 into the R18 
background. Zn2+ ions are represented as pale orange spheres. Zn2+ - β (transparent) is present in low occupancy 
in subunit A of R18+254S. Positions of Lys169, His55, His57, and Asp301 are unaffected by the Arg254Ser 
substitution. c) Stabilisation of the bent conformation of Arg254 in R18 through interaction with Glu233. Loop 7 
omitted for clarity. d) A solvent network in S5+254R has replaced the stabilising effects of Glu233, utilising 
Asp232; a position unaffected in either trajectory.   
Structures of epistatic variants R18+254S and S5+254R were solved to identify structural 
reasons for this genetic incompatibility (Supplementary Table 1). Reflecting the tolerance for 
the Ser254Arg substitution on the S5 background, the typical structure of the active site is 
conserved in S5+254R. Interestingly, in both subunits of S5+254R, the productive ‘bent’ 
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conformation of Arg254 is favoured, despite the continued lack of well-defined electron 
density for loop 7, and the absence of stabilising interactions from residue 233 (Figure 3.9).  
Inspection of S5+254R active site revealed a network of water molecules that may be acting to 
stabilise the bent conformation of Arg254 (Figure 3.9d). These water molecules are not present 
in R18, as they occupy the region filled by Glu233. In the S-trajectory, however, the presence 
of Ala233 leaves a substantial cavity that is occupied by solvent. The presence of solvent in 
this cavity creates a network between the bent conformation of Arg254 and Asp232. The 
mutation Ser254Arg is beneficial to arylesterase activity in S2, but neutral in S3. This 
corresponds to the creation of the cavity that houses the solvent network: Asp233Ala is 
introduced in S3. Asp232 is located on loop 6, and does not undergo mutation in either the R- 
or S-trajectory. The mutation Thr234Ala, however, is fixed in S6, and a second mutation on 
loop 6 is fixed in S8 (Leu240His). Excluding Asp233Glu, no further positions on loop 6 were 
mutated in the R-trajectory.  
The deleterious effects of the Arg254Ser substitution in R18+254S are substantial and far-
reaching. Most notably, the introduction of Ser254 on this background results in the 
introduction of significant disorder to the active site, specifically affecting the active site 
residues responsible for the coordination of the catalytic Zn2+ ions (Figure 3.14). Typically, 
Zn2+ - α is coordinated by His55, His57, Asp301, and carbamylated Lys169. Zn2+ - β is 
coordinated by Lys169, His201, His230, and a bridging water molecule, adopting a tetrahedral 
geometry. The incorporation of Ser254 has disrupted the architecture of the active site, 
resulting in His201 adopting a highly unusual ‘flipped’ conformation in subunit A (the more 
solvent exposed subunit). His230 is also displaced by approximately 3.4 Å. As a result, Zn2+ - 
β is present at low occupancy (~ 40%) in this subunit, despite the excess Zn2+included in 
purification and crystallisation buffers. The significant reduction in metal binding affinity 
caused by the displacement of His201 and His230 may be a primary cause of the lowered 
activity of the R18+254S variant.  
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DISCUSSION 
The complexities of molecular evolution are numerous and are difficult to unpick from one 
another. The prevalence of non-additive, epistatic effects in evolutionary trajectories has not 
yet been conclusively quantified, despite the significant degree to which these effects shape 
evolutionary landscapes. The challenges associated with predicting epistatic effects complicate 
rational engineering approaches, and the ruggedness of the evolutionary landscape could 
possibly explain the limited success of some directed evolution campaigns. The ‘variation and 
selection’ model of directed evolution suffers from the same problem faced in many 
optimisation protocols: becoming trapped at a local maximum. While epistasis is often viewed 
as a factor that ‘constrains’ the pathways that lead to fitness peaks, it is also responsible for 
allowing new optimisation possibilities. Permissive mutations that enhance thermostability can 
facilitate the acquisition of otherwise catastrophically destabilising substitutions in instances 
of non-specific epistasis. The effects of specific epistasis on evolving systems are, however, 
more challenging to identify. 
In this work, we endeavoured to investigate a ‘new pathway’, opened by the incorporation of 
a new, albeit non-ideal, initial substitution. While the starting-point variant S1 was an 
immediate neighbour of the R-trajectory starting point, the results of the directed evolution 
experiment were distinct; the final variant (S8) displayed genotypic and phenotypic distinction 
from the final variant of the R-trajectory (R18). In terms of the final sequences, only one 
substitution was identical in both trajectories (Phe306Ile), and, excluding the initial Ser254 
substitution, only two further sites of substitution were common to both trajectories.  
Not only do R18 and S8 differ with respect to their sequences, they have also reached distinct 
phenotypes. Networks of stabilising intramolecular interactions resulted in loop 7 becoming 
increasingly rigid throughout the R-trajectory; particularly, the network linking loop 7 to the 
productive, bent conformation of Arg254 was optimised and stabilised. No such network forms 
in the S-trajectory; loop 7 becomes increasingly disordered, and the tolerance to deletion of the 
loop from later round S-variants indicates that this increased disorder correlates with a lack of 
loop function. The drastically different fate of loop 7 throughout these two trajectories, both 
aimed at optimising the same function, highlights the phenotypic distinctions between the two 
final variants, who were initially separated by only one substitution. Additionally, the different 
active site architecture of the S-trajectory has stabilised a new binding mode of the arylester 
substrate, indicating that the evolution of arylesterase activity along this pathway is making use 
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of different mechanisms to those observed in the R-trajectory. Future work should be 
undertaken towards determining whether this new binding pose is catalytically productive, 
particularly given that KM of S8 with the arylester substrate is approximately 10-fold higher 
than in R18 (Supplementary Table 2). Co-crystallisation of S8 with HLN resulted in the 
imaging of the hydrolysis product in the enzyme active site, indicating that in its crystalline 
form, S8 still possesses some catalytic activity. Mix-and-Inject serial crystallography could be 
used to confirm and quantify this activity, as well as provide information about the nature of 
the new HLN binding pose27. The reintroduction of Arg254 into the S-trajectory confers less 
benefit as the trajectory continues. This suggests that the S-trajectory is not simply a less 
effective ‘walk’ down the same adaptive path as the R-trajectory, but is moving towards a truly 
distinct fitness peak. This, in addition to the differences in catalytic efficiency between S8 and 
R18, is indicative of two separate fitness peaks on the PTE  AE evolutionary landscape, 
isolated from each other by a single initial substitution.  
Rational mutagenesis reveals that this isolation is, however, one-way. The incorporation of 
Ser254 into the R18 background is highly deleterious, indicating that transition from the R-
trajectory phenotype to the S- would be highly improbable. This is logical; the intramolecular 
networks in R18 are far-reaching, highly interconnected, and centre upon the initial (and 
persistent) Arg254 substitution. Replacing this key residue with serine destabilises the R18 
network and renders the redundancy built into the system null, as those redundancies are built 
around Arg254. This is an example of ‘entrenchment’, where reversion to the WT identity at a 
particular position becomes increasingly deleterious along an evolutionary trajectory20. 
Conversely, incorporating Arg254 into the S5 background is relatively neutral. Analysis of 
intramolecular interactions in S8 reveal few interactions with Ser254, and suggest that a 
network like that observed in the R-trajectory, is not contingent to the evolution of AE activity 
in the S-trajectory. As a result, the Ser254Arg substitution is tolerated well in the S-
background. Additionally, while Ser254His in the S5 background is deleterious, it is 3 orders 
of magnitude less so than the Arg254His substitution in the R18 background. Is entrenchment, 
therefore, a hallmark of an effective evolutionary trajectory towards a highly efficient 
endpoint?  
While the incorporation of Arg254 on the S5 background is tolerated, it does not result in the 
sudden reacquisition of R-trajectory-like catalytic efficiency, further demonstrating the 
importance of second- and third-shell mutations in the original trajectory. What this Ser254Arg 
substitution could represent, however, is a potential one-way ‘bridge’ from the S-trajectory 
116
Chapter 3
fitness peak to some position on the R-trajectory pathway. Could the Ser254Arg substitution 
allow the evolving system to return to a trajectory more similar to the original R-trajectory 
experiment? This warrants further investigation.   
CONCLUSIONS 
The work presented in this paper goes some way to addressing the roles of epistasis, historical 
contingency, and mutational entrenchment in the evolution of new function. The evolution of 
a highly efficient arylesterase, R18, from a phosphotriesterase starting point, R0, was 
contingent on the acquisition of the His254Arg substitution at the start of the trajectory. 
Evolving the system from a similar phenotypic starting point has resulted in the isolation of an 
endpoint representing a distinct fitness peak: S8 is structurally and functionally different to 
R18. The role of loop 7 in the optimisation of arylesterase activity is vastly different in the two 
trajectories; in R18, loop 7 is rigid and is involved in long-range intramolecular networks that 
stabilise conformations productive for the hydrolysis of the arylester substrate, whereas loop 7  
in the S-trajectory becomes highly disordered, and can be deleted with no ill effect on arylester 
activity. A new binding mode has been identified in the S-trajectory, partly in response to the 
loss of the rigid, closed conformation of loop 7. These observations suggest that molecular 
evolution is highly contingent on historical events. 
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MATERIALS
2NH was a kind gift from the Tawfik Lab1, but was also purchased from Sigma. Fast Red TR 
hemi(zinc chloride) salt (Fast Red) was purchased from Sigma. The transition state analogue 
of 2NH, hexylphosphonate 2-naphthyl ester (HLN), was synthesised based on previously 
published procedures1,28.  
METHODS
Cloning. The gene encoding PTE-WT is identical to the one used in previous studies1,23,29. 
Note that PTE-WT had previously been evolved for improved expression levels in E. coli21 and 
thus contains seven amino acid mutations relative to the naturally occurring PTE (I106L, 
F132L, K185R, D208G, R319S, A176V, V341I). All PTE serine variants were cloned with 
flanking NcoI/XhoI sites into a kanamycin resistant pET-27-Strep vector for evolution and 
purification. These constructs differ from the arginine series of variants (Ampicillin, 
NcoI/HindIII) to avoid cross-contamination with the original trajectory. PCR products and 
vectors were digested with FastDigest restriction enzymes (Fermentas) for 1-2 h at 37 °C and 
subsequently purified from a 1% agarose gel using MicroElute DNA Clean-Up Kit (OMEGA). 
Ligations were performed at a vector:insert mass ratio of 3:1 using T4 DNA ligase (Fermentas) 
at 16 °C overnight. Prior to transformation, reactions were purified using the MicroElute DNA 
Clean-Up Kit (OMEGA). Transformation into electrocompetent E. cloni 10G (Lucigen) 
reliably yielded >20,000 colonies with 100 ng of DNA per ligation. Acyl phosphatase (ACP) 
cloned into the same pET-27-Strep vector served as a negative control for 2NH activity 
measurements. All constructs were confirmed by DNA sequencing. 
Single point mutations. Mutants were constructed using either the QuikChange Site-Directed 
Mutagenesis Kit (Agilent), or Type II restriction cloning (adapted from Golden Gate cloning30). 
Briefly, the Type II restriction cloning approach involved re-cloning PTE variants into a pET-
27-∆LguI_Strep vector (which does not contain an LguI site), followed by whole plasmid
amplification using primers containing Type II restriction sites (typically LguI), as well as the
desired mutation. The amplified linear DNA was purified using MicroElute DNA Clean-Up
Kit (OMEGA), and treated with DpnI and LguI (FastDigest, Fermentas) for 2-3 h at 37 °C.
DNA was then purified with the MicroElute DNA Clean-Up Kit (OMEGA), and <50ng of this
was incubated overnight at 16 °C to allow for self-ligation. The ligated product was
transformed into E. coli cells, as described above. All mutations were confirmed by DNA
sequencing.
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Library creation. 
Error-prone PCR (epPCR) – PTE libraries were generated via random mutagenesis by error-
prone PCR (epPCR) using the ‘wobble’ base analogues dPTP and 8-oxo-dGTP (TriLink), with 
slight alterations from previously reported protocols1. The first of two PCR reactions was 
performed over 20 cycles (2 min at 95 °C; 20 × [20 s at 98 °C, 15 s at 58 °C, 45 s at 72 °C]; 2 
min at 72 °C). The 50 μL reaction contained 1 ng plasmid template, 0.3 µM primers, 0.75 µM 
dPTP or 60 µM 8-oxo-dGTP, 0.25 mM each of the four standard dNTPs, 2.5 mM MgCl2, and 
1× of the supplied buffer (TriLink). The PCR products were then purified with the MicroElute 
DNA Clean-Up Kit (OMEGA), treated with DpnI for 2 h at 37 °C to digest the template 
plasmid, purified by gel electrophoresis, and the yield was quantified with a Nanodrop (Thermo 
Scientific). DNA products from each error-prone PCR reaction were then combined in 
equimolar quantities, and 10 ng of this mixture was used as a template for the second PCR 
reaction. The second PCR used the same protocol as above, except that nested primers (which 
flank the gene), and regular dNTPs, were used. The mutated inserts obtained were then digested 
and cloned into pET-27-Strep, as described above. This method consistently resulted in the 
creation of libraries that carried an average of 1.5 amino-acid mutations per gene, calculated 
from 10 randomly selected clones after transformation into E. cloni. 
Shuffling mutagenesis – At rounds 3 and 5, staggered extension protocol (StEP) PCR31 was 
used to recombine positive variants isolated from epPCR libraries. A 100 µL reaction with 500 
ng DNA template, which consisted of equimolar amounts of DNA from each variant of interest, 
was shuffled in the PCR reaction. The first PCR conditions are identical to the second epPCR, 
except that 0.1-1 nM primers were used and the PCR cycle profile was as follows: 100 cycles 
(5 min at 95 °C; 100 × [30 s at 95 °C, 5 s at 58 °C]). PCR products were digested with DpnI, 
purified with the MicroElute DNA Clean-Up Kit (OMEGA), and then 1.5 µL of this was used 
as a template for a second PCR: 20 cycles (2 min at 95 °C; 20 × [20 s at 98 °C, 15 s at 58 °C, 
45 s at 72 °C]; 2 min at 72 °C) using the EconoTaq Plus protocol (Lucigen). The PCR products 
were then digested, purified by gel electrophoresis, and cloned into pET-27-Strep as described 
above. 
Creation of saturation libraries. Libraries of variants of PTE-WT, PTE-R18, and PTE-S8 
containing all 20 amino acids at positions 254, 233, 271, and 306 were independently created 
with primers containing randomised DNA sequences at these positions, following the Type II 
restriction cloning method described above. 
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Esterase assays on agar plates. Plasmids were extracted from E. coli cells using a QIAprep 
Spin Miniprep Kit (Qiagen), and then re-transformed into E. coli BL21 (DE3) containing 
pGro7 plasmid for overexpression of the GroEL/ES chaperone system. The gene that encodes 
acyl phosphatase (ACP) was cloned into the pET-27-Strep, which served as a negative 
control. Transformation reactions were plated on an average of 10 large agar plates (140 mm 
diameter) containing 50 μg/mL kanamycin and 34 μg/mL chloramphenicol such that each 
plate contained ~1000 colonies, leading to a final screening capacity of ~10,000 clones. 
Colonies were blotted onto nitrocellulose membranes (BioTrace NT 0.2 μm, PALL Corp), 
and transferred facing up onto a second LB agar plate additionally containing 1 mM IPTG, 
200 μM ZnCl2 (to ensure availability of Zn2+ ions necessary for enzymatic activity) and 0.2% 
(w/v) arabinose for chaperone overexpression. The original agar plate was placed at 37 °C for 
colonies to re-grow, while the membrane-containing plate was left overnight at room 
temperature. The next day, membranes were placed into an empty petri dish and cells were 
lysed by three freeze/thaw cycles at -20 °C and 37 °C. For the activity assay, 25 mL of 0.5% 
agarose was dissolved in 50 mM Tris-HCl buffer pH 7.5, 100mM NaCl, 200 μM ZnCl2, 200 
μM 2NH, and 1 mM Fast Red, which was then poured onto the nitrocellulose membranes. A 
red colour developed within 10 - 60 minutes. Positive clones were then picked from the 
original agar plate. 
Esterase assay in cell lysate. 
Directed evolution screening – Active clones identified by colony screening were re-grown 
overnight at 30 °C in 4-6 96-well deep well plates containing 200 μL LB supplemented with 
50 μg/mL kanamycin, and 34 μg/mL chloramphenicol for pGro7 selection. This led to a 
focused library of ~360-560 pre-selected variants. Subsequently, 25 μL aliquots of overnight 
cultures were transferred to deep well plates containing 425 μL LB per well with kanamycin, 
chloramphenicol, 200 μM ZnCl2 and 0.2% (w/v) of arabinose (final concentrations) for 
chaperone co-expression. Cells were grown for ~2 h at 37 °C until the OD600 reached ~0.6. 
Expression of PTE variants was induced with 1mM IPTG, and cultures were incubated for an 
additional 2 h at 30 °C. Cells were spun down at 4 °C at maximum speed (3320 g) for 10 
minutes and the supernatant was drained. Pellets were frozen for a minimum of 1 h at -80 °C, 
and were subsequently lysed by addition of 200 μL of 50 mM Tris-HCl buffer, 100mM NaCl, 
pH 7.5 supplemented with 0.1% (w/v) Triton-X100, 200 μM ZnCl2, 100 μg/mL lysozyme and 
~ 1 μL of benzonase (Novagen, 25 U/μL) per 100 mL of lysis buffer. After 30 min of lysis, cell 
debris were spun down at 4 °C at 3320 g for 30 min. Depending on the activity level of the 
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library, the clarified lysate was diluted prior to the activity assay to obtain a good signal in the 
initial linear phase of the reaction. Reactions were performed in transparent 96-well plates 
(Corning Costar) containing 200 μL per well (20 μL lysate + 180 μL of substrate (200 μM of 
2NH + 1mM of Fast Red)) previously dissolved in the same lysis buffer. 2NH hydrolysis was 
monitored at 500 nm via complex formation with Fast Red. The gene that encodes acyl 
phosphatase (ACP) was cloned into pET-27-Strep, and served as a negative control for 2NH 
activity measurements. Improvements ≥1.3-fold relative to the previous round were considered 
significant. The best clones were picked, re-grown and re-assayed in triplicate. The initial rates 
were normalised to cell density (determined by OD600) and the average values were determined. 
Around 10 improved variants were sequenced after each round.  
PTE mutant assays – Single-point mutants of PTE were assayed as described above, except 
that the overnight cultures were inoculated directly from glycerol stocks of cells in triplicates 
in 2-3 independent experiments. Saturation mutagenesis libraries were first plated on agar 
plates where ~85 colonies were randomly picked for overnight cultures, prior to lysate 
screening as described above. 
Protein purification. 
Strep-tag purification  –  To determine their kinetic parameters, selected PTE variants at each 
round of the directed evolution were purified using Strep-Tactin Superflow High capacity 
columns (IBA, CV=2.5 mL) according to the manufacturer’s instructions (IBA 
BioTAGnology, Germany). Briefly, pET-Strep-PTE plasmids were transformed into E. coli 
BL21 (DE3) (without pGro7 chaperone expression for higher purity) and a single colony was 
used to grow a 2 mL LB culture overnight at 37 °C. Cells were inoculated into Overnight 
Express Instant TB medium (Novagen) containing 1% (v/v) glycerol, 50 µg/mL kanamycin, 
200 μM ZnCl2 and Strep-tagged proteins were expressed at 250 rpm shaking for 8 h at 30 °C, 
followed by 12 h at 16 °C. Cells were harvested by centrifugation and pellets were frozen 
overnight at -80 °C. Pellets were resuspended with 20 mL Lysis buffer containing a 1:1 mixture 
of B-PER Protein Extraction Reagent (Thermo Scientific): 50 mM Tris-HCl buffer, 100 mM 
NaCl, pH 7.5 supplemented with 200 μM ZnCl2, 100 μg/mL lysozyme and ~0.5 μL of 
benzonase. After a 1 h incubation on ice, cell debris was removed by centrifugation and the 
clarified lysate was passed through a 45 μm filter before loading onto a Strep-Tactin column. 
Strep-PTE variants were eluted with elution buffer (50 mM Tris-HCl, 100 mM NaCl, pH 7.5, 
200 μM ZnCl2, 2.5 mM desthiobiotin) according to the manufacturer’s instructions (IBA). 
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Fractions containing pure PTE (determined by SDS-PAGE and 2NH activity measurement) 
were subsequently pooled, loaded onto an Econo-Pac 10DG desalting column (Bio-Rad), and 
eluted with the same elution buffer without desthiobiotin. When needed, PTE variants were 
concentrated to 0.5 - 2 mg/mL using a 10 kDa MWCO spin concentrator (Microsep Advance 
centrifugal device, PALL Corp), their concentrations were measured in triplicate using the 
Pierce BCA Protein assay kit (Thermo Scientific) and they were stored at 4 °C.  
Purification of untagged variants for protein crystallisation –  PTE variants were cloned into 
pET32-trx plasmid (ampicillin resistant) without Strep-tag using FastDigest NcoI and HindIII 
as described in the cloning section, transformed into E. coli BL21 (DE3), and grown for 72 h 
at 30 °C in TB medium containing 100 μg/mL ampicillin and 500 μM ZnCl2. Cells were 
harvested by centrifugation at 3320×g and 4 °C for 10 min, resuspended in 20 mM Tris-HCl, 
pH 8 containing 100 μM ZnCl2 and lysed by sonication (OMNI Sonic Ruptor 400, Thermo 
Scientific, 50% pulse, 50% amplitude). Cell debris were removed by centrifugation at 
30,000×g and 4 °C for 60 min and the lysate was filtered through a 45 μm filter (Millipore). 
The lysate was loaded onto a Fractogel DEAE anion exchange column (Merck). PTE elutes in 
the flowthrough as well as in the early wash fractions. Fractions deemed to be >95% pure were 
pooled. Protein was concentrated to 12 mg/mL and stored at 4 °C. 
Enzyme kinetics. Initial velocities (v0) were determined in duplicate, at 16 different substrate 
concentrations (0–2 mM) in 50 mM Tris-HCl, 100 mM NaCl, pH 7.5, 200 μM ZnCl2 and 0.1% 
Triton X-100, at 25 °C. Hydrolysis rates were monitored using a microplate reader (Synergy 
H1, Biotek) by following product formation at 500 nm for 2NH (in the presence of FAST- Red, 
at a ratio of 1:5). Steady-state kinetic parameters were derived by fitting the experimental data 
to the Michaelis-Menten equation: v0/[E] = kcat • [S]/(KM + [S]), where v0 is the initial rate, [E] 
is the enzyme concentration, and [S] is the substrate concentration. In some cases, we observed 
substrate inhibition, or could not reach full saturation, in which case we used a linear fit: v0/[E] 
= (kcat /KM) • [S] or a substrate inhibition fit: v0/[E] = kcat • [S]/(KM + [S] • (1 + [S]/ Ki)), where 
Ki represents the inhibition constant. The data were corrected for the buffer-catalysed 
background reaction measured under the same conditions without enzyme.  
Crystallisation of PTE variants. Purified tag-less PTE variants were concentrated to 12 
mg/mL in 20 mM HEPES, 50 mM NaCl, 100 µM ZnCl2, pH 8. Crystals were grown at 4 °C in 
EasyXtal-15-Well Tools plates (Qiagen), using hanging-drop vapour diffusion. Drops 
consisting of 2 µL of reservoir solution and 1 µL of PTE were equilibrated over 500 µL of 
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reservoir solution. Reservoir solutions contained 100 mM sodium cacodylate (pH 6.3 - 6.7), 
distilled deionised water and 10 - 50% (w/v) 2-methyl-2,4-pentanediol (MPD). Crystals formed 
in initial screens were manually pulverised, and used for microseeding. Six serial dilutions of 
the pulverised crystals were made, from 1/10 to 1/1,000,000 in factors of 10. New crystal 
screens were set up varying MPD concentrations from 10% to 20%. Each well contained 1 µL 
of protein, 1.5 µL of reservoir solution and 0.5 µL of the microseed solution. To obtain crystal 
structures in the same space group and crystallisation condition, serial microseeding was used. 
Co-crystallisation of PTE variants with the transition state analogue HLN was achieved by 
adding a 4 times molar excess of HLN to crystallisation wells. Diffraction-quality crystals 
typically formed within one week. 
X-ray diffraction data collection and refinement. For data collection, crystals were soaked
in cryobuffer (100 mM sodium cacodylate, pH 6.5, 40% MPD) for 2 minutes before flash-
cooling to 100 K in a stream of nitrogen gas. PTE diffraction data were collected at the
Australian Synchrotron (beamlines MX1 and MX2) at a wavelength of 0.9537 Å. The X-ray
diffraction data were indexed and integrated using XDS32 and merged using AIMLESS as
implemented within the CCP4 program suite33. Data resolution cut-offs were chosen using half
dataset correlation coefficients, as described by Karplus and Deiderichs34. The structures of
PTE variants were solved by molecular replacement (MOLREP)35 using the PTE-R0 structure
(4PCP). Refinement was performed using REFMAC and phenix.refine, and manual rebuilding
was performed in Coot36. Automated fitting of multiple conformations was carried out with the
QFit web-server37, with manual inspection and removal of conformations that were not present
in good (at least 1.0 σ) electron density. Network analysis was performed using RING 2.025,
and results were visualised with Cytoscape38. Cα RMSD calculations were performed using
FATCAT24. B-factors were compared to each other by refining with a single major main-chain
conformation, averaging values of all chains within each structure, and normalising the B-
factor. Normalisation was achieved by scaling the average B-factor of each chain (with the
exception of the loops with variable B-factors) to achieve a comparable baseline.
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Supplementary Table 1: Data collection statistics 
S1 S2 S3 S5 S6 
Data collection 
Space group P21212 P21212 P21212 P21212 P21212 
Cell dimensions 
    a, b, c (Å) 85.7, 85.8, 88.2 85.2, 85.5, 88.2 85.5, 85.9, 88.4 85.2, 85.7, 88.5 85.6, 85.9, 88.4,  
    α, β, γ (°)  90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 
Resolution (Å) 30.72 – 1.74  (1.80 – 1.74) 
39.2 – 1.75   
(1.81 – 1.75) 
38.62 – 1.46  
(1.51 – 1.46) 
28.95 – 1.98  
(8.98 – 1.96) 
29.0 – 1.50  
(1.55 – 1.50) 
Rsym or Rmerge 0.4675 (0.6436) 0.1081 (0.987) 0.1052 (1.845) 0.0993 (1.043) 0.07566 (0.7204) 
CC1/2 0.77 (0.875) 0.999 (0.889) 0.999 (0.575) 0.997 (0.603) 0.999 (0.952) 
CC* 0.933 (0.966) 1 (0.97) 1 (0.854) 0.999 (0.867) 1 (0.988) 
I / σI 17.2 (5.6) 22.28 (3.16) 13.76 (1.18) 9.6 (1.3) 18.62 (3.50) 
Completeness (%) 99.91 (99.74) 99.96 (99.98) 99.42 (97.44) 99.7 (99.9) 99.81 (99.52) 
Redundancy 9.5 (9.2) 14.7 (14.8) 7.5 (7.5) 3.5 (3.5) 13.6 (13.3) 
Refinement 
Resolution (Å) 30.74 – 1.74  (1.80 – 1.74) 
39.2 – 1.75   
(1.81 – 1.75) 
38.62 – 1.46  
(1.51 – 1.46) 
28.95 – 1.98 
(8.98 – 1.96) 
29.0 – 1.50  
(1.55 – 1.50) 
No. reflections 642277 (60701) 963908 (95788) 855643 (84865) 46830 (4623) 1421131 (136639) 
Rwork / Rfree 0.1660/0.1979 0.1450/0.1826 0.2139/0.2377 0.2116/0.2329 0.1514/0.1747 
No. atoms 
    Protein 5183 5296 4829 4800 5198 
    Ligand/ion 38 70 38 38 62 
    Water 375 487 230 144 393 
B-factors
Protein 26.47 24.80 30.17 33.63 26.32 
Ligand/ion 34.14 36.20 33.02 42.06 37.06 
Water 31.25 33.38 29.69 31.40 34.60 
R.m.s. deviations
Bond lengths (Å) 0.008 0.018 0.010 0.005 0.017 
Bond angles (°) 1.19 1.50 1.14 0.92 1.53 
PDB ID 5W6B 5WCQ 5WCW 5WIZ 5WCP 
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S7 S8 S5+HLN S5+254R R18+254S 
Data collection 
Space group P21212 P21212 P21212 P21212 P21212 
Cell dimensions 
    a, b, c (Å) 85.7, 86.1, 176.9 85.1, 85.8, 88.7 84.7, 85.0, 87.9 85.4, 85.8, 88.3 85.7, 86.0, 88.7 
    α, β, γ (°)  90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 
Resolution (Å) 42.83 – 1.6  (1.657 – 1.6) 
39.38 – 1.46  
(1.512 – 1.46) 
30.56 – 1.77 
(1.87 – 1.77) 
29.43 – 1.65  
(1.709 – 1.65) 
22.18 – 1.4  
(1.45 – 1.4) 
Rsym or Rmerge 0.06579 (0.6699) 0.06952 (1.051) 0.845 (3.337) 0.1786 (2.36) 0.02632 (0.5627) 
CC1/2 0.999 (0.964) 0.999 (0.895) 0.872 (0.152) 0.999 (0.593) 0.999 (0.652) 
CC* 1 (0.991) 1 (0.972) 0.965 (0.513) 1 (0.863) 1 (0.888) 
I / σI 21.83 (4.49) 19.50 (2.89) 22.97 (2.11) 14.05 (1.18) 20.04 (1.35) 
Completeness (%) 99.86 (99.98) 99.75 (99.35) 97.82 (96.87) 99.87 (99.64) 99.9 (99.90) 
Redundancy 13.7 (13.3) 13.5 (13.6) 16.5 (14.8) 14.6 (14.2) 14.3 (13.8) 
Refinement 
Resolution (Å) 42.83 – 1.6  (1.657 – 1.6) 
39.38 – 1.46  
(1.512 – 1.46) 
30.56 – 1.77 
(1.87 – 1.77) 
29.43 – 1.65  
(1.709 – 1.65) 
22.18 – 1.35  
(1.43 – 1.35) 
No. reflections 2358496 (227175) 1524437 (150805) 60646 (5905) 1149452 (110655) 2042161 (283339) 
Rwork / Rfree 0.2699/0.2985 0.1530/0.1749 0.1957/0.2295 0.2151/0.2483  0.1670/0.1981 
No. atoms 
    Protein 9740 5485 5060 4933 6117 
    Ligand/ion 100 70 92 62 49 
    Water 466 410 275 206 304 
B-factors
Protein 32.35 29.01 26.77 27.80 23.88 
Ligand/ion 33.55 44.98 46.31 47.69 54.74 
Water 29.86 37.39 29.58 27.63 28.22 
R.m.s. deviations
Bond lengths (Å) 0.007 0.016 0.007 0.010 0.011 
Bond angles (°) 0.89 1.49 0.97 1.09 1.45 
PDB ID 5WMS 6AML 6B2F 5WJ0 6BH7 
128
Chapter 3
S5ΔL7 R18ΔL7 PTEWTΔL7 
Data collection 
Space group P21212 P21212 P21212 
Cell dimensions 
    a, b, c (Å) 85.1, 85.5, 88.5 85.8, 86.2, 177.7 86.1, 86.2, 88.8 
    α, β, γ (°)  90, 90, 90 90, 90, 90 90, 90, 90 
Resolution (Å) 30.75 – 1.40  (1.45 – 1.40) 
29.61 – 1.40  
(1.45 – 1.40) 
39.45 – 1.75 
(1.81 – 1.75) 
Rsym or Rmerge 0.0321 (0.3897) 0.01875 (0.3268) 0.0285 (0.6971) 
CC1/2 0.999 (0.594) 1 (0.874) 0.999 (0.611) 
CC* 1 (0.863) 1 (0.966) 1 (0.871) 
I / σI 7.1 (0.9) 17.91 (2.21) 13.09 (0.95) 
Completeness (%) 100.0 (99.9) 99.85 (99.86) 99.89 (99.92) 
Redundancy 2.0 (1.9) 13.6 (13.8) 2.0 (2.0) 
Refinement 
Resolution (Å) 30.75 – 1.40  (1.45 – 1.40) 
29.61 – 1.40  
(1.45 – 1.40) 
39.45 – 1.75 
(1.81 – 1.75) 
No. reflections 249659 (23283) 515979 (51092) 67134 (6646) 
Rwork / Rfree 0.1341/0.1614 0.1595/0.1797 0.1849/0.2012 
No. atoms 
    Protein 6096 10513 4988 
    Ligand/ion 78 128 30 
    Water 538 1029 178 
B-factors
Protein 16.08 24.09 40.24 
Ligand/ion 44.56 47.06 46.66 
Water 28.98 36.23 37.95 
R.m.s. deviations
Bond lengths (Å) 0.008 0.011 0.007 
Bond angles (°) 1.26 1.19 0.82 
PDB ID 6BHL 6BHK 5WCR 
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Supplementary Table 2: Kinetic data for Ser-trajectory variants 
Variant kcat (s-1) KM (µM) kcat/KM (M-1.s-1) 
2-napthyl hexanoate
PTEWT 0.08 ± 0.00 179 ± 21.0 4.19 × 102 ± 5.4 × 101 
S1 0.06 ± 0.00 104 ± 16.3 6.00 × 102  ± 1.03 × 102 
S2 2.35 ± 0.85 557 ± 240 4.21 × 103 ± 2.37 × 103 
S3 3.71 ± 0.45 230 ± 45.3 1.61 × 104 ± 3.72 × 103 
S5 6.47 ± 1.07 297 ± 63.5 2.17 × 104 ± 5.86 × 103 
S6 17.55 ± 5.53 819 ± 300 2.14 × 104 ± 1.03 × 104 
S7 18.60 ± 4.01 444 ± 118 4.19 × 104 ± 1.44 × 104 
S8 19.88 ± 19.75 705 ± 745 2.82 × 104 ± 4.09 × 104 
S5+254R 12.71 ± 1.37 164 ± 34.9 7.73 × 104 ± 1.84 × 104 
R18+254S 1.69 ± 0.19 109 ± 17.8 1.55 × 104 ± 3.05 × 103 
Paraoxon ethyl 
PTEWT 1270 ± 27.0 57 ± 5.00 2.23 × 107 ± 2.01 × 106 
S1 290 ± 290 35 ± 2.50 8.33 × 106 ± 6.11 × 105 
S2 69 ± 0.80 508 ± 18.76 1.36 × 105 ± 5.26 × 103 
S5 14 ± 0.34 5259 ± 194 2.59 × 103 ± 1.15 × 102 
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Previous page: Supplementary Figure 1 | Mutational tolerance at position 254 and 271 in PTE-
WT, S5 and R18 backgrounds. Libraries were built with the saturation mutagenesis method at position 
254X (top) and 271X (bottom), enabling all possible 20 amino acid (AA) substitutions at these positions 
for variants PTEWT (left), S5 (centre) and R18 (right). Library variants are shown as grey dots. A 2D 
scatter is obtained by plotting the evolved 2NH activity on the y-axis and the original paraoxonase 
activity on the x-axis for each variant. A deviation from the y = x axis (grey dotted line) indicates a 
change in specificity for a given clone.  Clones that have been sequenced are labelled and coloured by 
AA type, i.e. yellow for hydrophobic, red for charged, blue for polar uncharged and green for special 
cases (Cys, Gly or Pro). Lysate activities are normalised on the original parental background (PTEWT, 
S5, R18), which is displayed by a coloured halo.  
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Original artwork inspired by arPTE/OpdA engineering, designed by Oscar Mortlock as part 
of Shirty Science, 2016. Image used with permission.  
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CHAPTER 4:  
ENGINEERING AND IMMOBILIZATION OF ORGANOPHOSPHATE 
HYDROLASE ARPTE 
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that it is only cost effective in a small 
number of cases. An alternative, general-
izable, approach could involve extensive 
displacement of the solvent by a matrix 
that remains permeable to the substrate, 
thereby immobilizing and stabilizing pro-
teins for diverse applications.
Immobilization of biocatalysts on 
solid supports has been achieved and is 
often a more desirable alternative to the 
application of free enzymes in solution. 
Immobilized enzymes can have extended 
lifespans,[7,8] greater stability to tempera-
ture extremes,[9,10] tolerate nonaqueous 
solvents,[11,12] and display enhanced reac-
tion rates.[13] Immobilized enzymes can 
also be added to and removed from reac-
tion mixtures with ease. However, enzyme 
immobilization has limitations. Covalent 
attachment, generally considered the most 
robust form of immobilization, requires covalent tethering of 
the biocatalyst to a solid support. The chemical operations in 
these processes can be costly, time consuming, and require 
additional protection steps after enzyme immobilization.[14] 
Additionally, covalent attachment often results in enzymes 
adopting unfavorable orientations on the solid media, and 
unless the site for attachment is rigorously tested and selected, 
reduced activity can result from occlusion of the active site. 
Covalent chemical attachment also complicates recycling of 
the solid support since stripping degraded enzyme from the 
support requires further chemical processing and priming for 
reapplication of new enzyme.
There are alternatives[15] to covalent tethering, including the 
generation of catalytically active inclusion bodies (CatIBs), and 
gel encapsulation. The former technique involves the immo-
bilization of precipitated, catalytically active enzyme through 
The remarkable catalytic potential of enzymes in chemical synthesis, environ-
mental bioremediation, and medical therapeutics is limited by their longevity 
and stability. Immobilization of enzymes on solid supports is demonstrated 
to improve the stability of biocatalysts but often relies on multiple chemical 
steps for covalent attachment and is limited by the physical properties of 
the various supports. Here, production of enzyme: hydrogel complexes is 
described via engineering of a cationic supercharged phosphotriesterase. 
These enzyme: hydrogel complexes are remarkably robust displaying no loss 
of catalytic activity after 80 d of use and up to 105 turnovers when used in a 
flow reactor at catalyst loadings as low as 0.0008 mol%. In addition, excep-
tional resilience to organic solvents is observed. The use of enzyme: hydrogel 
complexes is likely to be of value in a diverse range of applications such as 
enantioselective continuous-flow chemistry, detoxification of poisons, and the 
formation of functionalized biomaterials.
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Biocatalysis
The catalytic power and specificity of enzymes is well docu-
mented,[1] but their use in industry and medicine can be lim-
ited by several factors. For example, many industrial processes 
require the use of organic solvents, which can be destabilizing 
to otherwise effective biocatalysts,[2] while enzymes in solution 
have a limited lifespan due to their tendency to unfold and 
aggregate[3] and are often not reusable in modern applications, 
which increases their cost.[4] Many of these deficiencies result 
from enzymes having evolved to function in vivo, where con-
ditions are generally aqueous and of moderate temperature. 
Additionally, since they can be readily resynthesized in vivo, 
enzymes generally have relatively short lifespans in solution. 
Although there are examples where proteins have been engi-
neered to tolerate nonaqueous solvents and to display greater 
stability,[5,6] the requirement to perform engineering and 
optimization on each individual enzyme to achieve this means 
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crosslinking.[16] Recent work has shown CatIBs to be long lived 
and stable toward organic solvents,[17] but their effective utiliza-
tion requires encapsulation in alginate or agar beads,[18,19] and 
while CatIBs offer interesting functional properties, their use is 
not widespread. Gel encapsulation involves the entrapment of a 
soluble enzyme in the matrix of a synthetic or natural gel. This 
can allow exploitation of the protective effects of the gel micro-
environment, increasing enzymes’ resilience to pH extremes 
and high temperatures.[20,21] The loss of enzymatic activity upon 
gelation or as a result of protein diffusing out of the matrix, 
however, has limited the application of such systems.[21] Protein 
“supercharging”, in which the surface charge of a protein is 
drastically altered, is a proven approach to modify enzyme sur-
face properties.[22] While supercharging has received significant 
attention in cell biology applications,[23–25] its application in pro-
tein purification and the generation of functionalized materials 
has been limited,[26] and it has not been examined in the con-
text of hydrogel immobilization for applications in biocatalysis.
Here, we report on a genetically supercharged bacterial 
phosphotriesterase from Agrobacterium radiobacter, arPTE, 
that can be immobilized on both commercially available syn-
thetic hydrogels and biologically compatible amino acid derived 
hydrogels. arPTE hydrolyses and detoxifies a broad range of 
organophosphorus compounds, including chemical warfare 
agents.[27,28] The increased surface charge of supercharged 
arPTE (R5-arPTE) places it in the top 0.001% of soluble pro-
teins in Escherichia coli by isoelectric point and allows one-step 
purification and ionic immobilization on various anionic hydro-
gels. The resultant immobilized enzyme displays remarkable 
stability in the presence of organic solvents, high substrate 
turnover, enantioselectivity, and longevity. These properties 
have allowed the demonstration of applications in enantioselec-
tive synthesis, detoxification, and the formation of novel bio-
compatible enzyme-hydrogel constructs.
Wild-type (WT)-arPTE was optimized for surface engineering 
through the incorporation of three point mutations previously 
demonstrated to increase its soluble expression: Ala60Val, 
Ala204Gly, and Lys185Arg[29] (Figure 1A). The relative thermo-
stabilities of WT-arPTE and the engineered variant (S3-arPTE) 
were investigated through differential scanning fluorimetry 
(DSF)[30] (Figure S1, Supporting Information). The proteins have 
almost identical melting temperatures (WT = 60.7 ± 0.085 °C, 
S3 = 59.5 ± 0.052 °C), indicating that no major stabilizing or 
destabilizing effects were imparted through the incorporation 
of the three solubilizing mutations, consistent with previous 
work suggesting that the increased soluble expression was not a 
result of stabilization of the holoenzyme.[31]
S3-arPTE was used as the basis for subsequent iterative 
screening of cationizing mutations. A series of target acidic 
amino acids was identified for mutation to positively charged 
amino acids (lysine or arginine), using the Rosetta supercharge 
protocol[22] with the structure of WT-arPTE (2D2J).[32] Absolute 
Surface Area View (ASAView)[33] was then used to calculate the 
solvent accessibility of WT-arPTE residues, since the more exposed 
residues make up a larger proportion of the protein surface. This 
was used to remove amino acids identified by the supercharge 
protocol that were too buried or within the dimer interface. 
Three additional polar amino acids (Ser238, Thr274, and Thr311) 
were added to the list of candidate mutations based on high 
solvent accessibility (Figure 1B). FoldX, which can accurately 
Adv. Biosys. 2018, 1700240
Figure 1. Engineering cationized arPTE. a) Positions of solubilizing mutations (K185R, A80V, and A204G) highlighted on WT-arPTE (2D2J).[32] Purple 
spheres represent Co2+. b) SDS–PAGE of WT-arPTE and each variant produced during the iterative engineering process. arPTE is visible at ≈35 kDa. 
c) Positions and identities of solubilizing and final cationizing mutations highlighted on R5-arPTE (5W7H).
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predict the stabilizing effect of point mutations, was then used to 
determine whether arginine or lysine was the least destabilizing 
amino acid mutation to make at each position.[34] The effects 
of the mutations on expression were then tested by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) 
(Table S1, Supporting Information). Those mutations that 
caused substantial loss of soluble expression were excluded, 
while those that did not were combined in a stepwise fashion. 
The final variant, R5-arPTE, comprised Gln148Arg, Gln155Arg, 
Ser238Arg, Glu263Arg, and Asp315Arg (Figure 1C and Table S2, 
Supporting Information). A decrease in soluble expression was 
observed throughout the construction of R5-arPTE. The loss of 
soluble expression upon incorporation of these additional posi-
tively charged residues is consistent with previous work that has 
suggested soluble expression of proteins correlates with a lack of 
positively charged surface,[35] but overexpression remained sub-
stantial (Figure 1D), confirming that the supercharging approach 
can allow high-yield enzyme production.
We then analyzed the effects of these mutations on sta-
bility, activity, structure, and net charge. Differential scanning 
fluorimetry indicated that no direct stabilizing effects were 
imparted by the incorporation of the cationizing mutations 
(R5 = 61.1 ± 0.29 °C) (Figure S1, Supporting Information). 
The kinetic parameters of the purified variants were character-
ized through assays with the substrate paraoxon-ethyl, moni-
toring the formation of p-nitrophenolate. The initial stabilizing 
mutations result in a decrease in activity of an order of magni-
tude, which can be attributed to the well-documented trade-off 
between enzyme stability and activity.[36] Because arPTE is a 
highly dynamic and active enzyme, it is likely that the solubi-
lizing mutations cause subtle changes in the conformational 
sampling to reduce the rate of substrate turnover; the relation-
ship between conformational dynamism and turnover rate has 
been demonstrated previously.[29,37] While these initial solubi-
lizing mutations decrease the catalytic efficiency of the enzyme 
approximately ninefold (which is offset by the twofold increase 
in soluble expression), the cationizing mutations have negli-
gible effects on the activity, relative to S3-arPTE (Table S3, Sup-
porting Information). The overall catalytic efficiency of R5-arPTE 
remained very high (kcat/KM = 3.77 × 106 m−1 s−1). Diffraction-
quality crystals of R5-arPTE were obtained in 0.2 m NaNO3, 
10% polyethylene glycol (PEG) 3350, pH 6.1. The structure of 
R5-arPTE was solved using molecular replacement with the 
structure of WT arPTE (2D2J)[32] (Table S4, Supporting Informa-
tion). Analysis of the R5-arPTE structure revealed that the C-α 
positions were essentially identical to that of the WT structure, 
with an root-mean-square deviation (RSMD) value of 0.76 Å.[38] 
The only region of note was loop 7 (residues 258–272), which is 
already very mobile but adopted a slightly different conforma-
tion than in the WT structure. One of the cationizing mutations, 
Glu263Arg, is located on this loop, and may be responsible for 
differences in C-α position, but is unlikely to be significant, given 
that the activity of R5-arPTE is essentially identical to S3-arPTE. 
Using the empirical structures of WT-arPTE and R5-arPTE, we 
were able to calculate the isoelectric point (pI) of each protein 
using PROPKA, which has been shown to be the most accurate 
computational method for calculation of pKa and pI values, with 
a level of error comparable to the best experimental methods.[39] 
The pI of R5-arPTE was estimated to be 10.01, a marked increase 
from the WT-arPTE pI of ≈6.79 (Figure 2).[40,41]
The Proteome-pI database indicates that of the 4314 known 
proteins in the E. coli (K12) proteome, 146 have an isoelectric 
point greater than 10.[43] Of these 145 proteins, only four have 
been experimentally determined to exist in the cytoplasm, and 
none in the periplasm. The remainder are either membrane-
associated (60), ribosomal (23) or have not been conclusively 
assigned a location in the cell (or are hypothetical proteins) 
(59).[44] This puts R5-arPTE in the top ≈0.001% of soluble 
proteins identified in the E. coli (K12) proteome based on iso-
electric point. Indeed, R5-arPTE could be purified from crude 
E. coli lysate in a single step over carboxymethyl (CM) Ceramic
HyperD resin (Figure S2, Supporting Information).
Adv. Biosys. 2018, 1700240
Figure 2. Monomer structures and electrostatic surface potentials of WT-arPTE (2D2J)[32] (top) and R5-arPTE (5W7H) (bottom) colored from −2.5 kT e−1 
(red) to +2.5 kT e−1 (blue). Isoelectric points as predicted by PROPKA[42] increase from 6.79 (WT) to 10.01 (R5) as a result of surface engineering.
139
www.adv-biosys.comwww.advancedsciencenews.com
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
To test the catalytic properties of ionically immobilized 
R5-arPTE, we used CM Ceramic HyperD resin, which is a com-
mercially available ceramic-encapsulated hydrogel. The hydrogel 
consists of a hydrophilic polymer containing 250–400 CM acidic 
groups (µEq mL−1), making it a weak cation exchanger. A 600 µL 
column of CM Ceramic HyperD resin has a protein binding 
capacity of 36 mg, although only 1 mg of purified R5-arPTE 
was loaded as the activity of the protein is so high that loss of 
activity could only be determined at lower loadings. Full binding 
was confirmed through the absence of any enzymatic activity in 
the flowthrough after loading. A second identical column was 
packed with resin only for use as an experimental control.
To determine the longevity of R5-arPTE immobilized in the 
hydrogel-resin, both in terms of protein “leaching” from the 
hydrogel and the long-term thermostability/denaturation, the 
substrate turnover by the immobilized enzyme was measured 
over the course of 85 d. Because the rate of hydrolysis of par-
aoxon-ethyl is very high (kcat/KM = 4 × 106 m−1 s−1), any loss of
activity is difficult to observe, since full substrate turnover is 
possible with only a small amount of active enzyme. Accord-
ingly, we used p-nitrophenyl butyrate, which is promiscuously 
turned over by arPTE at ≈1/1000th the rate of paraoxon-ethyl 
(Table S3, Supporting Information). Hydrolysis could be moni-
tored directly via the formation of p-nitrophenolate, and the con-
centration and flow rate were adjusted such that the initial total 
hydrolysis was ≈70%, meaning that any loss of activity would 
be in a detectable range. Hydrolysis was measured at the same 
flow rate, over the same column, at 2 g L−1 substrate loading, at 
25 intervals over a period of 85 d. This resulted in exposure of 
the immobilized enzyme to over 2 L of buffer (≈3000 column 
volumes with a biocatalyst loading of 0.0005 g L−1) with no evi-
dence of reduced enzymatic activity (Figure 3A). On average, 
67% of the loaded substrate was converted with each injection. 
The increase in activity observed after initial measurements was 
attributed to activation-period inactivation. This phenomenon 
has been observed in immobilization experiments a number 
of times.[45–47] The initial immobilization process can limit 
the conformational dynamism of the immobilized enzyme, 
increasing thermostability but decreasing catalytic activity. After 
being exposed to destabilizing conditions—in this instance, 
prolonged time spent at room temperature—conformation-
ally limited proteins are liberated, resulting in an increase of 
activity, before the steady loss of activity commences.
Having demonstrated that the supercharged protein was effec-
tively irreversibly immobilized and was extremely stable when 
bound to the hydrogel, with no detectable loss of activity over a 
period of 85 d, we then sought to estimate the level of substrate 
throughput that was achievable. From the long-term longevity 
analysis, we observe a turnover number of ≈7000 molsubstrate/
molcatalyst, with no loss of activity. We then set out to investigate 
the destruction of the neurotoxic pesticide paraoxon-ethyl. The 
World Health Organization’s recommended maximum concentra-
tion of parathion (the precursor molecule converted to paraoxon 
in vivo) is only 10 µg L−1,[48] while European Union directives 
limit pesticide concentration in drinking water to 0.1 µg L−1.[49] 
Here, we used concentrations several orders of magnitude higher 
than this, from 2.5 to 0.5 g L−1 in 10% methanol, with a small 
amount of catalyst immobilized on the resin (1.5 mg/600 µL 
resin, or 4.2 × 10−8 mol, which is ≈4% of the maximum loading 
capacity of the column) (Table 1). After several runs to determine 
the optimal conditions, an optimum flow rate and substrate 
loading of 0.5 g L−1 at 1 mL min−1 was identified. With these 
conditions, it was possible to hydrolyze ≈95% of 350 mg par-
aoxon-ethyl passed over the column over 11 h. Across the various 
experiments detailed in Table 1, the column achieved turnover of 
1.07 × 105 molproduct/molcatalyst over the course of ≈17 h.
To investigate the potential application of the ionically 
immobilized supercharged proteins in chiral resolution based 
enantioselective catalysis, the chiral organophosphate methyl 
(p-nitrophenyl) phenyl phosphate (MPP) was synthesized as 
a model substrate (Methods in the Supporting Information). 
While R5-arPTE showed no evidence of enantioselectivity with 
MPP (Figure 3B) previous work has shown that the related 
PTE from Pseudomonas diminuta could be engineered to confer 
enantioselectivity for the S- over the R-enantiomer.[50] Thus, 
we introduced one of the mutations previously observed to 
confer enantioselectivity (Gly60Ala) to R5-arPTE. The reaction 
of G60A-R5 and MPP was monitored spectrophotometrically, 
with the addition of NaOH used to determine the end-point of 
the hydrolysis. The hydrolysis of substrate MPP by G60A-R5 
was observed to plateau at 50% end-point hydrolysis, con-
sistent with an enantioselective enzyme-catalyzed hydrolysis 
of primarily one enantiomer of a racemic mixture (Figure 3B). 
Using the previously described immobilization protocol, 1 mg 
of G60A-R5 was applied to a 600 µL column containing the 
ceramic-encapsulated hydrogel. The enantioselectivity of immo-
bilized G60A-R5 was then investigated using high-performance 
liquid chromatography (HPLC) analysis with chiral stationary 
phases. MPP was injected at flow rates of 2–10 mL min−1 over 
the immobilized G60A-R5, and the flowthrough was analyzed 
by HPLC (Table 2). The flowthrough was determined to contain 
MPP with an enantiomeric excess of >99%. The reaction could 
be carried out on a preparative scale, producing synthetically rel-
evant quantities of enantiomerically enriched R-MPP in 30 min.
The stability of the immobilized R5-arPTE hydrogel in non-
aqueous solvents was investigated. A column was packed and 
loaded with R5-arPTE as described above. The destabilizing 
effects of methanol on enzymes are well established,[51] so this 
solvent was selected to test the stability of the immobilized 
enzyme. Increasing concentrations of methanol were passed 
over the R5-arPTE column, and the hydrolysis of p-nitrophenyl 
butyrate at each concentration measured (Figure 3C). The 
activity of R5-arPTE decreased consistently from 20% to 70% 
methanol, which is not unexpected given the catalytic mecha-
nism is dependent on free water molecules to act as nucleo-
philes. However, activity could be restored by washing the 
column with buffer containing no methanol (Figure 3D). The 
loss of activity was essentially fully reversible in methanol 
concentrations up to 70%, and partially reversible up to 90% 
methanol (≈80% recovery). It was only in 100% methanol that 
significant irreversible loss of activity occurred (<20% recovery) 
(Figure 3D). The reversible loss of activity in methanol is 
likely to be due to the stripping of catalytic water molecules 
by the polar organic solvent, which are then restored by the 
aqueous washes.[52] Exposure to concentrations of 80% meth-
anol and above, however, may have resulted in the stripping 
of structurally important water molecules, resulting in irre-
versible denaturing of the enzyme. The solvent resistance of 
Adv. Biosys. 2018, 1700240
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immobilized R5-arPTE was also tested with a less polar sol-
vent, ethyl acetate. An enzyme-bound column was subjected 
to 10 min of exposure to 100% ethyl acetate at a flow rate of 
5 mL min −1. The column was then flushed with buffer for a 
further 10 min at the same flow rate, before activity was tested 
with p-nitrophenyl butyrate at substrate loading of 2 g L−1. No 
reduction in catalytic activity was observed after exposure to a 
cumulative 100 mL of ethyl acetate (Figure 3E). As a control, 
free R5-arPTE in solution was exposed to ethyl acetate, and 
subsequently extracted from the aqueous fraction after solvent 
partitioning. Almost complete loss of activity was observed after 
only 1 min of contact time, indicating that the ionic adsorption 
of the enzyme onto the encapsulated hydrogel imparts signifi-
cant additional stability to organic solvents (Figure 3F).
While synthetic hydrogels, such as the immobilized CM-based 
hydrogel described above, have value in industry, self-assembled 
peptide hydrogels have been shown to have potential applica-
tions as scaffolds in transplant and new regenerative therapies, 
as they can more closely mimic the environment of the cell via 
the inclusion of bioactive amino acid sequences.[53] Enzymes 
embedded within these materials have been shown to have 
improved stability and retained function over extended time 
periods.[54] This combination of properties is of interest, as it 
could allow precise (therapeutic) delivery of enzymatic activity, 
with the biocompatible hydrogel acting to constrain enzymatic 
activity to the physical location. This has been achieved by con-
trol of the surface chemistry via the peptide sequence. The side 
chains of the peptides are presented at a high density within 
Adv. Biosys. 2018, 1700240
Figure 3. Properties of immobilized R5-arPTE. a) The longevity of immobilized R5-arPTE stored at room temperature, as measured by hydrolysis of 
p-nitrophenyl butyrate injected over the immobilized enzyme. b) Enantioselectivity of arPTE variants R5 and R5-G60A. At 6 min, addition of 5 m NaOH 
fully hydrolyses the substrate. 50% conversion is marked with a dotted line. c) Enzymatic hydrolysis of p-nitrophenyl butyrate in increasing concentra-
tions of MeOH. d) Enzymatic hydrolysis of p-nitrophenyl butyrate after exposure to increasing concentrations of MeOH and restoration to aqueous
buffer. e) Enzymatic hydrolysis of p-nitrophenyl butyrate after exposure to 100% EtOAc, and subsequent restoration to aqueous buffer. f) Activity of
R5-arPTE in solution after exposure to and extraction from 100% EtOAc.
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the final assembled structure. This localization of properties 
creates dense regions which enable biomacromolecule inclu-
sion by noncovalent incorporation. As the entire solvent is 
entrapped by the gelation process, all of the payload is incor-
porated within the system, and is dependent on the properties 
of the biomacromolecules and matrix. This presents via supra-
molecular interactions with the self-assembled matrix, such 
as hydrophobic,[55] steric,[56] and electrostatic interactions.[57] 
Previous studies have demonstrated the effects of electrostatic 
interactions on the rates of protein diffusion out of hydrogels, 
specifically showing that proteins with the opposite net charge 
of the hydrogel matrix in which they are encapsulated have a 
lower rate of diffusion.[58] With this in mind, we modified our 
previously described hydrogel,[57] which is comprised of Fmoc-
DIKVAV (DX) and has been shown to be biocompatible and to 
self-assemble at physiological pH, to Fmoc-DIKVAVD (DXD), 
which includes aspartic acid at the C-terminus to create a com-
plementary anionic matrix for the cationic enzyme. Samples of 
DX and DXD hydrogels were prepared by solid phase peptide 
synthesis. Solutions of R5-arPTE were added to the liquid 
phase gels to yield a final concentration of 1 mg (protein) mL 
(hydrogel)−1. The hydrogels were allowed to set, washed with 
phosphate buffered saline (PBS) to remove unbound enzyme, 
and tested for activity with paraoxon-ethyl. The structures of 
the hydrogels were not greatly perturbed by the addition of the 
supercharged protein, as estimated from transmission electron 
microscopy (TEM) and Fourier transform infrared spectroscopy 
(FTIR) (Figure 4A–E). Solutions of 200 × 10−3 m paraoxon-ethyl 
were applied to the surfaces of the DX: R5 and DXD: R5 gels, 
allowed to incubate at 25 °C with gentle shaking for 5 min, 
and then extracted for spectrophotometric analysis. The gels 
were then washed with PBS to remove excess substrate. This 
process was repeated five times. The neutral hydrogel DX: 
R5 complex showed a steady decrease in hydrolytic activity 
over the five rounds of washing and substrate addition, con-
sistent with leaching of R5-arPTE from the hydrogel, whereas 
DXD: R5 retained constant activity throughout the experiment 
(Figure 4F). This is consistent with R5-arPTE and DXD forming 
Adv. Biosys. 2018, 1700240
Table 2. Kinetic resolution of (±)-MPP using R5-G60A in flow.
Flow rate [mL min−1] t [min] Yielda) [%] e.r.b)
2 10 – >99:1
5 10 – >99:1
10 10 – >99:1
10 30 40 >99:1
a)Isolated yield following column chromatography; b)e.r. determined by HPLC on the RegisCell chiral stationary phase from Regis technologies.
Table 1. Destruction of paraoxon-ethyl using R5-arPTE in flow.
Run Substrate loading [g L−1] Flow rate [mL min−1] Mass paraoxon [mg] Time [min] Conversiona) [%]
1 1.25 5 375 60 67
2 2.5 2.5 375 60 76
3 2.5 1 375 150 86
4 1 1 50 50 91
5 0.5 1 350 700 95
Total 0.5–2.5 1–5 1525 1020 81
Catalyst loading [mol %] 0.0008
Turnover [molsubstrate/
molcatalyst]
1.07 × 105
a)Determined by 1H NMR of the crude residue after extraction with Et2O.
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a strong ionic interaction, resulting in immobilization of the 
enzyme in the hydrogel under neutral conditions.
For the application of biocatalysts in industrial pro-
cesses, ensuring enzymes can be produced and purified 
quickly and at low cost is vital. The supercharged arPTE 
variant, R5-arPTE, presented in this work was isolated in 
high purity over a single cation exchange column step using 
robust hydrogel-ceramic beads that can tolerate high pres-
sure and are reusable. The same hydrogel-ceramic resin has 
been demonstrated here to act as a versatile immobilization 
matrix for R5-arPTE. Significantly, this represents an efficient 
industrial biocatalysis platform utilizing a single-step process 
from crude E. coli lysate to pure, immobilized, catalytically 
active protein. A further benefit of ionic immobilization is 
the potential for rapid recycling of the resin when enzymatic 
activity eventually deteriorates. R5-arPTE can be stripped 
from the column with high salt buffer (2 m NaCl), allowing 
the resin to be recharged with fresh enzyme. The simplicity 
and flexibility that ionic immobilization allows cannot be 
achieved with covalent crosslinking to media.[59] Additionally, 
in contrast to previous examples of ionic adsorption methods, 
the immobilization and desorption processes are rapid, 
are essentially irreversible under normal conditions, do not 
require prior purification or modification of the enzyme and 
do not require long incubation periods.[60,61]
The immobilized R5-arPTE system could find application 
in bioremediation, particularly in agricultural settings wherein 
pesticides applied to crops can leach into groundwater. One 
of the advantages of continuous-flow chemistry is its ability to 
scale-up efficiently.[62] Thus, the encapsulated hydrogel system 
could be readily scaled up and incorporated into waste–water 
drainage systems in these settings; the ceramic-encapsulated 
hydrogels are resistant to high flow rates and pressures, and 
after depletion of enzymatic activity, the material can be 
stripped with an innocuous NaCl solution and recharged with 
fresh enzyme.
Adv. Biosys. 2018, 1700240
Figure 4. Hydrogel-enzyme constructs and their properties. TEM of a) DX hydrogel, b) DX: R5 construct, c) DXD hydrogel, d) DXD: R5 construct, 
showing that the nanofibrous morphology is largely unaffected by the addition of the enzyme. e) FTIR characterization of DX and DXD hydrogels 
imbued with R5-arPTE, showing consistent β-sheet formation, a further indication that the structural assembly is not affected by the enzyme addition. 
f) Addition of paraoxon-ethyl to the surface of DX and DXD gels imbued with R5-arPTE verifies catalytic activity of the constructs. DX: R5 shows a
statistically significant decrease in catalytic activity over the course of the experiment, as determined by unpaired student’s t-test (p = 0.0006) while
DXD: R5 does not (p = 0.112).
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Immobilized R5-arPTE maintained significant hydrolytic 
activity, even in the presence of substantial methanol concen-
trations, and could recover 100% of its catalytic activity after 
exposure to ethyl acetate (in comparison, the free enzyme is 
irreversibly denatured). These observations suggest that the ani-
onic hydrogel microenvironment stabilizes the natively folded 
state of the cationic protein. Polar solvents have been previously 
demonstrated to “strip” catalytic and structurally important 
water molecules from enzymes.[52] In the hydrogel, reduction 
in the polarity of the solvent will increase the strength of the 
ionic bonds between the surface of the protein and the hydrogel 
matrix, effectively stabilizing the structure and preventing 
structural rearrangement upon unfolding that could result 
in hydrophobic surfaces interacting, which normally leads to 
misfolding and aggregation. Indeed, tight interaction between 
the charged surface and the hydrogel may enhance any local 
refolding that might occur. Ionic immobilization of super-
charged proteins could therefore prove useful in flow chemistry 
applications where enzymes are required to function in organic 
solvents, such as in the acylation of alcohols by lipases.[63]
Catalysts, including enzymes, have found widespread appli-
cation in synthetic chemistry for the preparation of enantiopure 
compounds. The value of immobilized catalysts is particularly 
apparent in continuous-flow reactors, which are becoming 
more advanced and accessible. In flow chemistry applications, 
chemical transformations utilizing the specificity and selectivity 
of biocatalysts ideally require solvent-resistant components that 
can be readily stripped and recycled. The simplicity, durability, 
and reusability of supercharged enzyme: hydrogel matrices as 
described here could substantially reduce the costs and enhance 
the versatility of such components.
Finally, the nanostructured hydrogels formed by Fmoc-
self assembling peptides have recently gained interest for the 
potential in regenerative medicine applications. The flexibility 
afforded by these systems is exemplified by their deploy-
ment in the brain where they interface with the surrounding 
parenchyma, have no adverse effect on the immune system, 
and do not impede cell migration or growth. While self-
assembling organophosphate hydrolase gels have been previ-
ously described,[64] the flexibility afforded by a hybrid enzyme: 
hydrogel material is distinct; ionic entrapment in designer 
hydrogels could be readily generalized to any soluble enzyme, 
and both enzyme and gel properties could be tuned for specific 
applications. Further, the biocompatibility of enzyme-impreg-
nated Fmoc complexes broadens the scope of potential medical 
applications of such materials. We anticipate that the inclusion 
of further functionality to such hydrogels, via supercharged 
proteins as presented here, could extend their uses by confer-
ring catalytic activity, delivering bound ligands, or including 
components to promote the formation of protein: protein com-
plexes at the site of transplant.
In this study, we have demonstrated robust ionic immobili-
zation of an engineered, cationically supercharged, arPTE onto 
anionic hydrogels, resulting in a system capable of detoxifying 
organophosphates and catalyzing enantioselective reactions in 
flow. The substantial catalytic lifespan of the R5-arPTE-hydrogel 
system, both in terms of prolonged use and extended storage 
at room temperature, has been demonstrated. The cationic 
surface of R5-arPTE allows a simple ion exchange purification 
protocol, which could be readily scaled up for industrial appli-
cation of the enzyme, and the rapid immobilization on and des-
orption from the hydrogel results in an easily recyclable system, 
where degraded enzyme can be rapidly stripped from the gel 
and replaced with fresh protein. The flexibility and longevity of 
this system addresses some of the main drawbacks of current 
immobilization techniques; the high costs associated with puri-
fication of biocatalysts, the harsh conditions required for cova-
lent attachment, and the propensity for ionically immobilized 
proteins to leach from media with prolonged use. The advances 
demonstrated above provide insight into potential application 
of biocatalysis in industry, synthesis, and bioremediation.
Experimental Section
Site Directed Mutagenesis and Expression Tests: The arPTE gene was 
cloned into the pETMSCI expression vector between the Nde1 and 
EcoR1 restriction sites.[65] Mutants were constructed by the Gibson 
Assembly method.[66] Fragments containing the desired point mutation 
were generated using a pair of mutagenic QuikChange primers and 
a pair of gene-specific primers. pETMSCI vector was digested with 
Nde1 and EcoR1. Fragments and digested vector were purified via gel 
excision, then combined with a Gibson Assembly aliquot. The product 
of the Gibson reaction was transformed into electrocompetent E. coli 
Top 10 cells, and the cells plated on lysogeny broth (LB) agar with 
amp (100 µg mL−1 ampicillin) and incubated overnight. Colonies were 
selected, and colony polymerase chain reaction (PCR) performed with 
T7 forward and reverse primers. PCR product was sequenced to verify 
incorporation of the desired mutations.
Soluble expression of each arPTE variant was tested under consistent 
growth conditions. arPTE variant plasmids were transformed into 
electrocompetent E. coli BL21(DE3) cells, and the cells plated on LB agar 
with amp (100 µg mL−1 ampicillin) and incubated overnight. Colonies 
were selected and used to inoculate small-scale (10 mL) LB cultures, all 
supplemented with amp (100 µg mL−1 ampicillin) and 100 × 10−6 m CoCl2. 
Small-scale cultures were incubated overnight at 30 °C with shaking 
at 200 rpm. To quantify the soluble protein expression in each set of 
conditions, 1 mL of cells was pelleted, resuspended in lysis buffer (Buffer B: 
50 × 10−3 m (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES), 
100 × 10−6 m ZnCl2, 1.5 m NaCl, pH 8.0) with 10% v/v BugBuster (Novagen) 
and shaken for 1 h. The lysate was centrifuged at 4000 × g for 10 min and 
both the supernatant and insoluble pellet were analyzed by SDS–PAGE.
Analysis of soluble expression was performed using ImageJ.[67] An 
internal standard against which arPTE expression could be compared was 
selected. This ensured that variability caused by heterogeneous loading 
of samples would not affect perceived soluble expression, and allowed 
for expression to be compared across multiple SDS–PAGE experiments.
Preparative Scale Enzyme Expression and Purification: Electrocompetent 
E. coli BL21(DE3) cells were transformed with arPTE mutant plasmids
by electroporation. Transformants were plated on LB agar with amp
(100 µg mL−1 ampicillin) and incubated overnight. Colonies were
grown in LB medium supplemented with 100 µg mL−1 ampicillin for
8 h. These cultures were transferred to 1 L terrific broth (TB) medium
supplemented with 100 µg mL−1 ampicillin and 100 × 10−6 m CoCl2, and
incubated at 30 °C with shaking overnight. arPTE variants R4 and R5
were grown in large scale TB cultures supplemented with 10 g L−1 NaCl.
Cells were pelleted by centrifugation at 4000 × g for 15 min at 4 °C.
All enzymes in this study were purified through ion exchange 
chromatography.
WT, S1, S2, S3, R1, R2, R3: Pelleted cells were resuspended in 
Buffer A (50 × 10−3 m HEPES, 100 × 10−6 m ZnCl2, pH 8.0) and lyzed
through sonication. Lysate was centrifuged at 26 200 × g for 60 min at 
4 °C to remove cell debris. The resulting supernatant was loaded onto 
a Fractogel diethylaminoethyl (DEAE) anion exchange column (Merck), 
equilibrated with Buffer A. arPTE was collected in the flowthrough after 
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elution with Buffer A. Fractions were analyzed with SDS–PAGE. Purity of 
combined fractions was determined to be between 90% and 95%.
R4, R5: Pelleted cells were resuspended in Buffer B (50 × 10−3 m HEPES, 
1.5 m NaCl, 100 × 10−6 m ZnCl2, pH 8.0) and lyzed through sonication.
Lysate was centrifuged at 26 200 × g for 30 min at 4 °C to remove cell 
debris, and the clarified lysate was subjected to a heat purification 
step. The lysate was suspended in a water-bath heated to 60 °C for 
15 min, and then centrifuged at 26 200 × g for 30 min at 4 °C to pellet 
precipitated material. The resulting supernatant was diluted tenfold with 
Buffer C (50 × 10−3 m HEPES, 100 × 10−6 m ZnCl2, pH 6.5) and loaded
onto a column containing CM Ceramic HyperD resin (Pall LifeSciences). 
Unbound protein was washed away with Buffer C, and arPTE eluted with 
an increasing concentration of Buffer D (50 × 10−3 m HEPES, 100 × 10−6 m 
ZnCl2, 1.5 m NaCl, pH 7.0). Fractions were analyzed with SDS–PAGE. Pure 
fractions were pooled and purity was determined to be greater than 95%.
Enzyme Kinetics: Kinetic assays of arPTE variants were carried 
out according to a previously published protocol.[68] In brief, kinetic 
constants for the hydrolysis of paraoxon-ethyl and p-nitrophenyl butyrate 
were determined by monitoring the production of p-nitrophenolate at 
405 nm (ε405 = 17 700 m−1 cm−1) at room temperature. Reactions were
performed in 20 × 10−3 m Tris (pH 8.5), 100 × 10−3 m NaCl, 100 × 10−6 m 
ZnCl2, and 1 mg mL−1 bovine serum albumin. All kcat and KM values
were determined by fitting initial velocity data to the Michaelis–
Menten equation. All assays were performed in duplicate, and MeOH 
concentration was kept below 2.5% total reaction volume.
Structural Determination: Purified R5-arPTE was concentrated to 
≈5 mg mL−1 in 20 × 10−3 m HEPES, 50 × 10−3 m NaCl, 100 µL ZnCl2. Screens 
were optimized by hanging-drop vapor diffusion at 18 °C. Drops consisting
of 4 µL of reservoir and 2 µL of protein were equilibrated over a 500 µL 
reservoir in Crystalgen pregreased 24-well plates. Conditions were screened
between 100 × 10−3 m sodium nitrate (pH 6.1–6.7), distilled deionized
water and 4 – 20% (w/v) PEG 3350 g mol−1. Crystals were observed after
24 h of growth, with the largest crystals growing in 9% PEG 3350, pH 6.1.
For data collection, crystals were coated in cryobuffer (100 × 10−3 m 
sodium nitrate, pH 6.1, 40% PEG 3350) and cooled to 100 K in a stream 
of nitrogen gas. Diffraction data were collected at the Australian 
Synchrotron (MX2 beamline) at a wavelength of 0.9537 Å. X-ray diffraction 
data were indexed and integrated using X-ray detector software (XDS)[69] 
and merged using AIMLESS,[70] within the CCP4 program suite. The 
structure was solved by molecular replacement (MolRep)[71] using WT 
arPTE structure (2D2J).[32] Refinement was performed using PHENIX,[72] 
and manual rebuilding was performed using Coot.[73]
Immobilization of R5-arPTE: A small volume column (0.667 mL) 
was packed with CM Ceramic HyperD resin (Pall LifeSciences) and 
equilibrated with 20 column volumes of Buffer D (50 × 10−3 m HEPES, 
100 × 10−6 m ZnCl2, 1.5 m NaCl, pH 7.0), followed by 20 column volumes
of Buffer C (50 × 10−3 m HEPES, 100 × 10−6 m ZnCl2, pH 6.5). For activity
tests, 1 mg of purified R5-arPTE was loaded in Buffer C. The successful 
immobilization of R5-arPTE was verified by collecting the flowthrough 
from the loading step and observing UV absorbance at 280 nm. No 
evidence of protein was observed in the flowthrough. The “R5-arPTE 
column” was stored at room temperature in 50 × 10−3 m HEPES, 
100 × 10−6 m ZnCl2, pH 8.
Tests of Immobilized R5-arPTE Activity: To test the activity, longevity, 
and solvent stability of immobilized R5-arPTE, a flow-assay protocol 
was developed. In each case, 100 µL of 100 × 10−3 m p-nitrophenyl 
butyrate in MeOH was injected over the R5-arPTE column at a flow 
rate of 5 mL min−1, and the concentration of p-nitrophenolate in 
20 mL of flowthrough was determined spectrophotometrically. 100 µL 
of 5 m NaOH was added to 1 mL of this flowthrough to determine 
absorbance for 100% hydrolysis. This provided an internal standard for 
measurements carried out over the course of 85 d. An “empty” column, 
containing CM Ceramic HyperD resin (Pall LifeSciences) and no 
enzyme, was used to establish background hydrolysis of the substrate 
under identical reaction conditions. Stability of the immobilized 
R5-arPTE in methanol was determined by carrying out the standard 
flow-assay protocol in increasing concentrations of methanol in flow 
buffer (50 × 10−3 m HEPES, 100 × 10−6 m ZnCl2, pH 8). Due to the
limited miscibility of water in ethyl acetate, stability was tested only after 
exposure to 100% ethyl acetate rather than to increasing concentrations. 
50 mL of ethyl acetate was pumped over the R5-arPTE column at 
5 mL min−1, followed by 50 mL of flow buffer. Hydrolysis of substrate 
was then measured using the injection protocol described above. This 
experiment was performed over two separate washes with ethyl acetate, 
and hydrolysis measurements were taken after washes with 50 and 
100 mL of flow buffer. MeOH flow-assay measurements were made in 
triplicate. All other flow-assay measurements were made in duplicate.
Synthesis of Paraoxon-Ethyl: To a solution of p-nitrophenol (4.2 g, 
30 mmol) and potassium carbonate (4.2 g, 30 mmol) in acetone was 
added diethyl chlorophosphate (4.8 mL, 33 mmol) dropwise, and the 
reaction allowed to stir overnight. After this time, the solution was filtered 
and concentrated to yield the paraoxon as a pale yellow oil (6.4 g, 77%). 
1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 9.2 Hz, 2H), 7.37 (dd, 
J = 9.2, 0.8 Hz, 2H), 4.30–4.19 (m, 4H), 1.37 (t, J = 7.2, 3H), 1.33 
(t, J = 7.2, 3H); 13C NMR (101 MHz, CDCl3) δ 155.7 (d, J = 6.3 Hz), 
144.8, 125.8, 120.7 (d, J = 5.4 Hz), 65.3 (d, J = 6.3 Hz), 16.2 
(d, J = 6.6 Hz); 31P NMR (162 MHz, CDCl3) δ −7.11; IR νmax (cm−1) 
2986, 1592, 1522, 1491, 1346, 1225, 1020 (br), 921.
Synthesis of MPP: To a solution of methyl phosphodichloridate (1.4 g, 
9.5 mmol) and phenol (0.73 g, 9.5 mmol) in dichloromethane (40 mL) 
at 0 °C was added triethylamine (0.959 g, 9.5 mmol) dropwise, and the 
reaction allowed to warm to room temperature overnight. After this time, 
the reaction was cooled to 0 °C, and p-nitrophenol (1.16 g, 9.5 mmol) and 
triethylamine (0.959 g, 9.5 mmol) were added. The reaction was again 
allowed to warm to room temperature overnight. The solvent was then 
removed under reduced pressure, and the crude residue diluted with 
Et2O. After washing with dilute NaHCO3, the organic later was dried with 
MgSO4, filtered, concentrated under reduced pressure, and the residue 
purified by column chromatography (1:9 → 1:1, v/v EtOAc: hexanes) to 
afford MPP as a brown oil (1.04 g, 34% yield). Rf 0.49 (1:1, v/v EtOAc: 
hexanes); HPLC RegisCell L40, λ = 254 nm, hexane: iPrOH 95:5, flow 
rate 1 mL min−1, Rt 20.93 and 35.43 min; 1H NMR (400 MHz, CDCl3) 
δ 8.25 (dd, J = 9.6, 0.8 Hz, 2H), 7.41–7.34 (m, 4H), 7.26–7.19 (m, 3H),
4.01 (d, J = 11.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 155.2(2)
(d, J = 0.6 Hz), 150.2(3) (d, J = 0.8 Hz), 145.2, 130.2 (d, J = 0.5 Hz),
126.0 (d, J = 1.1 Hz), 125.9, 120.8 (d, J = 5.4 Hz), 120.0 (d, J = 4.8 Hz),
56.1 (d, J = 6.5 Hz); 31P NMR (162 MHz, CDCl3) δ −11.65; IR νmax
(cm−1) 3115, 3081, 1590, 1519, 1487, 1346, 1187, 932 (br).
Enantioselectivity Assays: To determine if arPTE variants R5 and 
G60A-R5 resolved racemic MPP, enzyme reactions were monitored using 
a Cary 60 UV–vis spectrophotometer. 800 µL of 80 × 10−6 m MPP in assay 
buffer (20 × 10−3 m Tris (pH 8.5), 100 × 10−3 m NaCl, 100 × 10−6 m ZnCl2, 
and 1 mg mL−1 bovine serum albumin) was added to a 1 mL plastic 
cuvette, and baseline absorbance at 405 nm was established before 
the addition of 200 µL of enzyme solution to a final concentration of 
40 × 10−9 m. Thorough mixing ensured a homogenous reaction mixture. 
Absorbance was monitored for ≈6 min, or until an obvious plateau was 
observed, suggesting the reaction had reached completion. 100 µL 
of 5 m NaOH was then added to the cuvette, mixed thoroughly, and 
subsequent absorbance monitored. Dilution of the reaction mixture 
upon addition of NaOH was factored into calculations.
Kinetic Resolution of MPP Under Continuous-Flow: Continuous-flow 
experiments were performed using a Vapourtec E-series easy-Medchem 
integrated flow chemistry system. The flow system was set up with 
reservoirs containing flow buffer and MPP (5 × 10−3 m in MeOH). The 
outlet of the column discharged into a beaker of Et2O. Buffer was passed 
over the column at 0.9 mL min−1 and MPP at 0.1 mL min−1, such that 
the column solvent was 1:9 buffer: MeOH. This ratio was maintained 
when flow rates were varied. Reaction time was measured from first 
observance of p-nitrophenolate at the column outlet. After the reaction 
time, the collected buffer/Et2O was extracted with Et2O until the yellow 
p-nitrophenolate was not visible in the aqueous layer. The combined
organics were dried with Na2SO4, filtered, and concentrated under 
reduced pressure. The crude residue was analyzed by 1H NMR and 
HPLC on a chiral stationary phase (RegisCell chiral stationary phase 
(4.6 mm × 25 cm) column from Regis).
Adv. Biosys. 2018, 1700240
145
www.adv-biosys.comwww.advancedsciencenews.com
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Destruction of Paraoxon-Ethyl in Flow: The flow system was set up 
with reservoirs containing flow buffer and paraoxon-ethyl (0.5–2.5 g L−1 
in MeOH). The outlet of the column discharged into a beaker of Et2O. 
Buffer was passed over the column at 0.9 mL min−1 and paraoxon-ethyl 
at 0.1 mL min−1, such that the column solvent was 1:9 buffer: MeOH. 
This ratio was maintained when flow rates were varied. Reaction time 
was measured from first observance of p-nitrophenolate at the column 
outlet. After the reaction time (see Table 1), the collected buffer/Et2O 
was extracted with Et2O until the yellow p-nitrophenolate was not visible 
in the aqueous layer. The combined organics were dried with Na2SO4, 
filtered, and concentrated under reduced pressure. The crude residue 
was analyzed by 1H NMR.
Differential Scanning Fluorimetry: Determination of Tm for WT-arPTE, 
S3-arPTE, and R5-arPTE was carried out by DSF with SYPRO Orange 
(Sigma) as the reporter dye. Assay solutions consisted of 10 × 10−6 m 
protein and a final concentration of 1 × SYPRO Orange, and were made 
up to a total volume of 30 µL with 20 × 10−3 m HEPES, 50 × 10−3 m NaCl, 
100 µL ZnCl2, pH 8. Temperature ramping was performed using a 7900HT 
Fast RealTime PCR (ThermoFisher, Applied Biosystems), and fluorescence 
data were collected (Excitation = 490 nm, Emission = 575 nm), before 
analysis with the SDS 2.4 software package (Applied Biosystems). DSF 
thermal shift assays were performed in triplicate.
Fmoc-Self-Assembling Peptide (SAP) Hydrogel Gelation: Fmoc-SAPs 
were engineered by solid phase peptide synthesis using a custom made 
rotating glass reaction vessel as previously reported.[74] Fmoc protected 
amino acids, hydroxybenzotriazole (HOBt), O-benzotriazole-N,N,N′,N′-
tetramethyl-uronium-hexa-fuoro-phosphate and Wang based resins were 
purchased from Pepmic (China). All other chemicals were purchased 
from Sigma-Aldrich. Fmoc-SAPs hydrogels were prepared at 15 mg mL−1. 
Briefly, 10 mg of peptide was dissolved into 200 µL of deionized water 
with 100 µL 0.5 m sodium hydroxide. Then 0.1 m of hydrochloric acid 
was slowly added with continuously vortexing and the pH of peptide 
solution was monitored until it reached physiological relevant pH. 
Typically, 300 µL of 0.1 m HCl was used to achieve this. Once the gel 
formed with the optimal pH attained, PBS was added to bring the gel up 
into 15 mg mL−1 concentration. The pH of the gels was measured by an 
Oaktron pH 700 micro pH electrode (Thermo Scientific).
FTIR Spectroscopy of Fmoc-SAP Hydrogels: FTIR spectra were collected 
by using an Alpha Platinum Platinum Attenuated total reflectance FTIR 
(Bruker Optics). Approximately 30 µL of peptide hydrogel (15 mg mL−1) 
was placed on the single reflection diamond and allowed to sit for 
10 min evaporating the solvent, which enables minimal contribution 
from the solvent to the spectra. Absorbance scans of the amide I region 
(1550–1750 cm−1) were obtained for each peptide, and the background 
buffer scan subtracted.
TEM of Fmoc-self-assembling peptide (SAP) Hydrogels: TEM was 
performed on a Hitachi H7100FA electron microscope using a 100 kV beam 
with a LaB6 cathode. Formvar coated copper grids were glow-discharged for 
30 s at 15 mA. Hydrogel samples were negatively stained with 0.75% uranyl 
formate (UF): after glow discharge the grids were gently immersed in the 
sample for 30 s, briefly immersed in two consecutive drops of deionized 
water, before two drops of the UF negative stain solution was added for 
20 s. The grids were gently blotted dry between immersions.
Determination of R5-arPTE Activity in Biocompatible Hydrogels: 
R5-arPTE was incorporated into DX and DXD gel samples (0.66 mL gel), 
to a final concentration of 1 mg (enzyme) mL (gel)−1. PBS was 
incorporated into identical DX and DXD samples to act as experimental 
controls. After gelation, the surfaces of DX + R5 and DXD + R5 were 
washed with 5 mL of PBS to remove unbound enzyme. Solutions 
of paraoxon-ethyl (200 × 10−3 m) were added to the surfaces of the 
enzyme-gel constructs, and the constructs were shaken gently at room 
temperature for 5 min. After the incubation period, solutions were 
removed from the surfaces of the gels and their absorbance at 405 nm 
was measured. The gels were washed with PBS to remove excess 
substrate (5 min incubation with PBS), and the addition of substrate 
was repeated. This process was repeated a total of five times.
Statistical Analysis: Wherever error is presented in figures, it is in the 
format mean ± SE. SE (standard error) is calculated using
= √SE
S
n (1)
where S is standard deviation from the mean and n is the sample size. 
Unless otherwise stated in the text, n = 2.
For enzyme kinetics, kcat and KM values were derived by fitting 
collected data to the Michaelis–Menten equation
( )
[ ]
[ ]= +0
max
M
V
V S
K S
(2)
where V0 is initial velocity, Vmax is maximum velocity, and [S] is substrate 
concentration.
Determination of statistical significance was carried out using an 
unpaired student’s t-test.
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Supplementary Data
Supplementary Figure 1 | Thermal shift assays of WT-arPTE and S3-arPTE, indicating a predicted 
Tm of 60.7 ± 0.085 °C for WT, and 59.5 ± 0.052 °C for S3. Line fit statistics and predicted Tm values 
are in-set. 
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Supplementary Figure 2 | Purification of R5-arPTE (approximately 35 kDa) over cation exchange 
resin. SDS-PAGE of eluted fractions 10 to 22 shows <95% purity in fractions 12 to 14.  
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Position Mutated to 
Effect on expression 
(relative to background onto which 
incorporated) 
Glu81 Arg 0.76‡ 
Asp121 Lys 0.81 
Gln148 Arg 1.03† 
Gln155 Arg 0.94 
Asp160 Lys 0.46 
Gln206 Arg 0.02# 
Glu210 Arg 0.47† 
Ser238 Arg 0.79 
150
Glu263 Arg 1.04 
Thr274 Arg 0.83 
Asp289 Arg 0.58 
Thr311 Arg 0.59 
Asp315 Arg 0.73‡ 
Glu338 Arg 0.69‡ 
Glu344 Arg 0.75‡ 
Supplementary Table 1 | The identities of the 15 cationizing mutations. The effects of the mutations 
on soluble protein expression were assessed using SDS-PAGE and image densitometry (ImageJ56,57), 
and are presented here as ratios relative to the genetic background into which they were incorporated. 
Numbers > 1 represent an increase in soluble expression. Mutations were made on S3-arPTE unless 
indicated otherwise. † made on S2-arPTE, ‡ made on R3-arPTE, # made on WT-arPTE.  
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Supplementary Table 2 | The identities of the stabilising and cationizing mutations accumulated in 
each round of testing.  
K185R A80V A204G Q148R Q155R E263R D315R S238R 
WT 
S1 X 
S2 X X 
S3 X X X 
R1 X X X X 
R2 X X X X X 
R3 X X X X X X 
R4 X X X X X X X 
R5 X X X X X X X X 
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Variant kcat (s-1) KM (µM) kcat/KM (M-1 s-1) 
Ethyl Paraoxon 
WT 509 ± 12 16 ± 0.018 3.18 × 107 
S1 50.7 ± 0.89 23 ± 0.89 2.18 × 106 
S2 41.0 ± 0.23 17 ± 1.5 2.35 × 106 
S3 130 ± 3.5 36 ± 3.2 3.63 × 106 
R1 117 ± 4.2 43 ± 2.6 2.74 × 106 
R2 105 ± 3.3 35 ± 0.38 3.00 × 106 
R3 126 ± 3.1 44 ± 3.6 2.84 × 106 
R4 49.1 ± 0.87 20 ± 3.0 2.47 × 106 
R5 69.8 ± 2.5 19 ± 0.88 3.77 × 106 
p-nitrophenyl butyrate
WT 6.02 ± 0.72 950 ± 189 6.33 × 103 
R5 3.16 ± 0.10 1072 ± 34 2.95 × 103 
Supplementary Table 3 | Kinetic parameters of arPTE variants with paraoxon-ethyl and p-
nitrophenyl butyrate. Means and s.e. of parameters were calculated from two independent 
measurements. 
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R5-arPTE 
Data collection 
Space group P212121 
Cell dimensions 
   a, b, c (Å) 48.391, 110.076, 112.277 
   α, β, γ ()  90.0, 90.0, 90.0 
Resolution (Å) 34.88  - 2.75 (2.848  - 2.75) 
Rsym or Rmerge 0.1527 (0.5932) 
CC1/2 0.998 (0.94) 
CC* 0.999 (0.984) 
I / σI 15.03 (4.54) 
Completeness (%) 91.52 (100.00) 
Redundancy 12.8 (13.0) 
Refinement 
Resolution (Å) 34.88  - 2.75 (2.848  - 2.75) 
No. reflections 188301 (20742) 
Rwork / Rfree 0.2254/0.2769 
No. atoms 
    Protein 5056 
    Ligand/ion 4 
    Water 69 
B-factors
Protein 42.20 
Ligand/ion 28.50 
Water 27.10 
R.M.S. deviations
Bond lengths (Å) 0.003 
Bond angles () 0.83 
PDB ID 5W7H 
Supplementary Table 4 | Data collection and refinement statistics for R5-arPTE 
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I was captured for life by chemistry and crystals. – Dorothy Crowfoot Hodgkin 
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CHAPTER 5:  
CONCLUSIONS 
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The work presented in this thesis seeks to improve our understanding of biocatalysts and 
broaden their application in chemical synthesis, therapeutics, and industry. Fundamental 
research into the mechanisms that underpin molecular evolution can provide valuable insights 
into the nature of highly efficient catalysts, and provide strategies for the rational improvement 
of designed enzymes.  
In Chapter 2 of this thesis, the study of evolutionary intermediates isolated from a directed 
evolution experiment (the R-trajectory) revealed several factors that influence the improvement 
of promiscuous activity during adaptive evolution selecting for that trait. We determined that 
adaptive evolution enriched productive conformations, with later round substitutions tuning the 
dynamics of loop regions to minimize motions that were important in the native activity, but 
did not play a productive role in the new activity. Structural characterisation of intermediates 
isolated from a ‘reversal’ of this evolutionary trajectory (starting from the endpoint of the R-
trajectory, and selecting for native activity) revealed convergence upon the native active site 
structure, albeit via a different evolutionary pathway. This demonstrates that phenotypic 
reversion is constrained by an ‘epistatic ratchet’ that prohibits the stepwise reversion of 
individual mutations, and provides an example of convergence in molecular evolution.  
Work presented in Chapter 3 of this thesis aimed to further investigate evolutionary 
convergence by characterizing variants isolated from a directed evolution campaign starting 
from a phenotypic ‘neighbour’ of the starting point of the R-trajectory. The results presented 
demonstrate that the new evolutionary trajectory (the S-trajectory) followed a different 
adaptive pathway to a distinct fitness peak; the final variant of this trajectory has lost the 
requirement of a closed loop conformation that was specifically enriched in the old trajectory, 
and has stabilized a new substrate binding mode. While the final variant of this trajectory is not 
as catalytically efficient as the final variant of the R-trajectory, it represents a different solution 
to the evolutionary problem with which it was faced. This speaks to the importance of historical 
contingency in adaptive evolution, and the pervasive nature of epistasis in the enhancement of 
traits; a single polymorphism forced evolution to take a new route. Further, the reduced 
tolerance of ‘swapping’ mutations from one trajectory’s genetic background to the other is an 
example of mutational entrenchment, in which a mutation becomes increasingly deleterious to 
reverse to its ancestral state along an evolutionary pathway. This effect is more profound in the 
substitution of Arg254Ser in the R-trajectory background, where Arg254 had served as the hub 
in an intricate intramolecular bonding network.   
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In Chapter 4 of this thesis, enzyme immobilization was investigated as a method of broadening 
the scope of biocatalyst application. Immobilization on a solid support can improve the lifespan 
of enzymes, and can enhance their resistance to organic solvents. Making use of commercially 
available and specifically designed charged hydrogels, a supercharged arPTE variant was 
successfully ionically immobilized. This ionic immobilization technique bypassed the need for 
harsh reaction conditions typically required for covalent immobilization, allowed for rapid 
adsorption and desorption of enzyme, thus ensuring the recyclability of the solid support, and 
resulted in catalytically active hydrogel-enzyme constructs. We successfully demonstrated the 
enhanced longevity of the immobilized enzyme, its significant resistance to organic solvents 
(including methanol, which is highly polar), and its application in the kinetic resolution of a 
chiral organophosphate in flow. Further, the super-cationic arPTE variant could be purified in 
a single step, greatly enhancing its appeal in large scale industrial processes, where efficient 
production of catalysts is vital for cost-effective methodologies.  
Taken as a whole, the work presented in this thesis represents both fundamental research into 
the design of efficient biocatalysts through the exploitation of nature’s preferred method, 
evolution, and the production of next-generation biocatalysts that take advantage of novel 
materials to maximise the applicability of enzymes in synthesis, medicine, and industry. 
Continued work in these fields aims to build a future in which we can identify a desired 
reaction, rapidly produce a designer biocatalyst, and incorporate it into a functional biomaterial 
for maximum efficiency.   
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Introduction
The conformational dynamism of proteins is well estab-
lished. Polypeptide chains are inherently flexible and
undergo conformational change in solution at a variety
of time scales. On the shortest of these timescales (fs–ps),
bonds vibrate and side chains rotate. On longer time
scales (ns–ms), macroscale motions can take place; loops
‘open’ and ‘close’, and domains can twist relative to each
other or move on hinge-like regions. One important
question in modern protein science asks how these con-
formations affect the function of the enzyme. The
continued improvement in available biophysical techni-
ques, including X-ray crystallography and NMR, in com-
bination with advances in computational protein simula-
tions, has allowed deeper analysis of protein motions. For
example, the role of protein dynamics in substrate bind-
ing and product release is well studied [1–4], and
cascades of conformational change are now known to
underpin numerous biological functions [5]. There
remains some controversy around the role of conforma-
tional dynamics in the catalytic step of enzymes; some
works have proposed a role for conformational dynamics
in the chemical step [6], while others suggest that experi-
mental models have not yet conclusively demonstrated
this link [7].
Given that protein structural dynamics clearly play impor-
tant roles in several aspects of protein function, it is
reasonable to assume that they must have evolved, or
become optimized through selective pressure. Thus, one
of the biggest questions relating to protein structural
dynamics regards the role of molecular evolution, and
how/if pathways for conformational change can be
altered. During the evolution of new enzyme function,
an enzyme active site must reorganize and adapt to a new
substrate and/or new chemical reaction. It is generally,
and reasonably, assumed that the adaptation of an
enzyme to catalyze a new chemical reaction predomi-
nantly involves modification of the active site via muta-
tion to better stabilize the transition state. However, the
composition of active sites among homologous enzymes is
often very similar, despite markedly different catalytic
specificities [8], and laboratory (directed) evolution rou-
tinely demonstrates that remote mutations somehow
have drastic effects on enzyme turnover rates or substrate
preference [9–11]. These observations — in addition to
our established understanding of allosteric communica-
tion between remote sites [12] — imply an important role
for second/third/outer shell residues in modulating
enzyme function, perhaps via control of protein structural
dynamics/conformational sampling. The difficulty in
studying the evolution of any trait, but especially struc-
tural dynamics, when relying on comparison between
different extant proteins, is that we are comparing already
highly evolved (and complex) states. To understand how
something can change or evolve, it is much more infor-
mative to study the evolutionary process directly.
5 Equal author contribution.
Available online at www.sciencedirect.com
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Laboratory directed evolution and ancestral
protein reconstruction
Laboratory directed evolution [Figure 1a] has been
extensively used in an engineering context to produce
many different proteins with a variety of improved func-
tions, such as increased or novel catalytic activity [13],
increased thermostability [14], and enhanced spectral
properties [15]. However, directed evolution also pro-
vides great advantages over the study of natural homologs
when it comes to the study of evolutionary processes.
First, we focus on the evolution of (often) a single gene/
protein of interest, rather than proteins that evolved in
concert with the whole organism, which can involve
complicated inter-gene epistatic relationships. Second,
the high throughput screening of randomly generated
mutants of a particular gene can result in the rapid
enhancement of a desired phenotype over far fewer
generations than is typical in natural systems, because
directed evolution experiments allow for tight control of
selection pressure, while natural evolutionary processes
typically must balance several requirements to maximise
the reproductive success of the organism. This results in
significantly less neutral sequence variation, which can
confound functional analysis. Finally, perhaps the most
important advantage of laboratory evolution is that it
allows for the study of as many intermediates along an
evolutionary trajectory as desired, which can provide
novel insights that cannot be gleaned through comparison
of extant enzymes where only one current state can be
assessed.
Ancestral protein reconstruction [Figure 1b] also seeks to
remedy the shortcomings of studying extant proteins in
isolation. Through the alignment of related sequences
and the calculation of phylogenetic relationships between
those sequences, points of diversification, or nodes,
representing the predicted ancestors of extant proteins
can be identified and probable sequences for these ances-
tral states inferred. This allows for the expression and
characterization of these ancestral proteins that represent
evolutionary intermediates, which can facilitate the study
of evolutionary divergence [16].
Directed evolution and ancestral protein reconstruction
have been instrumental in revealing fundamentally
important molecular processes that underlie many protein
functions. For example, our understanding of catalytic
promiscuity has been substantially broadened through
studying the evolution of substrate preference [17,18];
we have gained insights into the complex relationships
between thermostability and activity observed during the
acquisition and optimization of new function [19,20];
and the constraints of epistasis on evolutionary trajecto-
ries can be more readily analysed thanks to the accessi-
bility of evolutionary intermediates [21]. Most recently,
attention has shifted to the study of how structural
dynamics of proteins can change throughout an evolu-
tionary trajectory, which has been facilitated by develop-
ments in computational structural biology and biophysical
techniques.
Biophysical and computational analysis of
protein structural dynamics
Studying the evolution of protein structural dynamics
would not be possible without the use of computational
and biophysical methodologies that allow structural
dynamics to be dissected in different protein variants.
To provide some context to the subsequent discussion of
recent discoveries related to structural dynamics through
evolutionary studies, we must first provide a brief over-
view of some the key experimental approaches to the
study of structural dynamics.
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(a) The workflow of laboratory directed evolution involves the generation of a library of mutants of the gene of interest, and a screening or
selection process to iteratively enhance a desired phenotype. (b) Ancestral protein reconstruction requires that the phylogenetic relationships
between extant proteins are established, allowing ancestral sequences to be inferred and constructed.
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Often, a single technique is not sufficient to characterize
structural dynamics on the wide range of timescales of
interest in biological systems, and understanding the
evolution of protein structural dynamics requires integra-
tive structural biology [22]. X-ray crystallography is the
most commonly used tool and is valuable because pro-
teins often remain active in the crystalline state, which
has similar solvent content (30–80%) to the crowded
environment of cells [23]. Advances in modelling anhar-
monic disorder using time-averaged ensemble refinement
[24] and multi-conformer models [25] have proven to be
particularly useful as they can allow less common
(‘hidden’) conformational sub-states that exist among
the billions of molecules in a crystal lattice to be modelled
and studied. Likewise, the hunt for minor conformational
sub-states has reignited interest in room temperature X-
ray diffraction, which can eliminate the structural bias
introduced by crystal cryo-cooling, which may ‘freeze-
out’ higher energy sub-states [26,27]. Advances in NMR
have also allowed detailed study of protein dynamics.
Although often lacking the resolution of X-ray crystallog-
raphy, NMR can characterize transient, low occupancy
conformational sub-states, and the exchange kinetics
between sub-states, with timescales ranging from pico-
second-to-seconds [28]. While frequently limited to the
study of small proteins, isotope labelling can extend the
scope of NMR methods to study structural dynamics of
larger proteins [29] and the synergistic use of NMR with
X-ray crystallography can provide an integrated picture of
protein dynamics [30]. Finally, computational simulations
are now probing dynamic processes on increasing time-
scales [31] with improved accuracy and sampling [32]. As
with NMR, combining computational simulations of
molecular dynamics with empirically derived X-ray struc-
tures can provide a more detailed analysis of the confor-
mational sampling of amino acid sidechains and loop
regions that often have functional relevance [33]. Alto-
gether, the numerous biophysical and computational
techniques we now have at our disposal have given us
the ability to better dissect the molecular and dynamic
changes that occur through laboratory directed evolution
and ancestral protein reconstruction, providing unique
insight into the evolution of these complex traits.
Studying the evolution of protein dynamics
through laboratory directed evolution and
ancestral protein reconstruction
The application of laboratory directed evolution to bac-
terial phosphotriesterase (PTE), which had previously
been shown to undergo functionally important conforma-
tional fluctuations that could be modulated by mutations
[34], has resulted in several insights into the mechanisms
of protein evolution, particularly with regards to dynamics
[Figure 2]. Tokuriki et al. exploited the promiscuous
activity of PTE for arylester hydrolysis, and carried out
a 22 generation directed evolution experiment towards
arylesterase (AE) activity, followed by a 12 generation
‘reversal’, starting from the optimized arylesterase and
selecting for native PTE activity [35,36,37]. Over the
course of the forward evolution, AE activity increased
approximately 40 000-fold, and PTE activity dropped
40 000-fold. The reverse trajectory resulted in a 20 000-
fold increase in PTE activity. There were two particularly
notable characteristics of this evolutionary process: a
minority of the mutations were located in the active site,
despite the vast changes in activity, and the change in
activity was noticeably gradual and smooth. Mutational
analysis revealed that mutations were highly epistatic,
with many of the remote mutations interacting with and
modulating the effects of the active site mutations. The
ability to capture every intermediate allowed us to extend
beyond a simple description of mutation-activity-struc-
ture and probe what happened to the conformational
landscape at each step. X-ray crystallographic data and
molecular dynamics simulations of several intermediates
revealed a pattern of shifting dynamics throughout the
trajectory; large-scale motions of a ‘lid’ loop were mini-
mized through intramolecular hydrogen bonding net-
works, and the productive conformation of a key active
site residue was enriched by a radiating pattern of sub-
stitutions [36]. The midpoint of this trajectory, R6 (and
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The directed evolution of PTE. Ensemble refinement of PTE variants
R0, R6, R22 and rev6 illustrate the changing conformational dynamism
of key loops (loop 5 and loop 7). R0 (PTE activity) possesses a large
degree of flexibility in loop 7, while R22 (AE activity) possesses very
little flexibility in loop 7 but enhanced dynamism in loop 5. Bifunctional
‘midpoint’ variants R6 and rev6 retain conformational flexibility in both
regions, facilitating catalysis of both activities. The central panel
illustrates the stabilization of the productive conformation of Arg254
(the first substitution fixed in the forward trajectory), by later round
substitutions.
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Rev6 in the reverse direction), was of particular interest as
it demonstrated high efficiency with both substrates.
Crystallographic ensemble refinement of these midpoints
revealed that their bifunctionality was due to their abili-
ties to sample conformational sub-states similar to both
the original and ‘evolved’ variants. These intermediates,
only accessible through directed evolution experiments,
highlight the role of conformational flexibility in the
exploitation and evolution of promiscuous activities.
This pattern is observed in a different context in work by
Biel et al. [38] in which room-temperature X-ray crys-
tallography was utilized to investigate the conformational
heterogeneity of ubiquitin variants developed by Zhang
et al. [39] a ‘core’ variant was designed for increased
binding to deubiquitinase USP7, and then subjected to
‘affinity maturation’, in which random surface mutations
were incorporated and variants screened for enhanced
binding. Structures of the ‘core’ and ‘affinity matured’
variants were solved through room temperature X-ray
crystallography, allowing for the elucidation of conforma-
tional heterogeneity in several regions, including the
hinge-like b1b2 loop. The ‘core’ variant possessed sub-
stantial heterogeneity in this region, while the ‘affinity
matured’ variant did not, due to the introduction of
stabilizing interactions. The enrichment of a less-popu-
lated conformation through the rational selection of the
‘core’ mutations was proposed to disrupt the natural
dynamics of protein, allowing the variant to sample a
broader ensemble of sub-states (some of which are valu-
able in binding the target USP7), while the ‘affinity
maturation’ froze out non-functional states, resulting in
a stabilized, specialized variant. This mirrors the flexible,
bifunctional PTE variants, which were then stabilized
and specialized for their target activities.
Ancestral protein reconstruction experiments can also
provide insights into the role of dynamics in protein
evolution, by filling in some of the previously mysterious
gaps in the evolutionary trajectories to modern-day pro-
teins. For example, the ancestral reconstruction of GFP-
like proteins by Kim et al. led to the identification of long-
range conformational effects responsible for the evolution
of green-to-red photoconversion. Interestingly, these
effects were not accompanied by any substantial rear-
rangement of the active site residues or changes to the
protein backbone, highlighting the importance of confor-
mational sampling of amino acid sidechains and the
contribution of outer-shell regions [40]. The evolution
of mesophilic enzymes as organisms adapted to a cooler
Earth has also been investigated through ancestral protein
reconstruction. Nguyen et al. reconstructed ancient ade-
nylate kinases (Adk), and determined their thermostabil-
ities and activities, which showed no evidence of activity/
stability trade-offs occurring [19]. One ancestral Adk
variant possessed substantial activity at low temperatures
as well as significant thermostability. This is in-keeping
with the hypothesis that the magnitude of thermal
motions is not directly important to catalytic activity,
and is in fact often ‘frozen out’ (a rigid, thermostable
ancestor was still capable of enhancing reaction rates at
low temperatures), but rather conformational flexibility
may serve as a useful starting point for the evolution of
novel functions.
Perhaps the clearest example of the value for ancestral
protein reconstruction in the study of protein dynamics is
in deciphering the role of protein dynamics in the emer-
gence of promiscuous activities and the evolution of
specialist enzymes. In a study of amino acid binding
proteins (AABP), Clifton et al. constructed proteins that
represented common ancestors of modern AABP subfa-
milies [17]. One of these ancestors, AncQR, displayed
strong L-arginine binding, and promiscuous L-glutamine
binding. X-ray structures of AncQR in complex with
either L-arginine or L-glutamine revealed conformational
differences in the active sites of the two complexes, with
residual electron density in the AncQR-Arg complex
matching the conformation of the AncQR-Glu complex
active site. This suggested that the adventitious sampling
of alternative states by AncQR underlies its promiscuous
binding of glutamine, with evolution then stabilizing the
minor Gln-specific to produce contemporary Gln-specific
proteins. Recent work by Risso et al. studied ancestrally
reconstructed b-lactamases, revealing that incorporation
of a rationally selected mutation into highly dynamic
ancestral b-lactamases allowed promiscuous Kemp elim-
inase activity, while the same substitution in more rigid,
modern b-lactamases had no effect [41]. These studies
again highlight the importance of conformation freedom
in the acquisition of new functions; with numerous acces-
sible conformations increasing the likelihood of sampling
a productive conformation.
These studies reinforce the case for a model in which
functional promiscuity and conformational dynamism are
interlinked as proposed by Tawfik and Tokuriki [42],
where rare, adventitious, conformational sub-states can
become productive in changing environmental conditions
and be selected for and enriched through evolution. This
model, and the generally positive view of protein dynam-
ics that exists in the literature, has limitations, however.
High conformational freedom is associated with low
structural stability, a factor already identified as being
valuable in evolution. Indeed, work by Dellus-Gur
et al. highlights that while conformational flexibility can
be important in the evolution of new function, the intro-
duction of too much dynamism or disorder can impede
evolution through negative epistasis [43]. Similar obser-
vations were made in the study of PTE and ubiquitin,
where it was clear that one of the strongest selective
pressures was to minimize conformational dynamics, that
is, rather than making the enzyme more dynamic, the
optimization of the new activity involved stabilization of
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productive states. Thus, we should be cautious in terms of
how we view the role of dynamics in molecular evolution
and protein function — while they can make proteins
more evolvable by allowing sampling of unique states,
and some motions may be important for activity, proteins
in general evolve to maximise the sampling of productive
states (by minimizing the sampling of non-productive
ones) [Figure 3].
The study of designed enzymes
The design of efficient enzymes continues to challenge
our understanding of protein structure and function.
Progress in protein design [44] has remarkably allowed
the de novo creation of enzymes, although their substrate
turnover (kcat) values are typically several orders of mag-
nitude lower than natural enzymes [45]. The low initial
activity of some designed enzymes has meant that
directed evolution is frequently, and successfully, used
to optimize their activity. These studies are particularly
important because they can reveal how designs are
improved, and how subtle changes can turn a poor
enzyme into an efficient one.
The low initial activity of designed enzymes can in
some cases be traced to excessive active-site dynamics,
which allows catalytic residues to depart from their
designed conformations and sample non-productive
states [Figure 4]. For example, in a designed Diels–
Alderase [46], computational simulations suggested that
the catalytic tyrosine was sampling a non-productive
conformation due to a hydrogen bond with the backbone
of a nearby alanine. This prompted the substitution of the
alanine with a bulkier asparagine, which shifted the
tyrosine to the designed conformation, and improved
substrate activation [46]. In the designed KE07 Kemp
eliminase [47], the catalytic glutamate was adversely
affected by a salt bridge to a nearby lysine. Directed
evolution corrected this mistake by introducing a new
salt-bridge which shifted the lysine away from the cata-
lytic glutamate, thereby increasing the basicity of the
glutamate [48]. A similar correction was identified in the
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Evolution minimizes unnecessary motions. (a) An ensemble of conformations results in catalytic promiscuity. Selection for one of these activities
results in the enrichment of the relevant conformation, and the ‘freezing out’ of non-productive motions. (b) Multiple conformations of a key
residue are minimized through acquisition of substitutions that stabilize the productive conformation.
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optimization of the KE70 Kemp eliminase [49] in which
directed evolution removed a deleterious interaction
between the histidine-aspartic acid catalytic dyad and a
nearby arginine.
As observed in ancestral reconstruction, active site flexi-
bility has allowed alternative substrate binding modes,
which has promoted evolution [Figure 4]. In the designed
HG3 Kemp eliminase, the substrate was flipped by 90
relative to the design [50]. Although this new conforma-
tion precluded productive interaction with the designed
hydrogen bond donor, directed evolution introduced a
new hydrogen bond donor via a lysine to glutamine
substitution [51]. This new catalytic residue could only
function in the alternative substrate binding mode, and
was critical to the 230-fold increase in kcat. Flexibility
was also essential in the optimization of the RA95 retro-
aldolase [52], where loop mobility was exploited to create
a new substrate binding pocket with a new catalytic lysine
[53,54]. In subsequent rounds of directed evolution, the
original substrate binding pocket was re-created, however
the new catalytic lysine was retained [55].
These examples of directed evolution of designed pro-
teins mirror previous examples from directed evolution
of natural proteins, illustrating that enzyme evolvability
and dynamism are linked [56], but also that excessive
dynamics result in low efficiency that must be rescued
through the gradual elimination of non-productive
sampling.
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Overview of the role of flexibility in the optimization of designed enzymes. Left three panels: examples of designed enzymes where amino acid
side-chain flexibility enabled catalytic residues to sample non-productive states. Targeted mutagenesis/laboratory directed evolution (LDE)
selected productive states. Right top panel: an alternative substrate binding mode was selected and optimized in the laboratory directed
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Engineering protein dynamics
As our understanding of protein dynamics, and how
protein dynamics can evolve to enhance protein function,
develops, it is natural for attention to turn to the rational
design and implementation of protein structural dynam-
ics in an engineering setting. There are two related
aspects of structural dynamics that could potentially be
engineered: the conformational sampling of different
states, and the rates at which different regions move.
There have already been many studies in which rational
changes to protein structure been shown to alter protein
dynamics [36,57,58]. However, we are still some way
from being able to routinely improve protein function by
manipulating conformational sampling, although there
have been some notable achievements towards this ambi-
tious goal [59,60,61,62], and most protein design
approaches do incorporate optimization of second-shell
residues to constrain sampling of the active site [63–65].
Arguably, the biggest obstacle is the need to first under-
stand the conformational landscape of the protein to be
engineered, which is itself a major task. Interestingly, in
the case of enzyme loop dynamics, it has been demon-
strated that changes to the millisecond-timescale dynam-
ics of various loop-motions in some b-lactamase variants
did not have a substantial effect on activity, highlighting
the dependence of enzymatic turnover rates on the rate
limiting step, which is often chemical [58,66]. Similar
results have been obtained from computational studies of
adenylate kinase [67], suggesting that the rates of certain
motions are unlikely to affect turnover rates until they
approach the rate of the rate-limiting step, which in many
cases is the chemical (bond making/breaking) step.
Conclusions
The examples described in this short review exemplify
the profound insight that we can gain into complex
processes, such as the evolution of protein dynamics,
through observing intermediates in evolutionary pro-
cesses. In this sense, laboratory evolution and ancestral
protein reconstruction have been instrumental in build-
ing our understanding of how protein dynamics impact
function, and how the conformational sampling of differ-
ent sub-states can be subtly manipulated, in particular by
remote outer-shell mutations, which have for a long time
remained relatively mysterious. Two clear trends emerge
from these studies: first, it is clear that structural dyna-
mism allows sampling of states that could confer new
activities; second, beyond this initial capture of promis-
cuous activity, evolution seems to progressively eliminate
non-productive sampling, in a sense reducing non-essen-
tial dynamics.
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